Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | | | | 15 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ABHD5 CL E G H | 51099 | 21396 | ORPHA:98907 | Neutral lipid storage disease with ichthyosis | | | | 90 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ADAR CL E G H | 103 | 225 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 116 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ADAR CL E G H | 103 | 225 | OMIM:615010 | Aicardi-Goutieres syndrome 6 | | | | 116 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | | | | 26 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AHI1 CL E G H | 54806 | 21575 | ORPHA:475 | Joubert syndrome | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AHI1 CL E G H | 54806 | 21575 | ORPHA:220493 | Joubert syndrome with ocular defect | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AIFM1 CL E G H | 9131 | 8768 | OMIM:300816 | Combined oxidative phosphorylation deficiency 6 | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AIFM1 CL E G H | 9131 | 8768 | ORPHA:238329 | Severe X-linked mitochondrial encephalomyopathy | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AKT3 CL E G H | 10000 | 393 | OMIM:615937 | Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome 2 | | | | 19 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AKT3 CL E G H | 10000 | 393 | ORPHA:83473 | Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome | | | | 19 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ALDH4A1 CL E G H | 8659 | 406 | ORPHA:79101 | Hyperprolinemia type 2 | HP:0040281 - Very frequent | | | 74 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ALDH5A1 CL E G H | 7915 | 408 | OMIM:271980 | Succinic semialdehyde dehydrogenase deficiency | | | | 108 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ALDH7A1 CL E G H | 501 | 877 | OMIM:266100 | Epilepsy, pyridoxine-dependent | | | | 227 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ALG13 CL E G H | 79868 | 30881 | OMIM:300884 | Epileptic encephalopathy, early infantile, 36 | | | | 96 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AMER1 CL E G H | 139285 | 26837 | OMIM:300373 | Osteopathia striata with cranial sclerosis | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AP1S2 CL E G H | 8905 | 560 | ORPHA:85335 | Fried syndrome | | | | 13 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | AP1S2 CL E G H | 8905 | 560 | OMIM:304340 | Pettigrew syndrome | | | | 13 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARHGAP31 CL E G H | 57514 | 29216 | ORPHA:974 | Adams-Oliver syndrome | | | | 147 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARL13B CL E G H | 200894 | 25419 | ORPHA:475 | Joubert syndrome | | | | 62 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARL3 CL E G H | 403 | 694 | ORPHA:475 | Joubert syndrome | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARMC9 CL E G H | 80210 | 20730 | ORPHA:475 | Joubert syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARSA CL E G H | 410 | 713 | OMIM:250100 | Metachromatic leukodystrophy | | | | 253 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 253 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 253 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | | | | 253 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARSB CL E G H | 411 | 714 | OMIM:253200 | Mucopolysaccharidosis, type VI | | | | 120 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ASPA CL E G H | 443 | 756 | OMIM:271900 | Canavan disease | | | | 48 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 239 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ATP6 CL E G H | 4508 | 7414 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ATPAF2 CL E G H | 91647 | 18802 | OMIM:604273 | Mitochondrial complex V (atp synthase) deficiency, nuclear type 1 | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B3GALNT2 CL E G H | 148789 | 28596 | ORPHA:588 | Muscle-eye-brain disease | | | | 43 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B3GALNT2 CL E G H | 148789 | 28596 | OMIM:615181 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11 | | | | 43 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B3GALNT2 CL E G H | 148789 | 28596 | ORPHA:899 | Walker-Warburg syndrome | | | | 43 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B3GALT6 CL E G H | 126792 | 17978 | ORPHA:536467 | B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome | | | | 38 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B3GAT3 CL E G H | 26229 | 923 | OMIM:245600 | Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B3GLCT CL E G H | 145173 | 20207 | ORPHA:709 | Peters plus syndrome | | | | 36 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B3GLCT CL E G H | 145173 | 20207 | OMIM:261540 | Peters-Plus syndrome | | | | 36 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B4GALT1 CL E G H | 2683 | 924 | ORPHA:79332 | B4GALT1-CDG | | | | 85 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B4GAT1 CL E G H | 11041 | 15685 | OMIM:615287 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13 | | | | 17 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B4GAT1 CL E G H | 11041 | 15685 | ORPHA:899 | Walker-Warburg syndrome | | | | 17 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B9D1 CL E G H | 27077 | 24123 | ORPHA:475 | Joubert syndrome | | | | 28 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B9D1 CL E G H | 27077 | 24123 | ORPHA:564 | Meckel syndrome | | | | 28 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B9D2 CL E G H | 80776 | 28636 | ORPHA:475 | Joubert syndrome | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | B9D2 CL E G H | 80776 | 28636 | ORPHA:564 | Meckel syndrome | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BCAT2 CL E G H | 587 | 977 | OMIM:618850 | HYPERVALINEMIA AND HYPERLEUCINE-ISOLEUCINEMIA; HVLI | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BICRA CL E G H | 29998 | 4332 | OMIM:619325 | COFFIN-SIRIS SYNDROME 12; CSS12 | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BLTP1 CL E G H | 84162 | 26953 | OMIM:617822 | Alkuraya-Kucinskas syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | | | | 14 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:1340 | Cardiofaciocutaneous syndrome | | | | 276 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BRAF CL E G H | 673 | 1097 | OMIM:115150 | Cardiofaciocutaneous syndrome 1 | | | | 276 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:54595 | Craniopharyngioma | | | | 276 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BRCA1 CL E G H | 672 | 1100 | ORPHA:84 | Fanconi anemia | | | | 5769 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BRCA2 CL E G H | 675 | 1101 | ORPHA:84 | Fanconi anemia | | | | 7642 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BRIP1 CL E G H | 83990 | 20473 | ORPHA:84 | Fanconi anemia | | | | 1086 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BTNL2 CL E G H | 56244 | 1142 | ORPHA:797 | Sarcoidosis | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | BUB1B CL E G H | 701 | 1149 | OMIM:257300 | Mosaic variegated aneuploidy syndrome 1 | | | | 76 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 449 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CBY1 CL E G H | 25776 | 1307 | ORPHA:475 | Joubert syndrome | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CC2D2A CL E G H | 57545 | 29253 | OMIM:619111 | COACH SYNDROME 2; COACH2 | | | | 247 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CC2D2A CL E G H | 57545 | 29253 | ORPHA:1454 | Joubert syndrome with hepatic defect | | | | 247 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CC2D2A CL E G H | 57545 | 29253 | ORPHA:2318 | Joubert syndrome with oculorenal defect | | | | 247 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CC2D2A CL E G H | 57545 | 29253 | ORPHA:564 | Meckel syndrome | | | | 247 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CC2D2A CL E G H | 57545 | 29253 | OMIM:612284 | Meckel syndrome, type 6 | | | | 247 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCDC103 CL E G H | 388389 | 32700 | ORPHA:244 | Primary ciliary dyskinesia | | | | 36 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCDC22 CL E G H | 28952 | 28909 | ORPHA:7 | 3C syndrome | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCDC39 CL E G H | 339829 | 25244 | ORPHA:244 | Primary ciliary dyskinesia | | | | 126 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCDC40 CL E G H | 55036 | 26090 | ORPHA:244 | Primary ciliary dyskinesia | | | | 182 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCDC65 CL E G H | 85478 | 29937 | ORPHA:244 | Primary ciliary dyskinesia | | | | 23 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCDC88C CL E G H | 440193 | 19967 | OMIM:236600 | Hydrocephalus, nonsyndromic, autosomal recessive 1 | | | | 54 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCL2 CL E G H | 6347 | 10618 | OMIM:182940 | Neural tube defects, susceptibility to | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCND2 CL E G H | 894 | 1583 | OMIM:615938 | Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome 3 | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCND2 CL E G H | 894 | 1583 | ORPHA:83473 | Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CCNO CL E G H | 10309 | 18576 | ORPHA:244 | Primary ciliary dyskinesia | | | | 23 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CD59 CL E G H | 966 | 1689 | OMIM:612300 | Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CDC40 CL E G H | 51362 | 17350 | OMIM:619302 | PONTOCEREBELLAR HYPOPLASIA, TYPE 15; PCH15 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CDC42BPB CL E G H | 9578 | 1738 | OMIM:619841 | | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CDCA7 CL E G H | 83879 | 14628 | ORPHA:2268 | ICF syndrome | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:93925 | Alobar holoprosencephaly | | | | 200 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:93924 | Lobar holoprosencephaly | | | | 200 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 200 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 200 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEBPE CL E G H | 1053 | 1836 | OMIM:245480 | Specific granule deficiency | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CENPF CL E G H | 1063 | 1857 | OMIM:243605 | Stromme syndrome | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP104 CL E G H | 9731 | 24866 | ORPHA:475 | Joubert syndrome | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP120 CL E G H | 153241 | 26690 | ORPHA:475 | Joubert syndrome | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP120 CL E G H | 153241 | 26690 | ORPHA:220493 | Joubert syndrome with ocular defect | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP290 CL E G H | 80184 | 29021 | ORPHA:2318 | Joubert syndrome with oculorenal defect | | | | 342 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP290 CL E G H | 80184 | 29021 | ORPHA:564 | Meckel syndrome | | | | 342 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP290 CL E G H | 80184 | 29021 | OMIM:611134 | Meckel syndrome, type 4 | | | | 342 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP41 CL E G H | 95681 | 12370 | ORPHA:475 | Joubert syndrome | | | | 90 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP41 CL E G H | 95681 | 12370 | ORPHA:220493 | Joubert syndrome with ocular defect | | | | 90 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CEP83 CL E G H | 51134 | 17966 | OMIM:615862 | Nephronophthisis 18 | | | | 10 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CFAP221 CL E G H | 200373 | 33720 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CFAP298 CL E G H | 56683 | 1301 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CFAP300 CL E G H | 85016 | 28188 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CFAP43 CL E G H | 80217 | 26684 | OMIM:236690 | Hydrocephalus, normal pressure, 1 | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CHST3 CL E G H | 9469 | 1971 | OMIM:245600 | Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects | | | | 165 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CILK1 CL E G H | 22858 | 21219 | OMIM:612651 | ENDOCRINE-CEREBROOSTEODYSPLASIA | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CLCN3 CL E G H | 1182 | 2021 | OMIM:619512 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES; NEDHYBA | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CLCN7 CL E G H | 1186 | 2025 | ORPHA:53 | Albers-Schönberg osteopetrosis | | | | 102 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CLCN7 CL E G H | 1186 | 2025 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 102 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CLIC2 CL E G H | 1193 | 2063 | OMIM:300886 | MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32 | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CLPB CL E G H | 81570 | 30664 | OMIM:616271 | 3-Methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia | | | | 38 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COG6 CL E G H | 57511 | 18621 | OMIM:614576 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L | | | | 71 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COL18A1 CL E G H | 80781 | 2195 | ORPHA:1571 | Knobloch syndrome | | | | 177 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COL4A1 CL E G H | 1282 | 2202 | OMIM:175780 | Brain small vessel disease 1 with or without ocular anomalies | | | | 193 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COL4A1 CL E G H | 1282 | 2202 | ORPHA:899 | Walker-Warburg syndrome | | | | 193 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COPB2 CL E G H | 9276 | 2232 | OMIM:617800 | Microcephaly 19, primary, autosomal recessive | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COQ8A CL E G H | 56997 | 16812 | ORPHA:139485 | Autosomal recessive ataxia due to ubiquinone deficiency | | | | 136 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX10 CL E G H | 1352 | 2260 | OMIM:619046 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN3 | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX14 CL E G H | 84987 | 28216 | OMIM:619053 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10; MC4DN10 | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX15 CL E G H | 1355 | 2263 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 104 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX20 CL E G H | 116228 | 26970 | OMIM:619054 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11; MC4DN11 | | | | 25 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX4I1 CL E G H | 1327 | 2265 | OMIM:619060 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX6B1 CL E G H | 1340 | 2280 | OMIM:619051 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7 | | | | 10 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX7B CL E G H | 1349 | 2291 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX7B CL E G H | 1349 | 2291 | OMIM:309801 | Microphthalmia, syndromic 7 | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | COX8A CL E G H | 1351 | 2294 | OMIM:619059 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15 | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CPLANE1 CL E G H | 65250 | 25801 | ORPHA:475 | Joubert syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CPLX1 CL E G H | 10815 | 2309 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | | | | 101 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CRB2 CL E G H | 286204 | 18688 | OMIM:219730 | Ventriculomegaly with cystic kidney disease | | | | 12 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CRPPA CL E G H | 729920 | 37276 | OMIM:614643 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CRPPA CL E G H | 729920 | 37276 | ORPHA:899 | Walker-Warburg syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CSF1R CL E G H | 1436 | 2433 | OMIM:618476 | Brain abnormalities, neurodegeneration, and dysosteosclerosis | | | | 149 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CSPP1 CL E G H | 79848 | 26193 | ORPHA:475 | Joubert syndrome | | | | 57 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CSPP1 CL E G H | 79848 | 26193 | ORPHA:564 | Meckel syndrome | | | | 57 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CTBP1 CL E G H | 1487 | 2494 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:54595 | Craniopharyngioma | | | | 88 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CYP26C1 CL E G H | 340665 | 20577 | ORPHA:398189 | Focal facial dermal dysplasia type IV | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | CYTB CL E G H | 4519 | 7427 | ORPHA:137675 | Histiocytoid cardiomyopathy | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DAG1 CL E G H | 1605 | 2666 | OMIM:616538 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9 | | | | 108 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DAG1 CL E G H | 1605 | 2666 | ORPHA:899 | Walker-Warburg syndrome | | | | 108 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DARS2 CL E G H | 55157 | 25538 | ORPHA:137898 | Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DCC CL E G H | 1630 | 2701 | OMIM:617542 | GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 2; HGPPS2 | | | | 36 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DDC CL E G H | 1644 | 2719 | OMIM:608643 | Aromatic L-amino acid decarboxylase deficiency | | | | 43 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DENND5A CL E G H | 23258 | 19344 | OMIM:617281 | Epileptic encephalopathy, early infantile, 49 | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DHCR24 CL E G H | 1718 | 2859 | ORPHA:35107 | Desmosterolosis | | | | 72 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DHCR24 CL E G H | 1718 | 2859 | OMIM:602398 | DESMOSTEROLOSIS | | | | 72 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DHCR7 CL E G H | 1717 | 2860 | OMIM:270400 | Smith-Lemli-Opitz syndrome | | | | 159 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93925 | Alobar holoprosencephaly | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93924 | Lobar holoprosencephaly | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DLAT CL E G H | 1737 | 2896 | ORPHA:79244 | Pyruvate dehydrogenase E2 deficiency | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93925 | Alobar holoprosencephaly | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93924 | Lobar holoprosencephaly | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DLL1 CL E G H | 28514 | 2908 | OMIM:618709 | NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DLL4 CL E G H | 54567 | 2910 | ORPHA:974 | Adams-Oliver syndrome | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAAF1 CL E G H | 123872 | 30539 | ORPHA:244 | Primary ciliary dyskinesia | | | | 116 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAAF11 CL E G H | 23639 | 16725 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAAF2 CL E G H | 55172 | 20188 | ORPHA:244 | Primary ciliary dyskinesia | | | | 78 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAAF3 CL E G H | 352909 | 30492 | ORPHA:244 | Primary ciliary dyskinesia | | | | 63 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAAF4 CL E G H | 161582 | 21493 | ORPHA:244 | Primary ciliary dyskinesia | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAAF5 CL E G H | 54919 | 26013 | ORPHA:244 | Primary ciliary dyskinesia | | | | 62 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAAF6 CL E G H | 139212 | 28570 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAH1 CL E G H | 25981 | 2940 | ORPHA:244 | Primary ciliary dyskinesia | | | | 21 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAH11 CL E G H | 8701 | 2942 | ORPHA:244 | Primary ciliary dyskinesia | | | | 542 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAH5 CL E G H | 1767 | 2950 | ORPHA:244 | Primary ciliary dyskinesia | | | | 527 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAH9 CL E G H | 1770 | 2953 | ORPHA:244 | Primary ciliary dyskinesia | | | | 18 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAI1 CL E G H | 27019 | 2954 | OMIM:244400 | Ciliary dyskinesia, primary, 1 | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAI1 CL E G H | 27019 | 2954 | ORPHA:244 | Primary ciliary dyskinesia | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAI2 CL E G H | 64446 | 18744 | ORPHA:244 | Primary ciliary dyskinesia | | | | 104 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAJB13 CL E G H | 374407 | 30718 | ORPHA:244 | Primary ciliary dyskinesia | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNAL1 CL E G H | 83544 | 23247 | ORPHA:244 | Primary ciliary dyskinesia | | | | 167 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNM1L CL E G H | 10059 | 2973 | OMIM:614388 | Encephalopathy due to defective mitochondrial and peroxisomal fission 1 | | | | 94 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNMT1 CL E G H | 1786 | 2976 | ORPHA:314404 | Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome | HP:0040283 - Occasional | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DNMT3B CL E G H | 1789 | 2979 | ORPHA:2268 | ICF syndrome | | | | 79 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DOCK6 CL E G H | 57572 | 19189 | ORPHA:974 | Adams-Oliver syndrome | | | | 18 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DPH1 CL E G H | 1801 | 3003 | ORPHA:459061 | Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | DRC1 CL E G H | 92749 | 24245 | ORPHA:244 | Primary ciliary dyskinesia | | | | 44 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | EBP CL E G H | 10682 | 3133 | ORPHA:401973 | MEND syndrome | | | | 51 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | EBP CL E G H | 10682 | 3133 | OMIM:300960 | Mend syndrome | | | | 51 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ECHS1 CL E G H | 1892 | 3151 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ECHS1 CL E G H | 1892 | 3151 | OMIM:616277 | Mitochondrial short-chain enoyl-coa hydratase 1 deficiency | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | EGR2 CL E G H | 1959 | 3239 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | | | | 58 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | EML1 CL E G H | 2009 | 3330 | OMIM:600348 | Band heterotopia | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | EOGT CL E G H | 285203 | 28526 | ORPHA:974 | Adams-Oliver syndrome | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | EPHB4 CL E G H | 2050 | 3395 | ORPHA:137667 | Capillary malformation-arteriovenous malformation | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 106 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 54 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:84 | Fanconi anemia | | | | 158 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 158 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 83 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:133540 | Cockayne syndrome, type B | | | | 199 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:278800 | De Sanctis-Cacchione syndrome | | | | 199 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERCC8 CL E G H | 1161 | 3439 | OMIM:216400 | Cockayne syndrome A | | | | 55 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ERF CL E G H | 2077 | 3444 | ORPHA:207 | Crouzon disease | | | | 12 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ESCO2 CL E G H | 157570 | 27230 | OMIM:268300 | Roberts syndrome | | | | 92 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FAM111A CL E G H | 63901 | 24725 | OMIM:602361 | Gracile bone dysplasia | | | | 8 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FAM20C CL E G H | 56975 | 22140 | OMIM:259775 | Raine syndrome | | | | 35 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCA CL E G H | 2175 | 3582 | ORPHA:84 | Fanconi anemia | | | | 340 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCB CL E G H | 2187 | 3583 | ORPHA:84 | Fanconi anemia | | | | 58 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCB CL E G H | 2187 | 3583 | OMIM:300514 | FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB | | | | 58 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCB CL E G H | 2187 | 3583 | OMIM:314390 | VACTERL association, X-linked | | | | 58 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCB CL E G H | 2187 | 3583 | ORPHA:3412 | VACTERL with hydrocephalus | | | | 58 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCC CL E G H | 2176 | 3584 | ORPHA:84 | Fanconi anemia | | | | 410 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCD2 CL E G H | 2177 | 3585 | ORPHA:84 | Fanconi anemia | | | | 147 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCD2 CL E G H | 2177 | 3585 | OMIM:227646 | Fanconi anemia, complementation group D2 | | | | 147 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCE CL E G H | 2178 | 3586 | ORPHA:84 | Fanconi anemia | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCF CL E G H | 2188 | 3587 | ORPHA:84 | Fanconi anemia | | | | 87 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCG CL E G H | 2189 | 3588 | ORPHA:84 | Fanconi anemia | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCI CL E G H | 55215 | 25568 | ORPHA:84 | Fanconi anemia | | | | 157 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCL CL E G H | 55120 | 20748 | ORPHA:84 | Fanconi anemia | | | | 53 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCL CL E G H | 55120 | 20748 | OMIM:614083 | Fanconi anemia, complementation group L | | | | 53 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FANCM CL E G H | 57697 | 23168 | ORPHA:84 | Fanconi anemia | | | | 107 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FARS2 CL E G H | 10667 | 21062 | OMIM:614946 | Combined oxidative phosphorylation deficiency 14 | | | | 36 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FBN1 CL E G H | 2200 | 3603 | OMIM:616914 | Marfan lipodystrophy syndrome | | | | 1361 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FBN1 CL E G H | 2200 | 3603 | ORPHA:2462 | Shprintzen-Goldberg syndrome | | | | 1361 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93925 | Alobar holoprosencephaly | | | | 17 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93924 | Lobar holoprosencephaly | | | | 17 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 17 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 17 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR1 CL E G H | 2260 | 3688 | OMIM:613001 | Encephalocraniocutaneous lipomatosis | | | | 172 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:93924 | Lobar holoprosencephaly | | | | 172 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR1 CL E G H | 2260 | 3688 | OMIM:101600 | Pfeiffer syndrome | | | | 172 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 172 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR2 CL E G H | 2263 | 3689 | OMIM:207410 | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR2 CL E G H | 2263 | 3689 | OMIM:101200 | Apert syndrome | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:87 | Apert syndrome | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR2 CL E G H | 2263 | 3689 | OMIM:123790 | Beare-Stevenson cutis gyrata syndrome | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:207 | Crouzon disease | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:1555 | Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR2 CL E G H | 2263 | 3689 | OMIM:101600 | Pfeiffer syndrome | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:93259 | Pfeiffer syndrome type 2 | | | | 175 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | OMIM:100800 | ACHONDROPLASIA | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:15 | Achondroplasia | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | OMIM:616482 | Achondroplasia, severe, with developmental delay and acanthosis nigricans | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | OMIM:612247 | Crouzon syndrome with acanthosis nigricans | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:93262 | Crouzon syndrome-acanthosis nigricans syndrome | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:53271 | Muenke syndrome | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:1860 | Thanatophoric dysplasia type 1 | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:93274 | Thanatophoric dysplasia type 2 | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFR3 CL E G H | 2261 | 3690 | OMIM:187600 | Thanatophoric dysplasia, type I | | | | 145 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FGFRL1 CL E G H | 53834 | 3693 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FIG4 CL E G H | 9896 | 16873 | ORPHA:3472 | Yunis-Varon syndrome | | | | 111 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKRP CL E G H | 79147 | 17997 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 157 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKRP CL E G H | 79147 | 17997 | ORPHA:588 | Muscle-eye-brain disease | | | | 157 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKRP CL E G H | 79147 | 17997 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 157 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKRP CL E G H | 79147 | 17997 | OMIM:613153 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5 | | | | 157 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKRP CL E G H | 79147 | 17997 | ORPHA:899 | Walker-Warburg syndrome | | | | 157 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKTN CL E G H | 2218 | 3622 | ORPHA:272 | Congenital muscular dystrophy, Fukuyama type | | | | 184 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKTN CL E G H | 2218 | 3622 | ORPHA:588 | Muscle-eye-brain disease | | | | 184 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKTN CL E G H | 2218 | 3622 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 184 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKTN CL E G H | 2218 | 3622 | OMIM:253800 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4 | | | | 184 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FKTN CL E G H | 2218 | 3622 | ORPHA:899 | Walker-Warburg syndrome | | | | 184 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FLNA CL E G H | 2316 | 3754 | ORPHA:90652 | Otopalatodigital syndrome type 2 | | | | 493 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FLNA CL E G H | 2316 | 3754 | OMIM:304120 | Otopalatodigital syndrome, type II | | | | 493 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FLVCR2 CL E G H | 55640 | 20105 | OMIM:225790 | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome | | | | 47 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93925 | Alobar holoprosencephaly | | | | 48 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93924 | Lobar holoprosencephaly | | | | 48 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 48 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 48 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FOXJ1 CL E G H | 2302 | 3816 | OMIM:618699 | CILIARY DYSKINESIA, PRIMARY, 43; CILD43 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FOXJ1 CL E G H | 2302 | 3816 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:2609 | Isolated complex I deficiency | | | | 61 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 61 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FRAS1 CL E G H | 80144 | 19185 | OMIM:219000 | Fraser syndrome | | | | 353 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FTL CL E G H | 2512 | 3999 | ORPHA:157846 | Neuroferritinopathy | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FTO CL E G H | 79068 | 24678 | OMIM:612938 | Growth retardation, developmental delay, coarse facies, and earlydeath | | | | 70 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FUZ CL E G H | 80199 | 26219 | ORPHA:1136 | Arnold-Chiari malformation type II | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | FUZ CL E G H | 80199 | 26219 | OMIM:182940 | Neural tube defects, susceptibility to | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GALC CL E G H | 2581 | 4115 | ORPHA:206448 | Adult Krabbe disease | | | | 160 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GALC CL E G H | 2581 | 4115 | ORPHA:206436 | Infantile Krabbe disease | | | | 160 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GALC CL E G H | 2581 | 4115 | OMIM:245200 | Krabbe disease | | | | 160 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GALC CL E G H | 2581 | 4115 | ORPHA:206443 | Late-infantile/juvenile Krabbe disease | | | | 160 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93925 | Alobar holoprosencephaly | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93924 | Lobar holoprosencephaly | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GAS2L2 CL E G H | 246176 | 24846 | ORPHA:244 | Primary ciliary dyskinesia | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GAS8 CL E G H | 2622 | 4166 | ORPHA:244 | Primary ciliary dyskinesia | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:231005 | Gaucher disease, type IIIC | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GBE1 CL E G H | 2632 | 4180 | OMIM:263570 | Polyglucosan body neuropathy, adult form | | | | 86 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GCDH CL E G H | 2639 | 4189 | OMIM:231670 | Glutaric acidemia I | | | | 115 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GCDH CL E G H | 2639 | 4189 | ORPHA:25 | Glutaryl-CoA dehydrogenase deficiency | | | | 115 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GCH1 CL E G H | 2643 | 4193 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 86 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GFAP CL E G H | 2670 | 4235 | OMIM:203450 | Alexander disease | | | | 188 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GFAP CL E G H | 2670 | 4235 | ORPHA:363717 | Alexander disease type I | | | | 188 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GFM1 CL E G H | 85476 | 13780 | OMIM:609060 | Combined oxidative phosphorylation deficiency 1 | | | | 85 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GFM2 CL E G H | 84340 | 29682 | ORPHA:565624 | Combined oxidative phosphorylation defect type 39 | | | | 43 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GFM2 CL E G H | 84340 | 29682 | OMIM:618397 | Combined oxidative phosphorylation deficiency 39 | | | | 43 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93925 | Alobar holoprosencephaly | | | | 173 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLI2 CL E G H | 2736 | 4318 | OMIM:610829 | Holoprosencephaly 9 | | | | 173 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93924 | Lobar holoprosencephaly | | | | 173 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 173 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 173 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLI3 CL E G H | 2737 | 4319 | OMIM:175700 | Greig cephalopolysyndactyly syndrome | | | | 270 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLI3 CL E G H | 2737 | 4319 | ORPHA:380 | Greig cephalopolysyndactyly syndrome | | | | 270 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GMPPB CL E G H | 29925 | 22932 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GMPPB CL E G H | 29925 | 22932 | ORPHA:588 | Muscle-eye-brain disease | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GNAQ CL E G H | 2776 | 4390 | ORPHA:3205 | Sturge-Weber syndrome | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 8 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GPC3 CL E G H | 2719 | 4451 | OMIM:312870 | Simpson-golabi-behmel syndrome, type 1 | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GPC4 CL E G H | 2239 | 4452 | OMIM:312870 | Simpson-golabi-behmel syndrome, type 1 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GPSM2 CL E G H | 29899 | 29501 | OMIM:604213 | CHUDLEY-MCCULLOUGH SYNDROME; CMCS | | | | 74 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GRIK2 CL E G H | 2898 | 4580 | OMIM:619580 | NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | GUSB CL E G H | 2990 | 4696 | OMIM:253220 | Mucopolysaccharidosis, type VII | | | | 54 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | H4C9 CL E G H | 8294 | 4793 | OMIM:619951 | | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HBA1 CL E G H | 3039 | 4823 | ORPHA:163596 | Hb Bart's hydrops fetalis | | | | 200 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HBA2 CL E G H | 3040 | 4824 | ORPHA:163596 | Hb Bart's hydrops fetalis | | | | 88 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HCCS CL E G H | 3052 | 4837 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HCCS CL E G H | 3052 | 4837 | OMIM:309801 | Microphthalmia, syndromic 7 | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HDAC6 CL E G H | 10013 | 14064 | OMIM:300863 | Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HDAC6 CL E G H | 10013 | 14064 | ORPHA:163966 | X-linked dominant chondrodysplasia, Chassaing-Lacombe type | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HELLS CL E G H | 3070 | 4861 | ORPHA:2268 | ICF syndrome | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HERC1 CL E G H | 8925 | 4867 | OMIM:617011 | Macrocephaly, dysmorphic facies, and psychomotor retardation | | | | 16 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HERC1 CL E G H | 8925 | 4867 | ORPHA:457359 | Megalencephaly-severe kyphoscoliosis-overgrowth syndrome | | | | 16 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:797 | Sarcoidosis | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HNRNPU CL E G H | 3192 | 5048 | ORPHA:238769 | 1q44 microdeletion syndrome | | | | 39 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HPDL CL E G H | 84842 | 28242 | OMIM:619026 | NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HRAS CL E G H | 3265 | 5173 | OMIM:218040 | Costello syndrome | | | | 113 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HSD17B10 CL E G H | 3028 | 4800 | ORPHA:391428 | HSD10 disease, infantile type | | | | 19 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HSPG2 CL E G H | 3339 | 5273 | ORPHA:1865 | Dyssegmental dysplasia, Silverman-Handmaker type | | | | 345 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HTRA2 CL E G H | 27429 | 14348 | OMIM:617248 | 3-methylglutaconic aciduria, type VIII | | | | 39 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HYDIN CL E G H | 54768 | 19368 | ORPHA:244 | Primary ciliary dyskinesia | | | | 21 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HYLS1 CL E G H | 219844 | 26558 | ORPHA:2189 | Hydrolethalus | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HYLS1 CL E G H | 219844 | 26558 | OMIM:236680 | Hydrolethalus syndrome 1 | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | HYLS1 CL E G H | 219844 | 26558 | ORPHA:475 | Joubert syndrome | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IARS2 CL E G H | 55699 | 29685 | OMIM:616007 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia | | | | 25 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IDS CL E G H | 3423 | 5389 | OMIM:309900 | Mucopolysaccharidosis, type II | | | | 86 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IDUA CL E G H | 3425 | 5391 | ORPHA:93473 | Hurler syndrome | | | | 115 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IDUA CL E G H | 3425 | 5391 | OMIM:607014 | Hurler syndrome | | | | 115 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IFIH1 CL E G H | 64135 | 18873 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 28 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IFNG CL E G H | 3458 | 5438 | ORPHA:805 | Tuberous sclerosis complex | | | | 23 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IFT172 CL E G H | 26160 | 30391 | OMIM:615630 | Short-Rib thoracic dysplasia 10 with or without polydactyly | | | | 48 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IFT43 CL E G H | 112752 | 29669 | OMIM:617866 | SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18 | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IGHG2 CL E G H | 3501 | 5526 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IGKC CL E G H | 3514 | 5716 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IMPDH2 CL E G H | 3615 | 6053 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | INPP5E CL E G H | 56623 | 21474 | ORPHA:475 | Joubert syndrome | | | | 111 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | INPP5E CL E G H | 56623 | 21474 | ORPHA:1454 | Joubert syndrome with hepatic defect | | | | 111 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | INPP5E CL E G H | 56623 | 21474 | ORPHA:220493 | Joubert syndrome with ocular defect | | | | 111 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | IRF4 CL E G H | 3662 | 6119 | ORPHA:3452 | Whipple disease | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KANSL1 CL E G H | 284058 | 24565 | ORPHA:363958 | 17q21.31 microdeletion syndrome | | | | 283 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KANSL1 CL E G H | 284058 | 24565 | ORPHA:363965 | Koolen-De Vries syndrome due to a point mutation | | | | 283 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KARS1 CL E G H | 3735 | 6215 | OMIM:619147 | LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KATNIP CL E G H | 23247 | 29068 | ORPHA:475 | Joubert syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KDM4B CL E G H | 23030 | 29136 | OMIM:619320 | INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65; MRD65 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KDM6A CL E G H | 7403 | 12637 | ORPHA:2322 | Kabuki syndrome | | | | 53 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KDM6A CL E G H | 7403 | 12637 | OMIM:147920 | Kabuki syndrome 1 | | | | 53 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KIAA0586 CL E G H | 9786 | 19960 | ORPHA:475 | Joubert syndrome | | | | 24 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KIAA0586 CL E G H | 9786 | 19960 | OMIM:616546 | Short-Rib thoracic dysplasia 14 with polydactyly | | | | 24 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KIF1A CL E G H | 547 | 888 | ORPHA:2836 | PEHO syndrome | | | | 276 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KIF7 CL E G H | 374654 | 30497 | ORPHA:2189 | Hydrolethalus | | | | 167 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KIF7 CL E G H | 374654 | 30497 | OMIM:614120 | Hydrolethalus syndrome 2 | | | | 167 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KMT2D CL E G H | 8085 | 7133 | ORPHA:2322 | Kabuki syndrome | | | | 660 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KMT2D CL E G H | 8085 | 7133 | OMIM:147920 | Kabuki syndrome 1 | | | | 660 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | KRAS CL E G H | 3845 | 6407 | ORPHA:1340 | Cardiofaciocutaneous syndrome | | | | 196 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | L1CAM CL E G H | 3897 | 6470 | OMIM:304100 | Corpus callosum, partial agenesis of, X-linked | | | | 134 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | L1CAM CL E G H | 3897 | 6470 | OMIM:307000 | Hydrocephalus due to congenital stenosis of aqueduct of sylvius | | | | 134 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | L1CAM CL E G H | 3897 | 6470 | ORPHA:2182 | Hydrocephalus with stenosis of the aqueduct of Sylvius | | | | 134 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | L1CAM CL E G H | 3897 | 6470 | OMIM:303350 | MASA syndrome | | | | 134 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LAMB1 CL E G H | 3912 | 6486 | ORPHA:352682 | Cobblestone lissencephaly without muscular or ocular involvement | | | | 71 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LAMB1 CL E G H | 3912 | 6486 | OMIM:615191 | Lissencephaly 5 | | | | 71 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LARGE1 CL E G H | 9215 | 6511 | ORPHA:588 | Muscle-eye-brain disease | | | | 136 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LARGE1 CL E G H | 9215 | 6511 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 136 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LARGE1 CL E G H | 9215 | 6511 | OMIM:613154 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6 | | | | 136 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LARGE1 CL E G H | 9215 | 6511 | ORPHA:899 | Walker-Warburg syndrome | | | | 136 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LETM1 CL E G H | 3954 | 6556 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LIG3 CL E G H | 3980 | 6600 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LIG4 CL E G H | 3981 | 6601 | ORPHA:235 | Dubowitz syndrome | | | | 88 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LIPT1 CL E G H | 51601 | 29569 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 21 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LMBR1 CL E G H | 64327 | 13243 | ORPHA:2378 | Laurin-Sandrow syndrome | | | | 106 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LMNB1 CL E G H | 4001 | 6637 | ORPHA:99027 | Adult-onset autosomal dominant leukodystrophy | | | | 44 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LMNB1 CL E G H | 4001 | 6637 | OMIM:619179 | MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT; MCPH26 | | | | 44 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LMNB2 CL E G H | 84823 | 6638 | OMIM:619180 | MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT; MCPH27 | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 8 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LRPPRC CL E G H | 10128 | 15714 | ORPHA:70472 | Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | | | | 191 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LRPPRC CL E G H | 10128 | 15714 | OMIM:220111 | Leigh syndrome, french Canadian type | | | | 191 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LRRC56 CL E G H | 115399 | 25430 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LSM11 CL E G H | 134353 | 30860 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LSM11 CL E G H | 134353 | 30860 | OMIM:619486 | AICARDI-GOUTIERES SYNDROME 8; AGS8 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LYRM4 CL E G H | 57128 | 21365 | OMIM:615595 | Combined oxidative phosphorylation deficiency 19 | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | LYRM7 CL E G H | 90624 | 28072 | OMIM:615838 | Mitochondrial complex III deficiency, nuclear type 8 | | | | 10 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MAD2L2 CL E G H | 10459 | 6764 | ORPHA:84 | Fanconi anemia | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MADD CL E G H | 8567 | 6766 | OMIM:619004 | DEEAH SYNDROME; DEEAH | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MADD CL E G H | 8567 | 6766 | OMIM:619005 | NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA; NEDDISH | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MAF CL E G H | 4094 | 6776 | ORPHA:1272 | Aymé-Gripp syndrome | | | | 21 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309282 | Alpha-mannosidosis, infantile form | | | | 136 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MAP2K1 CL E G H | 5604 | 6840 | ORPHA:1340 | Cardiofaciocutaneous syndrome | | | | 134 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MAP2K2 CL E G H | 5605 | 6842 | ORPHA:1340 | Cardiofaciocutaneous syndrome | | | | 178 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:85284 | BRESEK syndrome | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MC1R CL E G H | 4157 | 6929 | ORPHA:626 | Large congenital melanocytic nevus | | | | 124 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MCIDAS CL E G H | 345643 | 40050 | ORPHA:244 | Primary ciliary dyskinesia | | | | 13 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MDH2 CL E G H | 4191 | 6971 | OMIM:617339 | Epileptic encephalopathy, early infantile, 51 | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MECP2 CL E G H | 4204 | 6990 | ORPHA:778 | Rett syndrome | | | | 950 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MED12 CL E G H | 9968 | 11957 | ORPHA:93932 | FG syndrome type 1 | | | | 228 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MED12 CL E G H | 9968 | 11957 | OMIM:305450 | Opitz-Kaveggia syndrome | | | | 228 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MFN2 CL E G H | 9927 | 16877 | ORPHA:99947 | Autosomal dominant Charcot-Marie-Tooth disease type 2A2 | | | | 203 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MICU1 CL E G H | 10367 | 1530 | OMIM:615673 | Myopathy with extrapyramidal signs | | | | 14 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MKS1 CL E G H | 54903 | 7121 | ORPHA:475 | Joubert syndrome | | | | 127 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MKS1 CL E G H | 54903 | 7121 | ORPHA:220493 | Joubert syndrome with ocular defect | | | | 127 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MKS1 CL E G H | 54903 | 7121 | ORPHA:564 | Meckel syndrome | | | | 127 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MKS1 CL E G H | 54903 | 7121 | OMIM:249000 | Meckel syndrome 1 | | | | 127 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | | | | 101 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MMACHC CL E G H | 25974 | 24525 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | | | | 101 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MPDZ CL E G H | 8777 | 7208 | OMIM:615219 | Hydrocephalus, congenital, 2, with or without brain or eye anomalies | | | | 29 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | | | | 56 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MPZ CL E G H | 4359 | 7225 | ORPHA:101082 | Charcot-Marie-Tooth disease type 1B | | | | 134 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MPZ CL E G H | 4359 | 7225 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | | | | 134 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MRPS34 CL E G H | 65993 | 16618 | OMIM:617664 | Combined oxidative phosphorylation deficiency 32 | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MTFMT CL E G H | 123263 | 29666 | OMIM:614947 | Combined oxidative phosphorylation deficiency 15 | | | | 29 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MTFMT CL E G H | 123263 | 29666 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 29 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MTHFR CL E G H | 4524 | 7436 | ORPHA:395 | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | | | | 183 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MTM1 CL E G H | 4534 | 7448 | OMIM:310400 | Myopathy, centronuclear, X-linked | | | | 185 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MTRR CL E G H | 4552 | 7473 | ORPHA:2169 | Methylcobalamin deficiency type cblE | | | | 88 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MUSK CL E G H | 4593 | 7525 | OMIM:208150 | Fetal akinesia deformation sequence | | | | 72 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | MYT1L CL E G H | 23040 | 7623 | OMIM:616521 | Mental retardation, autosomal dominant 39 | | | | 13 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NARS2 CL E G H | 79731 | 26274 | OMIM:616239 | Combined oxidative phosphorylation deficiency 24 | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NAXE CL E G H | 128240 | 18453 | OMIM:617186 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND2 CL E G H | 4536 | 7456 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND2 CL E G H | 4536 | 7456 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND3 CL E G H | 4537 | 7458 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND3 CL E G H | 4537 | 7458 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND4 CL E G H | 4538 | 7459 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND5 CL E G H | 4540 | 7461 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ND6 CL E G H | 4541 | 7462 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA1 CL E G H | 4694 | 7683 | ORPHA:2609 | Isolated complex I deficiency | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA10 CL E G H | 4705 | 7684 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 91 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA11 CL E G H | 126328 | 20371 | ORPHA:2609 | Isolated complex I deficiency | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA12 CL E G H | 55967 | 23987 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA12 CL E G H | 55967 | 23987 | OMIM:618244 | Mitochondrial complex I deficiency, nuclear type 23 | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA13 CL E G H | 51079 | 17194 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA2 CL E G H | 4695 | 7685 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 19 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA4 CL E G H | 4697 | 7687 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA6 CL E G H | 4700 | 7690 | ORPHA:2609 | Isolated complex I deficiency | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA6 CL E G H | 4700 | 7690 | OMIM:618253 | Mitochondrial complex I deficiency, nuclear type 33 | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA8 CL E G H | 4702 | 7692 | OMIM:619272 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37; MC1DN37 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFA9 CL E G H | 4704 | 7693 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF1 CL E G H | 51103 | 18828 | ORPHA:2609 | Isolated complex I deficiency | | | | 40 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:2609 | Isolated complex I deficiency | | | | 26 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 26 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:2609 | Isolated complex I deficiency | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF3 CL E G H | 25915 | 29918 | OMIM:618240 | Mitochondrial complex I deficiency, nuclear type 18 | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF4 CL E G H | 29078 | 21034 | ORPHA:2609 | Isolated complex I deficiency | | | | 50 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:2609 | Isolated complex I deficiency | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF5 CL E G H | 79133 | 15899 | OMIM:618238 | Mitochondrial complex I deficiency, nuclear type 16 | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 39 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFAF8 CL E G H | 284184 | 33551 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFB10 CL E G H | 4716 | 7696 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2609 | Isolated complex I deficiency | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFB11 CL E G H | 54539 | 20372 | OMIM:309801 | Microphthalmia, syndromic 7 | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFB3 CL E G H | 4709 | 7698 | ORPHA:2609 | Isolated complex I deficiency | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFB8 CL E G H | 4714 | 7703 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFB8 CL E G H | 4714 | 7703 | OMIM:618252 | Mitochondrial complex I deficiency, nuclear type 32 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFB9 CL E G H | 4715 | 7704 | ORPHA:2609 | Isolated complex I deficiency | | | | 16 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:2609 | Isolated complex I deficiency | | | | 81 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 81 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:2609 | Isolated complex I deficiency | | | | 65 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 65 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 65 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:2609 | Isolated complex I deficiency | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS3 CL E G H | 4722 | 7710 | OMIM:618230 | Mitochondrial complex I deficiency, nuclear type 8 | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:2609 | Isolated complex I deficiency | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS6 CL E G H | 4726 | 7713 | ORPHA:2609 | Isolated complex I deficiency | | | | 21 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:2609 | Isolated complex I deficiency | | | | 38 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 38 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:2609 | Isolated complex I deficiency | | | | 42 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 42 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:2609 | Isolated complex I deficiency | | | | 74 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 74 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFV1 CL E G H | 4723 | 7716 | OMIM:618225 | Mitochondrial complex I deficiency, nuclear type 4 | | | | 74 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:2609 | Isolated complex I deficiency | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NEK10 CL E G H | 152110 | 18592 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | | | | 43 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NF1 CL E G H | 4763 | 7765 | ORPHA:363700 | Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion | | | | 1952 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NF1 CL E G H | 4763 | 7765 | OMIM:162200 | Neurofibromatosis, type I | | | | 1952 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NF2 CL E G H | 4771 | 7773 | ORPHA:637 | Neurofibromatosis type 2 | | | | 220 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NFIX CL E G H | 4784 | 7788 | OMIM:602535 | Marshall-Smith syndrome | | | | 40 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NGLY1 CL E G H | 55768 | 17646 | OMIM:615273 | Congenital disorder of deglycosylation | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NKX3-2 CL E G H | 579 | 951 | OMIM:613330 | Spondylo-Megaepiphyseal-Metaphyseal dysplasia | | | | 10 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NME8 CL E G H | 51314 | 16473 | ORPHA:244 | Primary ciliary dyskinesia | | | | 50 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:93925 | Alobar holoprosencephaly | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:93924 | Lobar holoprosencephaly | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NOTCH1 CL E G H | 4851 | 7881 | ORPHA:974 | Adams-Oliver syndrome | | | | 452 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NOTCH2 CL E G H | 4853 | 7882 | ORPHA:955 | Hajdu-Cheney syndrome | | | | 138 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NOTCH2 CL E G H | 4853 | 7882 | OMIM:102500 | Hajdu-Cheney syndrome | | | | 138 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:603472 | NEURONAL INTRANUCLEAR INCLUSION DISEASE | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:619473 | OCULOPHARYNGODISTAL MYOPATHY 3; OPDM3 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NPHP1 CL E G H | 4867 | 7905 | ORPHA:220497 | Joubert syndrome with renal defect | | | | 85 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NR4A2 CL E G H | 4929 | 7981 | OMIM:619911 | | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NR4A2 CL E G H | 4929 | 7981 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NRAS CL E G H | 4893 | 7989 | ORPHA:626 | Large congenital melanocytic nevus | | | | 102 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NRAS CL E G H | 4893 | 7989 | OMIM:249400 | Neurocutaneous melanosis, somatic | | | | 102 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NRCAM CL E G H | 4897 | 7994 | OMIM:619833 | | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NSD2 CL E G H | 7468 | 12766 | OMIM:194190 | Wolf-Hirschhorn syndrome | | | | 118 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NSUN2 CL E G H | 54888 | 25994 | ORPHA:235 | Dubowitz syndrome | | | | 84 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NUBPL CL E G H | 80224 | 20278 | ORPHA:2609 | Isolated complex I deficiency | | | | 89 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | NUBPL CL E G H | 80224 | 20278 | OMIM:618242 | Mitochondrial complex I deficiency, nuclear type 21 | | | | 89 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | | | | 23 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ODAD1 CL E G H | 93233 | 26560 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ODAD2 CL E G H | 55130 | 25583 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ODAD3 CL E G H | 115948 | 28303 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ODAD4 CL E G H | 83538 | 25280 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | OFD1 CL E G H | 8481 | 2567 | OMIM:311200 | Orofaciodigital syndrome I | | | | 201 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | OFD1 CL E G H | 8481 | 2567 | ORPHA:244 | Primary ciliary dyskinesia | | | | 201 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | OGDH CL E G H | 4967 | 8124 | ORPHA:31 | Oxoglutaric aciduria | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | OSTM1 CL E G H | 28962 | 21652 | OMIM:259720 | Osteopetrosis, autosomal recessive 5 | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | P4HB CL E G H | 5034 | 8548 | ORPHA:2050 | Cole-Carpenter syndrome | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | P4HB CL E G H | 5034 | 8548 | OMIM:112240 | Cole-Carpenter syndrome 1 | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PAK2 CL E G H | 5062 | 8591 | ORPHA:1571 | Knobloch syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PAK3 CL E G H | 5063 | 8592 | OMIM:300558 | MENTAL RETARDATION, X-LINKED 30; MRX30 | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PALB2 CL E G H | 79728 | 26144 | ORPHA:84 | Fanconi anemia | | | | 1349 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 88 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 88 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PDHA1 CL E G H | 5160 | 8806 | OMIM:312170 | Pyruvate dehydrogenase e1-alpha deficiency | | | | 88 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PDHX CL E G H | 8050 | 21350 | ORPHA:255182 | Pyruvate dehydrogenase E3-binding protein deficiency | | | | 98 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PET100 CL E G H | 100131801 | 40038 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PET100 CL E G H | 100131801 | 40038 | OMIM:619055 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12 | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PEX19 CL E G H | 5824 | 9713 | OMIM:614886 | Peroxisome biogenesis disorder 12A (Zellweger) | | | | 62 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PEX7 CL E G H | 5191 | 8860 | OMIM:266500 | Refsum disease | | | | 72 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PHYH CL E G H | 5264 | 8940 | OMIM:266500 | Refsum disease | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIBF1 CL E G H | 10464 | 23352 | ORPHA:475 | Joubert syndrome | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIEZO2 CL E G H | 63895 | 26270 | ORPHA:2461 | Marden-Walker syndrome | | | | 77 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIGU CL E G H | 128869 | 15791 | OMIM:618590 | NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIGV CL E G H | 55650 | 26031 | OMIM:239300 | Hyperphosphatasia with mental retardation | | | | 57 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:60040 | Megalencephaly-capillary malformation-polymicrogyria syndrome | | | | 162 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIK3CA CL E G H | 5290 | 8975 | OMIM:602501 | Megalencephaly-Capillary malformation-polymicrogyria syndrome | | | | 162 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIK3R2 CL E G H | 5296 | 8980 | OMIM:603387 | Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome | | | | 12 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PIK3R2 CL E G H | 5296 | 8980 | ORPHA:83473 | Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome | | | | 12 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PLCH1 CL E G H | 23007 | 29185 | OMIM:619895 | | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PLCH1 CL E G H | 23007 | 29185 | ORPHA:93925 | Alobar holoprosencephaly | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PLG CL E G H | 5340 | 9071 | ORPHA:722 | Hypoplasminogenemia | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PLG CL E G H | 5340 | 9071 | OMIM:217090 | Plasminogen deficiency, type iligneous conjunctivitis, included | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PMP22 CL E G H | 5376 | 9118 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | | | | 79 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PNPO CL E G H | 55163 | 30260 | ORPHA:79096 | Pyridoxal phosphate-responsive seizures | | | | 92 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PNPO CL E G H | 55163 | 30260 | OMIM:610090 | Pyridoxamine 5-prime-phosphate oxidase deficiency | | | | 92 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PNPT1 CL E G H | 87178 | 23166 | ORPHA:319514 | Combined oxidative phosphorylation defect type 13 | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PNPT1 CL E G H | 87178 | 23166 | OMIM:614932 | Combined oxidative phosphorylation deficiency 13 | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POLG CL E G H | 5428 | 9179 | ORPHA:254886 | Autosomal recessive progressive external ophthalmoplegia | HP:0040283 - Occasional | | | 464 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POLG CL E G H | 5428 | 9179 | OMIM:203700 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | | | | 464 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POLG CL E G H | 5428 | 9179 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 464 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POLG CL E G H | 5428 | 9179 | OMIM:258450 | Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive | | | | 464 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POLR3A CL E G H | 11128 | 30074 | OMIM:264090 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMGNT1 CL E G H | 55624 | 19139 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 180 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMGNT1 CL E G H | 55624 | 19139 | ORPHA:588 | Muscle-eye-brain disease | | | | 180 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMGNT1 CL E G H | 55624 | 19139 | OMIM:253280 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3 | | | | 180 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMGNT1 CL E G H | 55624 | 19139 | ORPHA:899 | Walker-Warburg syndrome | | | | 180 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMGNT2 CL E G H | 84892 | 25902 | OMIM:614830 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8 | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMGNT2 CL E G H | 84892 | 25902 | ORPHA:899 | Walker-Warburg syndrome | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMK CL E G H | 84197 | 26267 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 18 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMK CL E G H | 84197 | 26267 | OMIM:615249 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12 | | | | 18 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMK CL E G H | 84197 | 26267 | ORPHA:899 | Walker-Warburg syndrome | | | | 18 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT1 CL E G H | 10585 | 9202 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 213 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT1 CL E G H | 10585 | 9202 | ORPHA:588 | Muscle-eye-brain disease | | | | 213 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT1 CL E G H | 10585 | 9202 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 213 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT1 CL E G H | 10585 | 9202 | OMIM:613155 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1 | | | | 213 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT1 CL E G H | 10585 | 9202 | ORPHA:899 | Walker-Warburg syndrome | | | | 213 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT2 CL E G H | 29954 | 19743 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | | | | 221 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT2 CL E G H | 29954 | 19743 | ORPHA:588 | Muscle-eye-brain disease | | | | 221 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT2 CL E G H | 29954 | 19743 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 221 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT2 CL E G H | 29954 | 19743 | OMIM:613150 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2 | | | | 221 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POMT2 CL E G H | 29954 | 19743 | ORPHA:899 | Walker-Warburg syndrome | | | | 221 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POR CL E G H | 5447 | 9208 | OMIM:207410 | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis | | | | 76 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | | | | 76 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PORCN CL E G H | 64840 | 17652 | OMIM:305600 | Focal dermal hypoplasia | | | | 20 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PPP1CB CL E G H | 5500 | 9282 | ORPHA:2701 | Noonan syndrome-like disorder with loose anagen hair | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PPP1R21 CL E G H | 129285 | 30595 | OMIM:619383 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES; NEDHFBA | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PPP2R1A CL E G H | 5518 | 9302 | OMIM:616362 | Mental retardation, autosomal dominant 36 | | | | 13 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PPP2R1A CL E G H | 5518 | 9302 | ORPHA:457284 | Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome | | | | 13 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PPP2R5D CL E G H | 5528 | 9312 | OMIM:616355 | Mental retardation, autosomal dominant 35 | | | | 10 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PRDX1 CL E G H | 5052 | 9352 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 58 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PRF1 CL E G H | 5551 | 9360 | OMIM:603553 | Hemophagocytic lymphohistiocytosis, familial, 2 | | | | 58 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:101800 | Acrodysostosis 1, with or without hormone resistance | | | | 134 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | 69 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PRNP CL E G H | 5621 | 9449 | ORPHA:282166 | Inherited Creutzfeldt-Jakob disease | | | | 69 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 94 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PRX CL E G H | 57716 | 13797 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | | | | 170 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:206436 | Infantile Krabbe disease | | | | 81 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PSAP CL E G H | 5660 | 9498 | OMIM:611722 | KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY | | | | 81 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 81 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 81 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | | | | 81 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93925 | Alobar holoprosencephaly | | | | 665 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH1 CL E G H | 5727 | 9585 | OMIM:109400 | Basal cell nevus syndrome | | | | 665 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:377 | Gorlin syndrome | | | | 665 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH1 CL E G H | 5727 | 9585 | OMIM:610828 | Holoprosencephaly 7 | | | | 665 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93924 | Lobar holoprosencephaly | | | | 665 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 665 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:77301 | Monosomy 9q22.3 | | | | 665 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 665 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH2 CL E G H | 8643 | 9586 | OMIM:109400 | Basal cell nevus syndrome | | | | 40 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTCH2 CL E G H | 8643 | 9586 | ORPHA:377 | Gorlin syndrome | | | | 40 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTDSS1 CL E G H | 9791 | 9587 | ORPHA:2658 | Lenz-Majewski hyperostotic dwarfism | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:65285 | Lhermitte-Duclos disease | | | | 948 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:2969 | Proteus-like syndrome | | | | 948 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | PYCR1 CL E G H | 5831 | 9721 | OMIM:612940 | Cutis laxa, autosomal recessive, type IIB | | | | 53 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RAC3 CL E G H | 5881 | 9803 | OMIM:618577 | NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RAD51 CL E G H | 5888 | 9817 | ORPHA:84 | Fanconi anemia | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RAD51 CL E G H | 5888 | 9817 | OMIM:617244 | Fanconi anemia, complementation group R | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RAD51C CL E G H | 5889 | 9820 | ORPHA:84 | Fanconi anemia | | | | 391 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RANBP2 CL E G H | 5903 | 9848 | OMIM:608033 | Encephalopathy, acute, infection-induced, susceptibility to, 3 | | | | 57 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RANBP2 CL E G H | 5903 | 9848 | ORPHA:88619 | Familial acute necrotizing encephalopathy | | | | 57 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RARS2 CL E G H | 57038 | 21406 | OMIM:611523 | Pontocerebellar hypoplasia, type 6 | | | | 93 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RASA1 CL E G H | 5921 | 9871 | ORPHA:137667 | Capillary malformation-arteriovenous malformation | | | | 88 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RBPJ CL E G H | 3516 | 5724 | ORPHA:974 | Adams-Oliver syndrome | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RECQL4 CL E G H | 9401 | 9949 | OMIM:218600 | Baller-Gerold syndrome | | | | 445 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RFWD3 CL E G H | 55159 | 25539 | ORPHA:84 | Fanconi anemia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RMND1 CL E G H | 55005 | 21176 | OMIM:614922 | Combined oxidative phosphorylation deficiency 11 | | | | 26 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNASEH2A CL E G H | 10535 | 18518 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNASEH2A CL E G H | 10535 | 18518 | OMIM:610333 | Aicardi-Goutieres syndrome 4 | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNASEH2B CL E G H | 79621 | 25671 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNASEH2B CL E G H | 79621 | 25671 | OMIM:610181 | Aicardi-Goutieres syndrome 2 | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNASEH2C CL E G H | 84153 | 24116 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNASEH2C CL E G H | 84153 | 24116 | OMIM:610329 | Aicardi-Goutieres syndrome 3 | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNF125 CL E G H | 54941 | 21150 | OMIM:616260 | Tenorio syndrome | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNU4ATAC CL E G H | 100151683 | 34016 | OMIM:210710 | Microcephalic osteodysplastic primordial dwarfism, type I | | | | 15 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RNU7-1 CL E G H | 100147744 | 34033 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ROGDI CL E G H | 79641 | 29478 | ORPHA:1946 | Amelocerebrohypohidrotic syndrome | | | | 57 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RPGR CL E G H | 6103 | 10295 | ORPHA:244 | Primary ciliary dyskinesia | | | | 200 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RPGRIP1 CL E G H | 57096 | 13436 | ORPHA:564 | Meckel syndrome | | | | 109 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RPGRIP1L CL E G H | 23322 | 29168 | ORPHA:1454 | Joubert syndrome with hepatic defect | | | | 167 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RPGRIP1L CL E G H | 23322 | 29168 | ORPHA:220497 | Joubert syndrome with renal defect | | | | 167 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RPGRIP1L CL E G H | 23322 | 29168 | ORPHA:564 | Meckel syndrome | | | | 167 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RPIA CL E G H | 22934 | 10297 | OMIM:608611 | Ribose 5-phosphate isomerase deficiency | | | | 18 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RRM2B CL E G H | 50484 | 17296 | OMIM:612075 | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) | | | | 125 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RRM2B CL E G H | 50484 | 17296 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 125 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RSPH1 CL E G H | 89765 | 12371 | ORPHA:244 | Primary ciliary dyskinesia | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RSPH3 CL E G H | 83861 | 21054 | ORPHA:244 | Primary ciliary dyskinesia | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RSPH4A CL E G H | 345895 | 21558 | ORPHA:244 | Primary ciliary dyskinesia | | | | 58 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RSPH9 CL E G H | 221421 | 21057 | ORPHA:244 | Primary ciliary dyskinesia | | | | 20 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RSPO2 CL E G H | 340419 | 28583 | ORPHA:3301 | Tetraamelia-multiple malformations syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | RXYLT1 CL E G H | 10329 | 13530 | ORPHA:899 | Walker-Warburg syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SALL1 CL E G H | 6299 | 10524 | OMIM:107480 | Townes-Brocks syndrome 1 | | | | 124 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | | | | 8 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SAMHD1 CL E G H | 25939 | 15925 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 55 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SAMHD1 CL E G H | 25939 | 15925 | OMIM:612952 | Aicardi-Goutieres syndrome 5 | | | | 55 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 1053 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SCO2 CL E G H | 9997 | 10604 | OMIM:604377 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | | | | 40 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SCO2 CL E G H | 9997 | 10604 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 40 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SDHA CL E G H | 6389 | 10680 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 304 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SEC24D CL E G H | 9871 | 10706 | ORPHA:2050 | Cole-Carpenter syndrome | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SEC24D CL E G H | 9871 | 10706 | OMIM:616294 | Cole-Carpenter syndrome 2 | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SF3B2 CL E G H | 10992 | 10769 | OMIM:164210 | Hemifacial microsomia | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SF3B4 CL E G H | 10262 | 10771 | OMIM:154400 | Acrofacial dysostosis 1, Nager type | | | | 49 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:93925 | Alobar holoprosencephaly | | | | 67 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:93924 | Lobar holoprosencephaly | | | | 67 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 67 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 67 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SHOC2 CL E G H | 8036 | 15454 | ORPHA:2701 | Noonan syndrome-like disorder with loose anagen hair | | | | 74 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SIK3 CL E G H | 23387 | 29165 | OMIM:618162 | Spondyloepimetaphyseal dysplasia, Krakow type | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93925 | Alobar holoprosencephaly | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93924 | Lobar holoprosencephaly | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SKI CL E G H | 6497 | 10896 | OMIM:182212 | Shprintzen-Goldberg craniosynostosis syndrome | | | | 150 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SKI CL E G H | 6497 | 10896 | ORPHA:2462 | Shprintzen-Goldberg syndrome | | | | 150 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC12A2 CL E G H | 6558 | 10911 | OMIM:619080 | KILQUIST SYNDROME; KILQS | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC12A6 CL E G H | 9990 | 10914 | OMIM:218000 | Agenesis of the corpus callosum with peripheral neuropathy | | | | 163 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC13A5 CL E G H | 284111 | 23089 | ORPHA:1946 | Amelocerebrohypohidrotic syndrome | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC17A5 CL E G H | 26503 | 10933 | OMIM:269920 | Infantile sialic acid storage disease | | | | 78 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC19A3 CL E G H | 80704 | 16266 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 110 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC25A19 CL E G H | 60386 | 14409 | OMIM:613710 | Thiamine metabolism dysfunction syndrome 4 (bilateral striatal degenerationand progressive polyneuropathy type) | | | | 36 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC25A24 CL E G H | 29957 | 20662 | OMIM:612289 | Fontaine progeroid syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC25A4 CL E G H | 291 | 10990 | OMIM:615418 | Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type) | | | | 68 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC25A4 CL E G H | 291 | 10990 | OMIM:617184 | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | | | | 68 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC29A3 CL E G H | 55315 | 23096 | ORPHA:168569 | H syndrome | | | | 68 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:71277 | Classic glucose transporter type 1 deficiency syndrome | | | | 255 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:606777 | Glut1 deficiency syndrome 1 | | | | 255 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:612126 | Glut1 deficiency syndrome 2 | | | | 255 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:168577 | Hereditary cryohydrocytosis with reduced stomatin | | | | 255 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:608885 | Stomatin-Deficient cryohydrocytosis with neurologic defects | | | | 255 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC39A8 CL E G H | 64116 | 20862 | ORPHA:468699 | SLC39A8-CDG | | | | 11 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLC6A3 CL E G H | 6531 | 11049 | OMIM:613135 | Parkinsonism-Dystonia, infantile, 1 | | | | 13 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SLX4 CL E G H | 84464 | 23845 | ORPHA:84 | Fanconi anemia | | | | 274 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:99966 | Atypical teratoid rhabdoid tumor | | | | 87 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SMC1A CL E G H | 8243 | 11111 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 135 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SMO CL E G H | 6608 | 11119 | OMIM:241800 | Hypothalamic hamartomascongenital hypothalamic hamartoma syndrome, included | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SMOC1 CL E G H | 64093 | 20318 | ORPHA:1106 | Microphthalmia with limb anomalies | | | | 15 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SNX10 CL E G H | 29887 | 14974 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SOX2 CL E G H | 6657 | 11195 | ORPHA:77298 | Anophthalmia/microphthalmia-esophageal atresia syndrome | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SOX9 CL E G H | 6662 | 11204 | OMIM:114290 | Campomelic dysplasia | | | | 109 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SPAG1 CL E G H | 6674 | 11212 | ORPHA:244 | Primary ciliary dyskinesia | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SPEF2 CL E G H | 79925 | 26293 | ORPHA:244 | Primary ciliary dyskinesia | | | | 15 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SPTBN1 CL E G H | 6711 | 11275 | OMIM:619475 | DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STAG2 CL E G H | 10735 | 11355 | ORPHA:93925 | Alobar holoprosencephaly | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STAG2 CL E G H | 10735 | 11355 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STAT2 CL E G H | 6773 | 11363 | OMIM:616636 | Immunodeficiency 44 | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STIL CL E G H | 6491 | 10879 | ORPHA:93925 | Alobar holoprosencephaly | | | | 99 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STIL CL E G H | 6491 | 10879 | ORPHA:93924 | Lobar holoprosencephaly | | | | 99 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STIL CL E G H | 6491 | 10879 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 99 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STIL CL E G H | 6491 | 10879 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 99 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STK36 CL E G H | 27148 | 17209 | ORPHA:244 | Primary ciliary dyskinesia | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 85 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 70 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SUCLG1 CL E G H | 8802 | 11449 | ORPHA:17 | Fatal infantile lactic acidosis with methylmalonic aciduria | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SUCLG1 CL E G H | 8802 | 11449 | OMIM:245400 | Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria) | | | | 60 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SUFU CL E G H | 51684 | 16466 | OMIM:109400 | Basal cell nevus syndrome | | | | 124 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:377 | Gorlin syndrome | | | | 124 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:475 | Joubert syndrome | | | | 124 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SUMF1 CL E G H | 285362 | 20376 | ORPHA:585 | Multiple sulfatase deficiency | | | | 80 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SUMF1 CL E G H | 285362 | 20376 | OMIM:272200 | Multiple sulfatase deficiency | | | | 80 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SURF1 CL E G H | 6834 | 11474 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SURF1 CL E G H | 6834 | 11474 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | SURF1 CL E G H | 6834 | 11474 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | 73 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TACO1 CL E G H | 51204 | 24316 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 23 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TAF2 CL E G H | 6873 | 11536 | OMIM:615599 | Mental retardation, autosomal recessive 40 | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TAF2 CL E G H | 6873 | 11536 | ORPHA:397951 | Microcephaly-thin corpus callosum-intellectual disability syndrome | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TAOK1 CL E G H | 57551 | 29259 | OMIM:619575 | DEVELOPMENTAL DELAY WITH OR WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES; DDIB | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TBCK CL E G H | 93627 | 28261 | OMIM:616900 | Hypotonia, infantile, with psychomotor retardation and characteristic facies 3 | | | | 13 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 20 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TBX15 CL E G H | 6913 | 11594 | OMIM:260660 | Cousin syndrome | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TBXT CL E G H | 6862 | 11515 | OMIM:182940 | Neural tube defects, susceptibility to | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TCIRG1 CL E G H | 10312 | 11647 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TCIRG1 CL E G H | 10312 | 11647 | OMIM:259700 | Osteopetrosis, autosomal recessive 1 | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TCTN1 CL E G H | 79600 | 26113 | ORPHA:475 | Joubert syndrome | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TCTN1 CL E G H | 79600 | 26113 | ORPHA:564 | Meckel syndrome | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TCTN2 CL E G H | 79867 | 25774 | ORPHA:475 | Joubert syndrome | | | | 76 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TCTN2 CL E G H | 79867 | 25774 | ORPHA:564 | Meckel syndrome | | | | 76 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TCTN3 CL E G H | 26123 | 24519 | ORPHA:564 | Meckel syndrome | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93925 | Alobar holoprosencephaly | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93924 | Lobar holoprosencephaly | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TET3 CL E G H | 200424 | 28313 | OMIM:618798 | BECK-FAHRNER SYNDROME; BEFAHRS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TGFBR1 CL E G H | 7046 | 11772 | OMIM:609192 | Loeys-Dietz syndrome 1 | | | | 239 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TGFBR2 CL E G H | 7048 | 11773 | OMIM:610168 | Loeys-Dietz syndrome 2 | | | | 253 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93925 | Alobar holoprosencephaly | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93924 | Lobar holoprosencephaly | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 32 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TH CL E G H | 7054 | 11782 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | | | | 80 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TH CL E G H | 7054 | 11782 | OMIM:605407 | Segawa syndrome, autosomal recessive | | | | 80 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TIMM50 CL E G H | 92609 | 23656 | OMIM:617698 | 3-methylglutaconic aciduria, type IX | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TIMMDC1 CL E G H | 51300 | 1321 | ORPHA:2609 | Isolated complex I deficiency | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TK2 CL E G H | 7084 | 11831 | ORPHA:254886 | Autosomal recessive progressive external ophthalmoplegia | HP:0040283 - Occasional | | | 103 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM107 CL E G H | 84314 | 28128 | ORPHA:564 | Meckel syndrome | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM126B CL E G H | 55863 | 30883 | ORPHA:2609 | Isolated complex I deficiency | | | | 4 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM138 CL E G H | 51524 | 26944 | ORPHA:2318 | Joubert syndrome with oculorenal defect | | | | 39 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM216 CL E G H | 51259 | 25018 | OMIM:608091 | Joubert syndrome 2 | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM216 CL E G H | 51259 | 25018 | ORPHA:2318 | Joubert syndrome with oculorenal defect | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM216 CL E G H | 51259 | 25018 | ORPHA:564 | Meckel syndrome | | | | 45 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM218 CL E G H | 219854 | 27344 | ORPHA:475 | Joubert syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM222 CL E G H | 84065 | 25363 | OMIM:619470 | NEURODEVELOPMENTAL DISORDER WITH MOTOR AND SPEECH DELAY AND BEHAVIORAL ABNORMALITIES; NEDMOSBA | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM231 CL E G H | 79583 | 37234 | ORPHA:2318 | Joubert syndrome with oculorenal defect | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM231 CL E G H | 79583 | 37234 | ORPHA:564 | Meckel syndrome | | | | 33 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:475 | Joubert syndrome | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM237 CL E G H | 65062 | 14432 | OMIM:614424 | Joubert syndrome 14 | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:2318 | Joubert syndrome with oculorenal defect | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:220497 | Joubert syndrome with renal defect | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:564 | Meckel syndrome | | | | 82 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM67 CL E G H | 91147 | 28396 | ORPHA:475 | Joubert syndrome | | | | 166 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM67 CL E G H | 91147 | 28396 | ORPHA:1454 | Joubert syndrome with hepatic defect | | | | 166 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM67 CL E G H | 91147 | 28396 | ORPHA:564 | Meckel syndrome | | | | 166 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TMEM67 CL E G H | 91147 | 28396 | OMIM:607361 | Meckel syndrome 3 | | | | 166 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TNFRSF11A CL E G H | 8792 | 11908 | OMIM:612301 | OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7 | | | | 72 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TNFSF11 CL E G H | 8600 | 11926 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 44 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TNFSF11 CL E G H | 8600 | 11926 | OMIM:259710 | Osteopetrosis, autosomal recessive 2 | | | | 44 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TOE1 CL E G H | 114034 | 15954 | OMIM:614969 | Pontocerebellar hypoplasia, type 7 | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TOGARAM1 CL E G H | 23116 | 19959 | ORPHA:475 | Joubert syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TP53 CL E G H | 7157 | 11998 | OMIM:260500 | Papilloma of choroid plexus | | | | 911 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:2807 | Papilloma of choroid plexus | | | | 911 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TPK1 CL E G H | 27010 | 17358 | OMIM:614458 | Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type) | | | | 21 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRAPPC12 CL E G H | 51112 | 24284 | ORPHA:500144 | Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TREM2 CL E G H | 54209 | 17761 | ORPHA:2770 | Nasu-Hakola disease | | | | 31 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TREX1 CL E G H | 11277 | 12269 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 56 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRIM71 CL E G H | 131405 | 32669 | OMIM:618667 | HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1; HYDCC1 | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRMT1 CL E G H | 55621 | 25980 | OMIM:618302 | Intellectual developmental disorder, autosomal recessive 68 | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRMT10C CL E G H | 54931 | 26022 | OMIM:616974 | Combined oxidative phosphorylation deficiency 30 | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNK CL E G H | 4566 | 7489 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNN CL E G H | 4570 | 7493 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNS1 CL E G H | 4574 | 7497 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNT1 CL E G H | 51095 | 17341 | OMIM:616084 | SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD | | | | 28 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNV CL E G H | 4577 | 7500 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRNW CL E G H | 4578 | 7501 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TRPV4 CL E G H | 59341 | 18083 | ORPHA:2635 | Metatropic dysplasia | | | | 214 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TSC1 CL E G H | 7248 | 12362 | ORPHA:538 | Lymphangioleiomyomatosis | | | | 1090 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TSC1 CL E G H | 7248 | 12362 | ORPHA:805 | Tuberous sclerosis complex | | | | 1090 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TSC2 CL E G H | 7249 | 12363 | ORPHA:538 | Lymphangioleiomyomatosis | | | | 2738 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TSC2 CL E G H | 7249 | 12363 | ORPHA:805 | Tuberous sclerosis complex | | | | 2738 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TSEN15 CL E G H | 116461 | 16791 | OMIM:617026 | Pontocerebellar hypoplasia, type 2F | | | | 3 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TSPOAP1 CL E G H | 9256 | 16831 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TTC12 CL E G H | 54970 | 23700 | ORPHA:244 | Primary ciliary dyskinesia | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TTC26 CL E G H | 79989 | 21882 | OMIM:619534 | BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TTR CL E G H | 7276 | 12405 | OMIM:105210 | Amyloidosis, hereditary, transthyretin-related | | | | 107 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TUBB3 CL E G H | 10381 | 20772 | ORPHA:300570 | Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation | | | | 64 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TXN2 CL E G H | 25828 | 17772 | ORPHA:478029 | Combined oxidative phosphorylation defect type 29 | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TXN2 CL E G H | 25828 | 17772 | OMIM:616811 | Combined oxidative phosphorylation deficiency 29 | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TXNDC15 CL E G H | 79770 | 20652 | ORPHA:564 | Meckel syndrome | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TYMP CL E G H | 1890 | 3148 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 138 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | TYROBP CL E G H | 7305 | 12449 | ORPHA:2770 | Nasu-Hakola disease | | | | 22 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | UBE2T CL E G H | 29089 | 25009 | ORPHA:84 | Fanconi anemia | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 116 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 5 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | UQCC2 CL E G H | 84300 | 21237 | OMIM:615824 | Mitochondrial complex III deficiency, nuclear type 7 | | | | 7 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | USP7 CL E G H | 7874 | 12630 | ORPHA:500055 | 16p13.2 microdeletion syndrome | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | VAC14 CL E G H | 55697 | 25507 | ORPHA:3472 | Yunis-Varon syndrome | | | | 6 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | VANGL1 CL E G H | 81839 | 15512 | OMIM:182940 | Neural tube defects, susceptibility to | | | | 111 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | VANGL1 CL E G H | 81839 | 15512 | OMIM:600145 | Sacral defect with anterior meningocele | | | | 111 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | VANGL2 CL E G H | 57216 | 15511 | OMIM:182940 | Neural tube defects, susceptibility to | | | | 2 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | VPS33A CL E G H | 65082 | 18179 | ORPHA:505248 | Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | VSX1 CL E G H | 30813 | 12723 | OMIM:614195 | Craniofacial anomalies and anterior segment dysgenesis syndrome | | | | 47 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | WASHC5 CL E G H | 9897 | 28984 | ORPHA:7 | 3C syndrome | | | | 83 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | WASHC5 CL E G H | 9897 | 28984 | OMIM:220210 | Ritscher-Schinzel syndrome 1 | | | | 83 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | WDR81 CL E G H | 124997 | 26600 | OMIM:617967 | Hydrocephalus, congenital, 3, with brain anomalies | | | | 27 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | WNT3 CL E G H | 7473 | 12782 | OMIM:273395 | Tetraamelia, autosomal recessive | | | | 12 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | WNT3 CL E G H | 7473 | 12782 | ORPHA:3301 | Tetraamelia-multiple malformations syndrome | | | | 12 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | XRCC2 CL E G H | 7516 | 12829 | ORPHA:84 | Fanconi anemia | | | | 125 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZBTB20 CL E G H | 26137 | 13503 | ORPHA:3042 | Intellectual disability-cataracts-calcified pinnae-myopathy syndrome | | | | 17 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZBTB24 CL E G H | 9841 | 21143 | ORPHA:2268 | ICF syndrome | | | | 9 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93925 | Alobar holoprosencephaly | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZIC2 CL E G H | 7546 | 12873 | OMIM:609637 | Holoprosencephaly 5 | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93924 | Lobar holoprosencephaly | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 34 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZIC3 CL E G H | 7547 | 12874 | OMIM:306955 | Heterotaxy, visceral, 1, X-linked | | | | 39 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZIC3 CL E G H | 7547 | 12874 | OMIM:314390 | VACTERL association, X-linked | | | | 39 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZMYND10 CL E G H | 51364 | 19412 | ORPHA:244 | Primary ciliary dyskinesia | | | | 20 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZNF423 CL E G H | 23090 | 16762 | ORPHA:2318 | Joubert syndrome with oculorenal defect | | | | 49 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZNHIT3 CL E G H | 9326 | 12309 | ORPHA:2836 | PEHO syndrome | | | | 1 | | |
HP:0002921 | HP:0002921 | Abnormal cerebrospinal fluid morphology | 0 | ZPR1 CL E G H | 8882 | 13051 | OMIM:619321 | GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF | | | | | | |
HP:0002921 | HP:0034429 | Bacteria in cerebrospinal fluid | 1 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | | | | 15 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ABHD5 CL E G H | 51099 | 21396 | ORPHA:98907 | Neutral lipid storage disease with ichthyosis | | | | 90 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | ADAR CL E G H | 103 | 225 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 116 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ADAR CL E G H | 103 | 225 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 116 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ADAR CL E G H | 103 | 225 | OMIM:615010 | Aicardi-Goutieres syndrome 6 | | | | 116 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | ADAR CL E G H | 103 | 225 | OMIM:615010 | Aicardi-Goutieres syndrome 6 | | | | 116 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | | | | 26 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | AHI1 CL E G H | 54806 | 21575 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | AHI1 CL E G H | 54806 | 21575 | ORPHA:220493 | Joubert syndrome with ocular defect | HP:0040283 - Occasional | | | 175 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | AIFM1 CL E G H | 9131 | 8768 | OMIM:300816 | Combined oxidative phosphorylation deficiency 6 | | | | 60 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | AIFM1 CL E G H | 9131 | 8768 | ORPHA:238329 | Severe X-linked mitochondrial encephalomyopathy | | | | 60 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 54 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | AKT3 CL E G H | 10000 | 393 | OMIM:615937 | Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome 2 | . | | | 19 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | AKT3 CL E G H | 10000 | 393 | ORPHA:83473 | Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome | HP:0040281 - Very frequent | | | 19 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ALDH4A1 CL E G H | 8659 | 406 | ORPHA:79101 | Hyperprolinemia type 2 | | | | 74 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ALDH4A1 CL E G H | 8659 | 406 | ORPHA:79101 | Hyperprolinemia type 2 | | | | 74 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ALDH5A1 CL E G H | 7915 | 408 | OMIM:271980 | Succinic semialdehyde dehydrogenase deficiency | | | | 108 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ALDH7A1 CL E G H | 501 | 877 | OMIM:266100 | Epilepsy, pyridoxine-dependent | | | | 227 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ALG13 CL E G H | 79868 | 30881 | OMIM:300884 | Epileptic encephalopathy, early infantile, 36 | HP:0040283 - Occasional | | | 96 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | AMER1 CL E G H | 139285 | 26837 | OMIM:300373 | Osteopathia striata with cranial sclerosis | . | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | AP1S2 CL E G H | 8905 | 560 | ORPHA:85335 | Fried syndrome | HP:0040281 - Very frequent | | | 13 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | AP1S2 CL E G H | 8905 | 560 | OMIM:304340 | Pettigrew syndrome | HP:0040283 - Occasional | | | 13 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ARHGAP31 CL E G H | 57514 | 29216 | ORPHA:974 | Adams-Oliver syndrome | HP:0040282 - Frequent | | | 147 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ARL13B CL E G H | 200894 | 25419 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 62 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ARL3 CL E G H | 403 | 694 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ARMC9 CL E G H | 80210 | 20730 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ARSA CL E G H | 410 | 713 | OMIM:250100 | Metachromatic leukodystrophy | | | | 253 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 253 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 253 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | | | | 253 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ARSB CL E G H | 411 | 714 | OMIM:253200 | Mucopolysaccharidosis, type VI | . | | | 120 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ASPA CL E G H | 443 | 756 | OMIM:271900 | Canavan disease | | | | 48 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 239 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 239 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ATP6 CL E G H | 4508 | 7414 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ATPAF2 CL E G H | 91647 | 18802 | OMIM:604273 | Mitochondrial complex V (atp synthase) deficiency, nuclear type 1 | | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B3GALNT2 CL E G H | 148789 | 28596 | ORPHA:588 | Muscle-eye-brain disease | HP:0040281 - Very frequent | | | 43 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B3GALNT2 CL E G H | 148789 | 28596 | OMIM:615181 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11 | . | | | 43 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B3GALNT2 CL E G H | 148789 | 28596 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 43 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B3GALT6 CL E G H | 126792 | 17978 | ORPHA:536467 | B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome | HP:0040282 - Frequent | | | 38 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B3GAT3 CL E G H | 26229 | 923 | OMIM:245600 | Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects | . | | | 5 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B3GLCT CL E G H | 145173 | 20207 | ORPHA:709 | Peters plus syndrome | HP:0040282 - Frequent | | | 36 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B3GLCT CL E G H | 145173 | 20207 | OMIM:261540 | Peters-Plus syndrome | . | | | 36 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B4GALT1 CL E G H | 2683 | 924 | ORPHA:79332 | B4GALT1-CDG | HP:0040281 - Very frequent | | | 85 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B4GAT1 CL E G H | 11041 | 15685 | OMIM:615287 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13 | . | | | 17 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B4GAT1 CL E G H | 11041 | 15685 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 17 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B9D1 CL E G H | 27077 | 24123 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 28 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B9D1 CL E G H | 27077 | 24123 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 28 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B9D2 CL E G H | 80776 | 28636 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | B9D2 CL E G H | 80776 | 28636 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 184 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | BCAT2 CL E G H | 587 | 977 | OMIM:618850 | HYPERVALINEMIA AND HYPERLEUCINE-ISOLEUCINEMIA; HVLI | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BICRA CL E G H | 29998 | 4332 | OMIM:619325 | COFFIN-SIRIS SYNDROME 12; CSS12 | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BLTP1 CL E G H | 84162 | 26953 | OMIM:617822 | Alkuraya-Kucinskas syndrome | . | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | | | | 14 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:1340 | Cardiofaciocutaneous syndrome | HP:0040283 - Occasional | | | 276 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BRAF CL E G H | 673 | 1097 | OMIM:115150 | Cardiofaciocutaneous syndrome 1 | . | | | 276 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:54595 | Craniopharyngioma | HP:0040283 - Occasional | | | 276 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BRCA1 CL E G H | 672 | 1100 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 5769 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BRCA2 CL E G H | 675 | 1101 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 7642 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BRIP1 CL E G H | 83990 | 20473 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 1086 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | BTNL2 CL E G H | 56244 | 1142 | ORPHA:797 | Sarcoidosis | | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | BUB1B CL E G H | 701 | 1149 | OMIM:257300 | Mosaic variegated aneuploidy syndrome 1 | . | | | 76 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 449 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 449 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CBY1 CL E G H | 25776 | 1307 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CC2D2A CL E G H | 57545 | 29253 | OMIM:619111 | COACH SYNDROME 2; COACH2 | | | | 247 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CC2D2A CL E G H | 57545 | 29253 | ORPHA:1454 | Joubert syndrome with hepatic defect | HP:0040283 - Occasional | | | 247 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CC2D2A CL E G H | 57545 | 29253 | ORPHA:2318 | Joubert syndrome with oculorenal defect | HP:0040283 - Occasional | | | 247 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CC2D2A CL E G H | 57545 | 29253 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 247 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CC2D2A CL E G H | 57545 | 29253 | OMIM:612284 | Meckel syndrome, type 6 | HP:0040283 - Occasional | | | 247 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCDC103 CL E G H | 388389 | 32700 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 36 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCDC22 CL E G H | 28952 | 28909 | ORPHA:7 | 3C syndrome | HP:0040282 - Frequent | | | 33 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCDC39 CL E G H | 339829 | 25244 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 126 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCDC40 CL E G H | 55036 | 26090 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 182 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCDC65 CL E G H | 85478 | 29937 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 23 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCDC88C CL E G H | 440193 | 19967 | OMIM:236600 | Hydrocephalus, nonsyndromic, autosomal recessive 1 | . | | | 54 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCL2 CL E G H | 6347 | 10618 | OMIM:182940 | Neural tube defects, susceptibility to | . | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCND2 CL E G H | 894 | 1583 | OMIM:615938 | Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome 3 | . | | | 11 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCND2 CL E G H | 894 | 1583 | ORPHA:83473 | Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome | HP:0040281 - Very frequent | | | 11 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CCNO CL E G H | 10309 | 18576 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 23 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | CD59 CL E G H | 966 | 1689 | OMIM:612300 | Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy | | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CDC40 CL E G H | 51362 | 17350 | OMIM:619302 | PONTOCEREBELLAR HYPOPLASIA, TYPE 15; PCH15 | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CDC42BPB CL E G H | 9578 | 1738 | OMIM:619841 | | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CDCA7 CL E G H | 83879 | 14628 | ORPHA:2268 | ICF syndrome | | | | 4 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CDON CL E G H | 50937 | 17104 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 200 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CDON CL E G H | 50937 | 17104 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 200 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CDON CL E G H | 50937 | 17104 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 200 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CDON CL E G H | 50937 | 17104 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 200 | | |
HP:0002921 | HP:0410310 | Abnormality of neutrophil morphology in CSF | 1 | CEBPE CL E G H | 1053 | 1836 | OMIM:245480 | Specific granule deficiency | | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CENPF CL E G H | 1063 | 1857 | OMIM:243605 | Stromme syndrome | . | | | 27 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP104 CL E G H | 9731 | 24866 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 5 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP120 CL E G H | 153241 | 26690 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP120 CL E G H | 153241 | 26690 | ORPHA:220493 | Joubert syndrome with ocular defect | HP:0040283 - Occasional | | | 7 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP290 CL E G H | 80184 | 29021 | ORPHA:2318 | Joubert syndrome with oculorenal defect | HP:0040283 - Occasional | | | 342 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP290 CL E G H | 80184 | 29021 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 342 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP290 CL E G H | 80184 | 29021 | OMIM:611134 | Meckel syndrome, type 4 | HP:0040283 - Occasional | | | 342 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP41 CL E G H | 95681 | 12370 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 90 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP41 CL E G H | 95681 | 12370 | ORPHA:220493 | Joubert syndrome with ocular defect | HP:0040283 - Occasional | | | 90 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CEP83 CL E G H | 51134 | 17966 | OMIM:615862 | Nephronophthisis 18 | HP:0040283 - Occasional | | | 10 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CFAP221 CL E G H | 200373 | 33720 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CFAP298 CL E G H | 56683 | 1301 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CFAP300 CL E G H | 85016 | 28188 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CFAP43 CL E G H | 80217 | 26684 | OMIM:236690 | Hydrocephalus, normal pressure, 1 | | | | 6 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CHST3 CL E G H | 9469 | 1971 | OMIM:245600 | Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects | . | | | 165 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CILK1 CL E G H | 22858 | 21219 | OMIM:612651 | ENDOCRINE-CEREBROOSTEODYSPLASIA | . | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CLCN3 CL E G H | 1182 | 2021 | OMIM:619512 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES; NEDHYBA | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CLCN7 CL E G H | 1186 | 2025 | ORPHA:53 | Albers-Schönberg osteopetrosis | HP:0040283 - Occasional | | | 102 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CLCN7 CL E G H | 1186 | 2025 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | HP:0040281 - Very frequent | | | 102 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CLIC2 CL E G H | 1193 | 2063 | OMIM:300886 | MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32 | | | | 4 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | CLPB CL E G H | 81570 | 30664 | OMIM:616271 | 3-Methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia | | | | 38 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | COG6 CL E G H | 57511 | 18621 | OMIM:614576 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L | | | | 71 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | COL18A1 CL E G H | 80781 | 2195 | ORPHA:1571 | Knobloch syndrome | HP:0040282 - Frequent | | | 177 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | COL4A1 CL E G H | 1282 | 2202 | OMIM:175780 | Brain small vessel disease 1 with or without ocular anomalies | . | | | 193 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | COL4A1 CL E G H | 1282 | 2202 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 193 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | COPB2 CL E G H | 9276 | 2232 | OMIM:617800 | Microcephaly 19, primary, autosomal recessive | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COQ8A CL E G H | 56997 | 16812 | ORPHA:139485 | Autosomal recessive ataxia due to ubiquinone deficiency | | | | 136 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX10 CL E G H | 1352 | 2260 | OMIM:619046 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN3 | | | | 82 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX14 CL E G H | 84987 | 28216 | OMIM:619053 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10; MC4DN10 | | | | 4 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX15 CL E G H | 1355 | 2263 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 104 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX20 CL E G H | 116228 | 26970 | OMIM:619054 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11; MC4DN11 | | | | 25 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX4I1 CL E G H | 1327 | 2265 | OMIM:619060 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16 | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX6B1 CL E G H | 1340 | 2280 | OMIM:619051 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7 | | | | 10 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | COX7B CL E G H | 1349 | 2291 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | COX7B CL E G H | 1349 | 2291 | OMIM:309801 | Microphthalmia, syndromic 7 | . | | | 6 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | COX8A CL E G H | 1351 | 2294 | OMIM:619059 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15 | | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CPLANE1 CL E G H | 65250 | 25801 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CPLX1 CL E G H | 10815 | 2309 | OMIM:194190 | Wolf-Hirschhorn syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | HP:0040283 - Occasional | | | 101 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CRB2 CL E G H | 286204 | 18688 | OMIM:219730 | Ventriculomegaly with cystic kidney disease | . | | | 12 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CRPPA CL E G H | 729920 | 37276 | OMIM:614643 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 | . | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CRPPA CL E G H | 729920 | 37276 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CSF1R CL E G H | 1436 | 2433 | OMIM:618476 | Brain abnormalities, neurodegeneration, and dysosteosclerosis | . | | | 149 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CSPP1 CL E G H | 79848 | 26193 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 57 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CSPP1 CL E G H | 79848 | 26193 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 57 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CTBP1 CL E G H | 1487 | 2494 | OMIM:194190 | Wolf-Hirschhorn syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:54595 | Craniopharyngioma | HP:0040283 - Occasional | | | 88 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CYP26C1 CL E G H | 340665 | 20577 | ORPHA:398189 | Focal facial dermal dysplasia type IV | HP:0040282 - Frequent | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | CYTB CL E G H | 4519 | 7427 | ORPHA:137675 | Histiocytoid cardiomyopathy | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DAG1 CL E G H | 1605 | 2666 | OMIM:616538 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9 | . | | | 108 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DAG1 CL E G H | 1605 | 2666 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 108 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | DARS2 CL E G H | 55157 | 25538 | ORPHA:137898 | Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome | | | | 60 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DCC CL E G H | 1630 | 2701 | OMIM:617542 | GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 2; HGPPS2 | | | | 36 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | DDC CL E G H | 1644 | 2719 | OMIM:608643 | Aromatic L-amino acid decarboxylase deficiency | | | | 43 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DENND5A CL E G H | 23258 | 19344 | OMIM:617281 | Epileptic encephalopathy, early infantile, 49 | HP:0040284 - Very rare | | | 6 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DHCR24 CL E G H | 1718 | 2859 | ORPHA:35107 | Desmosterolosis | HP:0040283 - Occasional | | | 72 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DHCR24 CL E G H | 1718 | 2859 | OMIM:602398 | DESMOSTEROLOSIS | . | | | 72 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DHCR7 CL E G H | 1717 | 2860 | OMIM:270400 | Smith-Lemli-Opitz syndrome | . | | | 159 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 22 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 22 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 22 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DISP1 CL E G H | 84976 | 19711 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 22 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | DLAT CL E G H | 1737 | 2896 | ORPHA:79244 | Pyruvate dehydrogenase E2 deficiency | | | | 82 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DLL1 CL E G H | 28514 | 2908 | OMIM:618709 | NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS | | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DLL1 CL E G H | 28514 | 2908 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DLL4 CL E G H | 54567 | 2910 | ORPHA:974 | Adams-Oliver syndrome | HP:0040282 - Frequent | | | 9 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAAF1 CL E G H | 123872 | 30539 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 116 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAAF11 CL E G H | 23639 | 16725 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAAF2 CL E G H | 55172 | 20188 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 78 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAAF3 CL E G H | 352909 | 30492 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 63 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAAF4 CL E G H | 161582 | 21493 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 27 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAAF5 CL E G H | 54919 | 26013 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 62 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAAF6 CL E G H | 139212 | 28570 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAH1 CL E G H | 25981 | 2940 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 21 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAH11 CL E G H | 8701 | 2942 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 542 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAH5 CL E G H | 1767 | 2950 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 527 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAH9 CL E G H | 1770 | 2953 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 18 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAI1 CL E G H | 27019 | 2954 | OMIM:244400 | Ciliary dyskinesia, primary, 1 | | | | 73 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAI1 CL E G H | 27019 | 2954 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 73 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAI2 CL E G H | 64446 | 18744 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 104 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAJB13 CL E G H | 374407 | 30718 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNAL1 CL E G H | 83544 | 23247 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 167 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | DNM1L CL E G H | 10059 | 2973 | OMIM:614388 | Encephalopathy due to defective mitochondrial and peroxisomal fission 1 | | | | 94 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DNMT3B CL E G H | 1789 | 2979 | ORPHA:2268 | ICF syndrome | | | | 79 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DOCK6 CL E G H | 57572 | 19189 | ORPHA:974 | Adams-Oliver syndrome | HP:0040282 - Frequent | | | 18 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DPH1 CL E G H | 1801 | 3003 | ORPHA:459061 | Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome | HP:0040282 - Frequent | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | DRC1 CL E G H | 92749 | 24245 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 44 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | EBP CL E G H | 10682 | 3133 | ORPHA:401973 | MEND syndrome | HP:0040282 - Frequent | | | 51 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | EBP CL E G H | 10682 | 3133 | OMIM:300960 | Mend syndrome | . | | | 51 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ECHS1 CL E G H | 1892 | 3151 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 33 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ECHS1 CL E G H | 1892 | 3151 | OMIM:616277 | Mitochondrial short-chain enoyl-coa hydratase 1 deficiency | | | | 33 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | EGR2 CL E G H | 1959 | 3239 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | | | | 58 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | EML1 CL E G H | 2009 | 3330 | OMIM:600348 | Band heterotopia | . | HP:0003577 - Congenital onset | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | EOGT CL E G H | 285203 | 28526 | ORPHA:974 | Adams-Oliver syndrome | HP:0040282 - Frequent | | | 4 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | EPHB4 CL E G H | 2050 | 3395 | ORPHA:137667 | Capillary malformation-arteriovenous malformation | HP:0040284 - Very rare | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040281 - Very frequent | | | 106 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040281 - Very frequent | | | 54 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 158 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040281 - Very frequent | | | 158 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040281 - Very frequent | | | 83 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ERCC6 CL E G H | 2074 | 3438 | OMIM:133540 | Cockayne syndrome, type B | | | | 199 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ERCC6 CL E G H | 2074 | 3438 | OMIM:278800 | De Sanctis-Cacchione syndrome | | | | 199 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ERCC8 CL E G H | 1161 | 3439 | OMIM:216400 | Cockayne syndrome A | | | | 55 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ERF CL E G H | 2077 | 3444 | ORPHA:207 | Crouzon disease | HP:0040283 - Occasional | | | 12 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ESCO2 CL E G H | 157570 | 27230 | OMIM:268300 | Roberts syndrome | . | | | 92 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FAM111A CL E G H | 63901 | 24725 | OMIM:602361 | Gracile bone dysplasia | . | | | 8 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FAM20C CL E G H | 56975 | 22140 | OMIM:259775 | Raine syndrome | HP:0040283 - Occasional | | | 35 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCA CL E G H | 2175 | 3582 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 340 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCB CL E G H | 2187 | 3583 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 58 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCB CL E G H | 2187 | 3583 | OMIM:300514 | FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB | | | | 58 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCB CL E G H | 2187 | 3583 | OMIM:314390 | VACTERL association, X-linked | . | | | 58 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCB CL E G H | 2187 | 3583 | ORPHA:3412 | VACTERL with hydrocephalus | HP:0040281 - Very frequent | | | 58 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCC CL E G H | 2176 | 3584 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 410 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCD2 CL E G H | 2177 | 3585 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 147 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCD2 CL E G H | 2177 | 3585 | OMIM:227646 | Fanconi anemia, complementation group D2 | | | | 147 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCE CL E G H | 2178 | 3586 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 73 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCF CL E G H | 2188 | 3587 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 87 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCG CL E G H | 2189 | 3588 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 73 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCI CL E G H | 55215 | 25568 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 157 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCL CL E G H | 55120 | 20748 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 53 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCL CL E G H | 55120 | 20748 | OMIM:614083 | Fanconi anemia, complementation group L | HP:0040283 - Occasional | | | 53 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FANCM CL E G H | 57697 | 23168 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 107 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | FARS2 CL E G H | 10667 | 21062 | OMIM:614946 | Combined oxidative phosphorylation deficiency 14 | | | | 36 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FBN1 CL E G H | 2200 | 3603 | OMIM:616914 | Marfan lipodystrophy syndrome | | | | 1361 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FBN1 CL E G H | 2200 | 3603 | ORPHA:2462 | Shprintzen-Goldberg syndrome | | | | 1361 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 17 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 17 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 17 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGF8 CL E G H | 2253 | 3686 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 17 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR1 CL E G H | 2260 | 3688 | OMIM:613001 | Encephalocraniocutaneous lipomatosis | . | | | 172 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 172 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR1 CL E G H | 2260 | 3688 | OMIM:101600 | Pfeiffer syndrome | . | | | 172 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 172 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR2 CL E G H | 2263 | 3689 | OMIM:207410 | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis | . | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR2 CL E G H | 2263 | 3689 | OMIM:101200 | Apert syndrome | . | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:87 | Apert syndrome | HP:0040283 - Occasional | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR2 CL E G H | 2263 | 3689 | OMIM:123790 | Beare-Stevenson cutis gyrata syndrome | | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:207 | Crouzon disease | HP:0040283 - Occasional | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:1555 | Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome | HP:0040283 - Occasional | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR2 CL E G H | 2263 | 3689 | OMIM:101600 | Pfeiffer syndrome | . | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:93259 | Pfeiffer syndrome type 2 | HP:0040282 - Frequent | | | 175 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:15 | Achondroplasia | HP:0040284 - Very rare | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | OMIM:100800 | ACHONDROPLASIA | HP:0040283 - Occasional | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | OMIM:616482 | Achondroplasia, severe, with developmental delay and acanthosis nigricans | . | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | OMIM:612247 | Crouzon syndrome with acanthosis nigricans | HP:0040283 - Occasional | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:93262 | Crouzon syndrome-acanthosis nigricans syndrome | HP:0040282 - Frequent | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:53271 | Muenke syndrome | HP:0040283 - Occasional | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:1860 | Thanatophoric dysplasia type 1 | HP:0040283 - Occasional | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:93274 | Thanatophoric dysplasia type 2 | HP:0040283 - Occasional | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFR3 CL E G H | 2261 | 3690 | OMIM:187600 | Thanatophoric dysplasia, type I | . | | | 145 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FGFRL1 CL E G H | 53834 | 3693 | OMIM:194190 | Wolf-Hirschhorn syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FIG4 CL E G H | 9896 | 16873 | ORPHA:3472 | Yunis-Varon syndrome | HP:0040283 - Occasional | | | 111 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKRP CL E G H | 79147 | 17997 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | HP:0040282 - Frequent | | | 157 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKRP CL E G H | 79147 | 17997 | ORPHA:588 | Muscle-eye-brain disease | HP:0040281 - Very frequent | | | 157 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKRP CL E G H | 79147 | 17997 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 157 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKRP CL E G H | 79147 | 17997 | OMIM:613153 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5 | . | | | 157 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKRP CL E G H | 79147 | 17997 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 157 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKTN CL E G H | 2218 | 3622 | ORPHA:272 | Congenital muscular dystrophy, Fukuyama type | HP:0040282 - Frequent | | | 184 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKTN CL E G H | 2218 | 3622 | ORPHA:588 | Muscle-eye-brain disease | HP:0040281 - Very frequent | | | 184 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKTN CL E G H | 2218 | 3622 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 184 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKTN CL E G H | 2218 | 3622 | OMIM:253800 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4 | . | | | 184 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FKTN CL E G H | 2218 | 3622 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 184 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FLNA CL E G H | 2316 | 3754 | ORPHA:90652 | Otopalatodigital syndrome type 2 | HP:0040282 - Frequent | | | 493 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FLNA CL E G H | 2316 | 3754 | OMIM:304120 | Otopalatodigital syndrome, type II | . | | | 493 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FLVCR2 CL E G H | 55640 | 20105 | OMIM:225790 | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome | . | | | 47 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 48 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 48 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 48 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 48 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FOXJ1 CL E G H | 2302 | 3816 | OMIM:618699 | CILIARY DYSKINESIA, PRIMARY, 43; CILD43 | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FOXJ1 CL E G H | 2302 | 3816 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:2609 | Isolated complex I deficiency | | | | 61 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 61 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FRAS1 CL E G H | 80144 | 19185 | OMIM:219000 | Fraser syndrome | . | | | 353 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | FTL CL E G H | 2512 | 3999 | ORPHA:157846 | Neuroferritinopathy | | | | 33 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FTO CL E G H | 79068 | 24678 | OMIM:612938 | Growth retardation, developmental delay, coarse facies, and earlydeath | . | | | 70 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FUZ CL E G H | 80199 | 26219 | ORPHA:1136 | Arnold-Chiari malformation type II | HP:0040282 - Frequent | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | FUZ CL E G H | 80199 | 26219 | OMIM:182940 | Neural tube defects, susceptibility to | . | | | 3 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | GALC CL E G H | 2581 | 4115 | ORPHA:206448 | Adult Krabbe disease | | | | 160 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | GALC CL E G H | 2581 | 4115 | ORPHA:206436 | Infantile Krabbe disease | | | | 160 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | GALC CL E G H | 2581 | 4115 | OMIM:245200 | Krabbe disease | | | | 160 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GALC CL E G H | 2581 | 4115 | OMIM:245200 | Krabbe disease | . | | | 160 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | GALC CL E G H | 2581 | 4115 | ORPHA:206443 | Late-infantile/juvenile Krabbe disease | | | | 160 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GAS1 CL E G H | 2619 | 4165 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GAS2L2 CL E G H | 246176 | 24846 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GAS8 CL E G H | 2622 | 4166 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 9 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:231005 | Gaucher disease, type IIIC | . | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | GBE1 CL E G H | 2632 | 4180 | OMIM:263570 | Polyglucosan body neuropathy, adult form | | | | 86 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GCDH CL E G H | 2639 | 4189 | OMIM:231670 | Glutaric acidemia I | | | | 115 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GCDH CL E G H | 2639 | 4189 | ORPHA:25 | Glutaryl-CoA dehydrogenase deficiency | | | | 115 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | GCH1 CL E G H | 2643 | 4193 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 86 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | GFAP CL E G H | 2670 | 4235 | OMIM:203450 | Alexander disease | | | | 188 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GFAP CL E G H | 2670 | 4235 | OMIM:203450 | Alexander disease | . | | | 188 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GFAP CL E G H | 2670 | 4235 | ORPHA:363717 | Alexander disease type I | | | | 188 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | GFM1 CL E G H | 85476 | 13780 | OMIM:609060 | Combined oxidative phosphorylation deficiency 1 | | | | 85 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | GFM2 CL E G H | 84340 | 29682 | ORPHA:565624 | Combined oxidative phosphorylation defect type 39 | | | | 43 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | GFM2 CL E G H | 84340 | 29682 | OMIM:618397 | Combined oxidative phosphorylation deficiency 39 | | | | 43 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 173 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GLI2 CL E G H | 2736 | 4318 | OMIM:610829 | Holoprosencephaly 9 | | | | 173 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 173 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 173 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 173 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GLI3 CL E G H | 2737 | 4319 | ORPHA:380 | Greig cephalopolysyndactyly syndrome | HP:0040283 - Occasional | | | 270 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GLI3 CL E G H | 2737 | 4319 | OMIM:175700 | Greig cephalopolysyndactyly syndrome | | | | 270 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | | | | 6 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GMPPB CL E G H | 29925 | 22932 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | HP:0040282 - Frequent | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GMPPB CL E G H | 29925 | 22932 | ORPHA:588 | Muscle-eye-brain disease | HP:0040281 - Very frequent | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GNAQ CL E G H | 2776 | 4390 | ORPHA:3205 | Sturge-Weber syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GPC3 CL E G H | 2719 | 4451 | OMIM:312870 | Simpson-golabi-behmel syndrome, type 1 | | | | 73 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GPC4 CL E G H | 2239 | 4452 | OMIM:312870 | Simpson-golabi-behmel syndrome, type 1 | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GPSM2 CL E G H | 29899 | 29501 | OMIM:604213 | CHUDLEY-MCCULLOUGH SYNDROME; CMCS | | | | 74 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | GRIK2 CL E G H | 2898 | 4580 | OMIM:619580 | NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS | | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | GUSB CL E G H | 2990 | 4696 | OMIM:253220 | Mucopolysaccharidosis, type VII | . | | | 54 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | H4C9 CL E G H | 8294 | 4793 | OMIM:619951 | | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HBA1 CL E G H | 3039 | 4823 | ORPHA:163596 | Hb Bart's hydrops fetalis | HP:0040282 - Frequent | | | 200 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HBA2 CL E G H | 3040 | 4824 | ORPHA:163596 | Hb Bart's hydrops fetalis | HP:0040282 - Frequent | | | 88 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HCCS CL E G H | 3052 | 4837 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | HP:0040283 - Occasional | | | 11 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HCCS CL E G H | 3052 | 4837 | OMIM:309801 | Microphthalmia, syndromic 7 | . | | | 11 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HDAC6 CL E G H | 10013 | 14064 | OMIM:300863 | Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia | . | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HDAC6 CL E G H | 10013 | 14064 | ORPHA:163966 | X-linked dominant chondrodysplasia, Chassaing-Lacombe type | HP:0040281 - Very frequent | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HELLS CL E G H | 3070 | 4861 | ORPHA:2268 | ICF syndrome | | | | 6 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HERC1 CL E G H | 8925 | 4867 | OMIM:617011 | Macrocephaly, dysmorphic facies, and psychomotor retardation | HP:0040283 - Occasional | | | 16 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HERC1 CL E G H | 8925 | 4867 | ORPHA:457359 | Megalencephaly-severe kyphoscoliosis-overgrowth syndrome | | | | 16 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:797 | Sarcoidosis | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HNRNPU CL E G H | 3192 | 5048 | ORPHA:238769 | 1q44 microdeletion syndrome | HP:0040283 - Occasional | | | 39 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | HPDL CL E G H | 84842 | 28242 | OMIM:619026 | NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HRAS CL E G H | 3265 | 5173 | OMIM:218040 | Costello syndrome | . | | | 113 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | HSD17B10 CL E G H | 3028 | 4800 | ORPHA:391428 | HSD10 disease, infantile type | | | | 19 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HSPG2 CL E G H | 3339 | 5273 | ORPHA:1865 | Dyssegmental dysplasia, Silverman-Handmaker type | HP:0040283 - Occasional | | | 345 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | HTRA2 CL E G H | 27429 | 14348 | OMIM:617248 | 3-methylglutaconic aciduria, type VIII | | | | 39 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HYDIN CL E G H | 54768 | 19368 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 21 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HYLS1 CL E G H | 219844 | 26558 | ORPHA:2189 | Hydrolethalus | HP:0040281 - Very frequent | | | 31 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HYLS1 CL E G H | 219844 | 26558 | OMIM:236680 | Hydrolethalus syndrome 1 | | | | 31 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | HYLS1 CL E G H | 219844 | 26558 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 31 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | IARS2 CL E G H | 55699 | 29685 | OMIM:616007 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia | | | | 25 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | IDS CL E G H | 3423 | 5389 | OMIM:309900 | Mucopolysaccharidosis, type II | . | | | 86 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | IDUA CL E G H | 3425 | 5391 | ORPHA:93473 | Hurler syndrome | HP:0040282 - Frequent | | | 115 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | IDUA CL E G H | 3425 | 5391 | OMIM:607014 | Hurler syndrome | . | | | 115 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | IFIH1 CL E G H | 64135 | 18873 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 28 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | IFIH1 CL E G H | 64135 | 18873 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 28 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | IFNG CL E G H | 3458 | 5438 | ORPHA:805 | Tuberous sclerosis complex | | | | 23 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | IFT172 CL E G H | 26160 | 30391 | OMIM:615630 | Short-Rib thoracic dysplasia 10 with or without polydactyly | HP:0040283 - Occasional | | | 48 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | IFT43 CL E G H | 112752 | 29669 | OMIM:617866 | SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18 | | | | 11 | | |
HP:0002921 | HP:0030998 | Cerebrospinal fluid rhinorrhoea | 1 | IGHG2 CL E G H | 3501 | 5526 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 1 | | |
HP:0002921 | HP:0030998 | Cerebrospinal fluid rhinorrhoea | 1 | IGKC CL E G H | 3514 | 5716 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 5 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | IMPDH2 CL E G H | 3615 | 6053 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | INPP5E CL E G H | 56623 | 21474 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 111 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | INPP5E CL E G H | 56623 | 21474 | ORPHA:1454 | Joubert syndrome with hepatic defect | HP:0040283 - Occasional | | | 111 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | INPP5E CL E G H | 56623 | 21474 | ORPHA:220493 | Joubert syndrome with ocular defect | HP:0040283 - Occasional | | | 111 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | IRF4 CL E G H | 3662 | 6119 | ORPHA:3452 | Whipple disease | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KANSL1 CL E G H | 284058 | 24565 | ORPHA:363958 | 17q21.31 microdeletion syndrome | HP:0040283 - Occasional | | | 283 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KANSL1 CL E G H | 284058 | 24565 | ORPHA:363965 | Koolen-De Vries syndrome due to a point mutation | HP:0040283 - Occasional | | | 283 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | KARS1 CL E G H | 3735 | 6215 | OMIM:619147 | LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KATNIP CL E G H | 23247 | 29068 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KDM4B CL E G H | 23030 | 29136 | OMIM:619320 | INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65; MRD65 | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KDM6A CL E G H | 7403 | 12637 | ORPHA:2322 | Kabuki syndrome | HP:0040282 - Frequent | | | 53 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KDM6A CL E G H | 7403 | 12637 | OMIM:147920 | Kabuki syndrome 1 | | | | 53 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KIAA0586 CL E G H | 9786 | 19960 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 24 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KIAA0586 CL E G H | 9786 | 19960 | OMIM:616546 | Short-Rib thoracic dysplasia 14 with polydactyly | . | | | 24 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KIF1A CL E G H | 547 | 888 | ORPHA:2836 | PEHO syndrome | HP:0040282 - Frequent | | | 276 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KIF7 CL E G H | 374654 | 30497 | ORPHA:2189 | Hydrolethalus | HP:0040281 - Very frequent | | | 167 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KIF7 CL E G H | 374654 | 30497 | OMIM:614120 | Hydrolethalus syndrome 2 | . | | | 167 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KMT2D CL E G H | 8085 | 7133 | ORPHA:2322 | Kabuki syndrome | HP:0040282 - Frequent | | | 660 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KMT2D CL E G H | 8085 | 7133 | OMIM:147920 | Kabuki syndrome 1 | | | | 660 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | KRAS CL E G H | 3845 | 6407 | ORPHA:1340 | Cardiofaciocutaneous syndrome | HP:0040283 - Occasional | | | 196 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | L1CAM CL E G H | 3897 | 6470 | OMIM:304100 | Corpus callosum, partial agenesis of, X-linked | . | | | 134 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | L1CAM CL E G H | 3897 | 6470 | OMIM:307000 | Hydrocephalus due to congenital stenosis of aqueduct of sylvius | . | | | 134 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | L1CAM CL E G H | 3897 | 6470 | ORPHA:2182 | Hydrocephalus with stenosis of the aqueduct of Sylvius | HP:0040281 - Very frequent | | | 134 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | L1CAM CL E G H | 3897 | 6470 | OMIM:303350 | MASA syndrome | . | | | 134 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LAMB1 CL E G H | 3912 | 6486 | ORPHA:352682 | Cobblestone lissencephaly without muscular or ocular involvement | HP:0040282 - Frequent | | | 71 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LAMB1 CL E G H | 3912 | 6486 | OMIM:615191 | Lissencephaly 5 | | | | 71 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LARGE1 CL E G H | 9215 | 6511 | ORPHA:588 | Muscle-eye-brain disease | HP:0040281 - Very frequent | | | 136 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LARGE1 CL E G H | 9215 | 6511 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 136 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LARGE1 CL E G H | 9215 | 6511 | OMIM:613154 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6 | . | | | 136 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LARGE1 CL E G H | 9215 | 6511 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 136 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LETM1 CL E G H | 3954 | 6556 | OMIM:194190 | Wolf-Hirschhorn syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | LIG3 CL E G H | 3980 | 6600 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LIG4 CL E G H | 3981 | 6601 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 88 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | LIPT1 CL E G H | 51601 | 29569 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 21 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LMBR1 CL E G H | 64327 | 13243 | ORPHA:2378 | Laurin-Sandrow syndrome | HP:0040283 - Occasional | | | 106 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | LMNB1 CL E G H | 4001 | 6637 | ORPHA:99027 | Adult-onset autosomal dominant leukodystrophy | | | | 44 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | LMNB1 CL E G H | 4001 | 6637 | OMIM:619179 | MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT; MCPH26 | | | | 44 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | LMNB2 CL E G H | 84823 | 6638 | OMIM:619180 | MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT; MCPH27 | | | | 11 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 8 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | LRPPRC CL E G H | 10128 | 15714 | ORPHA:70472 | Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | | | | 191 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | LRPPRC CL E G H | 10128 | 15714 | OMIM:220111 | Leigh syndrome, french Canadian type | | | | 191 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | LRRC56 CL E G H | 115399 | 25430 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | LSM11 CL E G H | 134353 | 30860 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | LSM11 CL E G H | 134353 | 30860 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | LSM11 CL E G H | 134353 | 30860 | OMIM:619486 | AICARDI-GOUTIERES SYNDROME 8; AGS8 | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | LYRM4 CL E G H | 57128 | 21365 | OMIM:615595 | Combined oxidative phosphorylation deficiency 19 | | | | 4 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | LYRM7 CL E G H | 90624 | 28072 | OMIM:615838 | Mitochondrial complex III deficiency, nuclear type 8 | | | | 10 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MAD2L2 CL E G H | 10459 | 6764 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | MADD CL E G H | 8567 | 6766 | OMIM:619004 | DEEAH SYNDROME; DEEAH | | | | 5 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | MADD CL E G H | 8567 | 6766 | OMIM:619005 | NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA; NEDDISH | | | | 5 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MAF CL E G H | 4094 | 6776 | ORPHA:1272 | Aymé-Gripp syndrome | HP:0040282 - Frequent | | | 21 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309282 | Alpha-mannosidosis, infantile form | | | | 136 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MAP2K1 CL E G H | 5604 | 6840 | ORPHA:1340 | Cardiofaciocutaneous syndrome | HP:0040283 - Occasional | | | 134 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MAP2K2 CL E G H | 5605 | 6842 | ORPHA:1340 | Cardiofaciocutaneous syndrome | HP:0040283 - Occasional | | | 178 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:85284 | BRESEK syndrome | HP:0040281 - Very frequent | | | 22 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MC1R CL E G H | 4157 | 6929 | ORPHA:626 | Large congenital melanocytic nevus | HP:0040283 - Occasional | | | 124 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MCIDAS CL E G H | 345643 | 40050 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 13 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | MDH2 CL E G H | 4191 | 6971 | OMIM:617339 | Epileptic encephalopathy, early infantile, 51 | | | | 4 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | MECP2 CL E G H | 4204 | 6990 | ORPHA:778 | Rett syndrome | | | | 950 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MED12 CL E G H | 9968 | 11957 | ORPHA:93932 | FG syndrome type 1 | HP:0040283 - Occasional | | | 228 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MED12 CL E G H | 9968 | 11957 | OMIM:305450 | Opitz-Kaveggia syndrome | . | | | 228 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MFN2 CL E G H | 9927 | 16877 | ORPHA:99947 | Autosomal dominant Charcot-Marie-Tooth disease type 2A2 | HP:0040284 - Very rare | | | 203 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | MICU1 CL E G H | 10367 | 1530 | OMIM:615673 | Myopathy with extrapyramidal signs | | | | 14 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MKS1 CL E G H | 54903 | 7121 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 127 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MKS1 CL E G H | 54903 | 7121 | ORPHA:220493 | Joubert syndrome with ocular defect | HP:0040283 - Occasional | | | 127 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MKS1 CL E G H | 54903 | 7121 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 127 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MKS1 CL E G H | 54903 | 7121 | OMIM:249000 | Meckel syndrome 1 | . | | | 127 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | HP:0040284 - Very rare | | | 101 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MMACHC CL E G H | 25974 | 24525 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | 101 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MPDZ CL E G H | 8777 | 7208 | OMIM:615219 | Hydrocephalus, congenital, 2, with or without brain or eye anomalies | | | | 29 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | | | | 56 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | MPZ CL E G H | 4359 | 7225 | ORPHA:101082 | Charcot-Marie-Tooth disease type 1B | | | | 134 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | MPZ CL E G H | 4359 | 7225 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | | | | 134 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | MRPS34 CL E G H | 65993 | 16618 | OMIM:617664 | Combined oxidative phosphorylation deficiency 32 | | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | MTFMT CL E G H | 123263 | 29666 | OMIM:614947 | Combined oxidative phosphorylation deficiency 15 | | | | 29 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | MTFMT CL E G H | 123263 | 29666 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 29 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MTHFR CL E G H | 4524 | 7436 | ORPHA:395 | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | HP:0040284 - Very rare | | | 183 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MTM1 CL E G H | 4534 | 7448 | OMIM:310400 | Myopathy, centronuclear, X-linked | . | | | 185 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MTRR CL E G H | 4552 | 7473 | ORPHA:2169 | Methylcobalamin deficiency type cblE | HP:0040283 - Occasional | | | 88 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MUSK CL E G H | 4593 | 7525 | OMIM:208150 | Fetal akinesia deformation sequence | . | | | 72 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | MYT1L CL E G H | 23040 | 7623 | OMIM:616521 | Mental retardation, autosomal dominant 39 | | | | 13 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NARS2 CL E G H | 79731 | 26274 | OMIM:616239 | Combined oxidative phosphorylation deficiency 24 | | | | 34 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NAXE CL E G H | 128240 | 18453 | OMIM:617186 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | | | | 9 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND2 CL E G H | 4536 | 7456 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND2 CL E G H | 4536 | 7456 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND3 CL E G H | 4537 | 7458 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND3 CL E G H | 4537 | 7458 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND4 CL E G H | 4538 | 7459 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND5 CL E G H | 4540 | 7461 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | ND6 CL E G H | 4541 | 7462 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA1 CL E G H | 4694 | 7683 | ORPHA:2609 | Isolated complex I deficiency | | | | 7 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA10 CL E G H | 4705 | 7684 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 91 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA11 CL E G H | 126328 | 20371 | ORPHA:2609 | Isolated complex I deficiency | | | | 32 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA12 CL E G H | 55967 | 23987 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 7 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA12 CL E G H | 55967 | 23987 | OMIM:618244 | Mitochondrial complex I deficiency, nuclear type 23 | | | | 7 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA13 CL E G H | 51079 | 17194 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 3 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA2 CL E G H | 4695 | 7685 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 19 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA4 CL E G H | 4697 | 7687 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 4 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA6 CL E G H | 4700 | 7690 | ORPHA:2609 | Isolated complex I deficiency | | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA6 CL E G H | 4700 | 7690 | OMIM:618253 | Mitochondrial complex I deficiency, nuclear type 33 | | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA8 CL E G H | 4702 | 7692 | OMIM:619272 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37; MC1DN37 | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFA9 CL E G H | 4704 | 7693 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF1 CL E G H | 51103 | 18828 | ORPHA:2609 | Isolated complex I deficiency | | | | 40 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:2609 | Isolated complex I deficiency | | | | 26 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 26 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:2609 | Isolated complex I deficiency | | | | 31 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 31 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF3 CL E G H | 25915 | 29918 | OMIM:618240 | Mitochondrial complex I deficiency, nuclear type 18 | | | | 31 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF4 CL E G H | 29078 | 21034 | ORPHA:2609 | Isolated complex I deficiency | | | | 50 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:2609 | Isolated complex I deficiency | | | | 34 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 34 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF5 CL E G H | 79133 | 15899 | OMIM:618238 | Mitochondrial complex I deficiency, nuclear type 16 | | | | 34 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 39 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFAF8 CL E G H | 284184 | 33551 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFB10 CL E G H | 4716 | 7696 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2609 | Isolated complex I deficiency | | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NDUFB11 CL E G H | 54539 | 20372 | OMIM:309801 | Microphthalmia, syndromic 7 | . | | | 3 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFB3 CL E G H | 4709 | 7698 | ORPHA:2609 | Isolated complex I deficiency | | | | 9 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFB8 CL E G H | 4714 | 7703 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFB8 CL E G H | 4714 | 7703 | OMIM:618252 | Mitochondrial complex I deficiency, nuclear type 32 | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFB9 CL E G H | 4715 | 7704 | ORPHA:2609 | Isolated complex I deficiency | | | | 16 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:2609 | Isolated complex I deficiency | | | | 81 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 81 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:2609 | Isolated complex I deficiency | | | | 65 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 65 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 65 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:2609 | Isolated complex I deficiency | | | | 22 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 22 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS3 CL E G H | 4722 | 7710 | OMIM:618230 | Mitochondrial complex I deficiency, nuclear type 8 | | | | 22 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:2609 | Isolated complex I deficiency | | | | 27 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | | | | 27 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | | | | 27 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS6 CL E G H | 4726 | 7713 | ORPHA:2609 | Isolated complex I deficiency | | | | 21 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:2609 | Isolated complex I deficiency | | | | 38 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 38 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:2609 | Isolated complex I deficiency | | | | 42 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 42 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:2609 | Isolated complex I deficiency | | | | 74 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 74 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFV1 CL E G H | 4723 | 7716 | OMIM:618225 | Mitochondrial complex I deficiency, nuclear type 4 | | | | 74 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:2609 | Isolated complex I deficiency | | | | 27 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NEK10 CL E G H | 152110 | 18592 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | HP:0040283 - Occasional | | | 43 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NF1 CL E G H | 4763 | 7765 | ORPHA:363700 | Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion | HP:0040284 - Very rare | | | 1952 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NF1 CL E G H | 4763 | 7765 | OMIM:162200 | Neurofibromatosis, type I | . | | | 1952 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 220 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:637 | Neurofibromatosis type 2 | HP:0040283 - Occasional | | | 220 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NFIX CL E G H | 4784 | 7788 | OMIM:602535 | Marshall-Smith syndrome | | | | 40 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | | | | 32 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | | | | 32 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | NGLY1 CL E G H | 55768 | 17646 | OMIM:615273 | Congenital disorder of deglycosylation | | | | 32 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NGLY1 CL E G H | 55768 | 17646 | OMIM:615273 | Congenital disorder of deglycosylation | | | | 32 | | |
HP:0002921 | HP:0030981 | Abnormal CSF/serum albumin ratio | 1 | NGLY1 CL E G H | 55768 | 17646 | OMIM:615273 | Congenital disorder of deglycosylation | | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NKX3-2 CL E G H | 579 | 951 | OMIM:613330 | Spondylo-Megaepiphyseal-Metaphyseal dysplasia | | | | 10 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NME8 CL E G H | 51314 | 16473 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 50 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NODAL CL E G H | 4838 | 7865 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NODAL CL E G H | 4838 | 7865 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NODAL CL E G H | 4838 | 7865 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NODAL CL E G H | 4838 | 7865 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NOTCH1 CL E G H | 4851 | 7881 | ORPHA:974 | Adams-Oliver syndrome | HP:0040282 - Frequent | | | 452 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NOTCH2 CL E G H | 4853 | 7882 | ORPHA:955 | Hajdu-Cheney syndrome | HP:0040283 - Occasional | | | 138 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NOTCH2 CL E G H | 4853 | 7882 | OMIM:102500 | Hajdu-Cheney syndrome | . | | | 138 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:603472 | NEURONAL INTRANUCLEAR INCLUSION DISEASE | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:603472 | NEURONAL INTRANUCLEAR INCLUSION DISEASE | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:619473 | OCULOPHARYNGODISTAL MYOPATHY 3; OPDM3 | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NPHP1 CL E G H | 4867 | 7905 | ORPHA:220497 | Joubert syndrome with renal defect | HP:0040283 - Occasional | | | 85 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NR4A2 CL E G H | 4929 | 7981 | OMIM:619911 | | | | | 27 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NR4A2 CL E G H | 4929 | 7981 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 27 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NRAS CL E G H | 4893 | 7989 | ORPHA:626 | Large congenital melanocytic nevus | HP:0040283 - Occasional | | | 102 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NRAS CL E G H | 4893 | 7989 | OMIM:249400 | Neurocutaneous melanosis, somatic | HP:0040283 - Occasional | | | 102 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NRCAM CL E G H | 4897 | 7994 | OMIM:619833 | | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NSD2 CL E G H | 7468 | 12766 | OMIM:194190 | Wolf-Hirschhorn syndrome | HP:0040283 - Occasional | | | 118 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | NSUN2 CL E G H | 54888 | 25994 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 84 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NUBPL CL E G H | 80224 | 20278 | ORPHA:2609 | Isolated complex I deficiency | | | | 89 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | NUBPL CL E G H | 80224 | 20278 | OMIM:618242 | Mitochondrial complex I deficiency, nuclear type 21 | | | | 89 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | | | | 23 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ODAD1 CL E G H | 93233 | 26560 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ODAD2 CL E G H | 55130 | 25583 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ODAD3 CL E G H | 115948 | 28303 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ODAD4 CL E G H | 83538 | 25280 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | OFD1 CL E G H | 8481 | 2567 | OMIM:311200 | Orofaciodigital syndrome I | . | | | 201 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | OFD1 CL E G H | 8481 | 2567 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 201 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | OGDH CL E G H | 4967 | 8124 | ORPHA:31 | Oxoglutaric aciduria | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | OSTM1 CL E G H | 28962 | 21652 | OMIM:259720 | Osteopetrosis, autosomal recessive 5 | . | | | 73 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | P4HB CL E G H | 5034 | 8548 | ORPHA:2050 | Cole-Carpenter syndrome | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | P4HB CL E G H | 5034 | 8548 | OMIM:112240 | Cole-Carpenter syndrome 1 | . | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PAK2 CL E G H | 5062 | 8591 | ORPHA:1571 | Knobloch syndrome | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PAK3 CL E G H | 5063 | 8592 | OMIM:300558 | MENTAL RETARDATION, X-LINKED 30; MRX30 | | | | 27 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PALB2 CL E G H | 79728 | 26144 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 1349 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 9 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 88 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 88 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PDHA1 CL E G H | 5160 | 8806 | OMIM:312170 | Pyruvate dehydrogenase e1-alpha deficiency | | | | 88 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PDHX CL E G H | 8050 | 21350 | ORPHA:255182 | Pyruvate dehydrogenase E3-binding protein deficiency | | | | 98 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PET100 CL E G H | 100131801 | 40038 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 6 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PET100 CL E G H | 100131801 | 40038 | OMIM:619055 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12 | | | | 6 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PEX19 CL E G H | 5824 | 9713 | OMIM:614886 | Peroxisome biogenesis disorder 12A (Zellweger) | . | | | 62 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PEX7 CL E G H | 5191 | 8860 | OMIM:266500 | Refsum disease | | | | 72 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PHYH CL E G H | 5264 | 8940 | OMIM:266500 | Refsum disease | | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIBF1 CL E G H | 10464 | 23352 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 4 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIEZO2 CL E G H | 63895 | 26270 | ORPHA:2461 | Marden-Walker syndrome | HP:0040283 - Occasional | | | 77 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIGU CL E G H | 128869 | 15791 | OMIM:618590 | NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIGV CL E G H | 55650 | 26031 | OMIM:239300 | Hyperphosphatasia with mental retardation | | | | 57 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIK3CA CL E G H | 5290 | 8975 | OMIM:602501 | Megalencephaly-Capillary malformation-polymicrogyria syndrome | . | | | 162 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:60040 | Megalencephaly-capillary malformation-polymicrogyria syndrome | HP:0040282 - Frequent | | | 162 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 162 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIK3R2 CL E G H | 5296 | 8980 | OMIM:603387 | Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome | . | | | 12 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PIK3R2 CL E G H | 5296 | 8980 | ORPHA:83473 | Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome | HP:0040281 - Very frequent | | | 12 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PLCH1 CL E G H | 23007 | 29185 | OMIM:619895 | | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PLCH1 CL E G H | 23007 | 29185 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PLG CL E G H | 5340 | 9071 | ORPHA:722 | Hypoplasminogenemia | HP:0040283 - Occasional | | | 11 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PLG CL E G H | 5340 | 9071 | OMIM:217090 | Plasminogen deficiency, type iligneous conjunctivitis, included | . | | | 11 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PMP22 CL E G H | 5376 | 9118 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | | | | 79 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PNPO CL E G H | 55163 | 30260 | ORPHA:79096 | Pyridoxal phosphate-responsive seizures | | | | 92 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PNPO CL E G H | 55163 | 30260 | OMIM:610090 | Pyridoxamine 5-prime-phosphate oxidase deficiency | | | | 92 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PNPT1 CL E G H | 87178 | 23166 | ORPHA:319514 | Combined oxidative phosphorylation defect type 13 | | | | 60 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PNPT1 CL E G H | 87178 | 23166 | OMIM:614932 | Combined oxidative phosphorylation deficiency 13 | | | | 60 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | POLG CL E G H | 5428 | 9179 | OMIM:203700 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | | | | 464 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | POLG CL E G H | 5428 | 9179 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 464 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | POLG CL E G H | 5428 | 9179 | OMIM:258450 | Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive | | | | 464 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POLR3A CL E G H | 11128 | 30074 | OMIM:264090 | Wiedemann-Rautenstrauch syndrome | . | | | 138 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | HP:0040282 - Frequent | | | 138 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMGNT1 CL E G H | 55624 | 19139 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | HP:0040282 - Frequent | | | 180 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMGNT1 CL E G H | 55624 | 19139 | ORPHA:588 | Muscle-eye-brain disease | HP:0040281 - Very frequent | | | 180 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMGNT1 CL E G H | 55624 | 19139 | OMIM:253280 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3 | | | | 180 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMGNT1 CL E G H | 55624 | 19139 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 180 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMGNT2 CL E G H | 84892 | 25902 | OMIM:614830 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8 | . | | | 33 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMGNT2 CL E G H | 84892 | 25902 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 33 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMK CL E G H | 84197 | 26267 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | HP:0040282 - Frequent | | | 18 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMK CL E G H | 84197 | 26267 | OMIM:615249 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12 | HP:0040283 - Occasional | | | 18 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMK CL E G H | 84197 | 26267 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 18 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT1 CL E G H | 10585 | 9202 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | HP:0040282 - Frequent | | | 213 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT1 CL E G H | 10585 | 9202 | ORPHA:588 | Muscle-eye-brain disease | HP:0040281 - Very frequent | | | 213 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT1 CL E G H | 10585 | 9202 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 213 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT1 CL E G H | 10585 | 9202 | OMIM:613155 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1 | | | | 213 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT1 CL E G H | 10585 | 9202 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 213 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT2 CL E G H | 29954 | 19743 | ORPHA:370959 | Congenital muscular dystrophy with cerebellar involvement | HP:0040282 - Frequent | | | 221 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT2 CL E G H | 29954 | 19743 | ORPHA:588 | Muscle-eye-brain disease | HP:0040281 - Very frequent | | | 221 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT2 CL E G H | 29954 | 19743 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 221 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT2 CL E G H | 29954 | 19743 | OMIM:613150 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2 | | | | 221 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POMT2 CL E G H | 29954 | 19743 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | 221 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POR CL E G H | 5447 | 9208 | OMIM:207410 | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis | . | | | 76 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | HP:0040283 - Occasional | | | 76 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PORCN CL E G H | 64840 | 17652 | OMIM:305600 | Focal dermal hypoplasia | . | | | 20 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PPP1CB CL E G H | 5500 | 9282 | ORPHA:2701 | Noonan syndrome-like disorder with loose anagen hair | HP:0040282 - Frequent | | | 9 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | PPP1R21 CL E G H | 129285 | 30595 | OMIM:619383 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES; NEDHFBA | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PPP2R1A CL E G H | 5518 | 9302 | OMIM:616362 | Mental retardation, autosomal dominant 36 | . | | | 13 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PPP2R1A CL E G H | 5518 | 9302 | ORPHA:457284 | Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome | HP:0040283 - Occasional | | | 13 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PPP2R5D CL E G H | 5528 | 9312 | OMIM:616355 | Mental retardation, autosomal dominant 35 | . | | | 10 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PRDX1 CL E G H | 5052 | 9352 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 58 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | PRF1 CL E G H | 5551 | 9360 | OMIM:603553 | Hemophagocytic lymphohistiocytosis, familial, 2 | | | | 58 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PRF1 CL E G H | 5551 | 9360 | OMIM:603553 | Hemophagocytic lymphohistiocytosis, familial, 2 | | | | 58 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:101800 | Acrodysostosis 1, with or without hormone resistance | . | | | 134 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PRNP CL E G H | 5621 | 9449 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | 69 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PRNP CL E G H | 5621 | 9449 | ORPHA:282166 | Inherited Creutzfeldt-Jakob disease | | | | 69 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 94 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 94 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PRX CL E G H | 57716 | 13797 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | | | | 170 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:206436 | Infantile Krabbe disease | | | | 81 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PSAP CL E G H | 5660 | 9498 | OMIM:611722 | KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY | | | | 81 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 81 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 81 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | | | | 81 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 665 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH1 CL E G H | 5727 | 9585 | OMIM:109400 | Basal cell nevus syndrome | | | | 665 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:377 | Gorlin syndrome | HP:0040283 - Occasional | | | 665 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH1 CL E G H | 5727 | 9585 | OMIM:610828 | Holoprosencephaly 7 | | | | 665 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 665 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 665 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:77301 | Monosomy 9q22.3 | HP:0040282 - Frequent | | | 665 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 665 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH2 CL E G H | 8643 | 9586 | OMIM:109400 | Basal cell nevus syndrome | | | | 40 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTCH2 CL E G H | 8643 | 9586 | ORPHA:377 | Gorlin syndrome | HP:0040283 - Occasional | | | 40 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTDSS1 CL E G H | 9791 | 9587 | ORPHA:2658 | Lenz-Majewski hyperostotic dwarfism | HP:0040283 - Occasional | | | 6 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:65285 | Lhermitte-Duclos disease | HP:0040281 - Very frequent | | | 948 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:2969 | Proteus-like syndrome | HP:0040282 - Frequent | | | 948 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | PYCR1 CL E G H | 5831 | 9721 | OMIM:612940 | Cutis laxa, autosomal recessive, type IIB | . | | | 53 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RAC3 CL E G H | 5881 | 9803 | OMIM:618577 | NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF | | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RAD51 CL E G H | 5888 | 9817 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 9 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RAD51 CL E G H | 5888 | 9817 | OMIM:617244 | Fanconi anemia, complementation group R | . | | | 9 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RAD51C CL E G H | 5889 | 9820 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 391 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | RANBP2 CL E G H | 5903 | 9848 | OMIM:608033 | Encephalopathy, acute, infection-induced, susceptibility to, 3 | | | | 57 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | RANBP2 CL E G H | 5903 | 9848 | ORPHA:88619 | Familial acute necrotizing encephalopathy | | | | 57 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | RARS2 CL E G H | 57038 | 21406 | OMIM:611523 | Pontocerebellar hypoplasia, type 6 | | | | 93 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RASA1 CL E G H | 5921 | 9871 | ORPHA:137667 | Capillary malformation-arteriovenous malformation | HP:0040284 - Very rare | | | 88 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RBPJ CL E G H | 3516 | 5724 | ORPHA:974 | Adams-Oliver syndrome | HP:0040282 - Frequent | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RECQL4 CL E G H | 9401 | 9949 | OMIM:218600 | Baller-Gerold syndrome | . | | | 445 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RFWD3 CL E G H | 55159 | 25539 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | RMND1 CL E G H | 55005 | 21176 | OMIM:614922 | Combined oxidative phosphorylation deficiency 11 | | | | 26 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | RNASEH2A CL E G H | 10535 | 18518 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 33 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | RNASEH2A CL E G H | 10535 | 18518 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 33 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RNASEH2A CL E G H | 10535 | 18518 | OMIM:610333 | Aicardi-Goutieres syndrome 4 | . | | | 33 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | RNASEH2A CL E G H | 10535 | 18518 | OMIM:610333 | Aicardi-Goutieres syndrome 4 | | | | 33 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | RNASEH2B CL E G H | 79621 | 25671 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 34 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | RNASEH2B CL E G H | 79621 | 25671 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 34 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | RNASEH2B CL E G H | 79621 | 25671 | OMIM:610181 | Aicardi-Goutieres syndrome 2 | | | | 34 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | RNASEH2C CL E G H | 84153 | 24116 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 60 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | RNASEH2C CL E G H | 84153 | 24116 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 60 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | RNASEH2C CL E G H | 84153 | 24116 | OMIM:610329 | Aicardi-Goutieres syndrome 3 | | | | 60 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RNF125 CL E G H | 54941 | 21150 | OMIM:616260 | Tenorio syndrome | . | | | 5 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RNU4ATAC CL E G H | 100151683 | 34016 | OMIM:210710 | Microcephalic osteodysplastic primordial dwarfism, type I | | | | 15 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | RNU7-1 CL E G H | 100147744 | 34033 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | RNU7-1 CL E G H | 100147744 | 34033 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ROGDI CL E G H | 79641 | 29478 | ORPHA:1946 | Amelocerebrohypohidrotic syndrome | HP:0040283 - Occasional | | | 57 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RPGR CL E G H | 6103 | 10295 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 200 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RPGRIP1 CL E G H | 57096 | 13436 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 109 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RPGRIP1L CL E G H | 23322 | 29168 | ORPHA:1454 | Joubert syndrome with hepatic defect | HP:0040283 - Occasional | | | 167 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RPGRIP1L CL E G H | 23322 | 29168 | ORPHA:220497 | Joubert syndrome with renal defect | HP:0040283 - Occasional | | | 167 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RPGRIP1L CL E G H | 23322 | 29168 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 167 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | RPIA CL E G H | 22934 | 10297 | OMIM:608611 | Ribose 5-phosphate isomerase deficiency | | | | 18 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | RRM2B CL E G H | 50484 | 17296 | OMIM:612075 | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) | | | | 125 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | RRM2B CL E G H | 50484 | 17296 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 125 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RSPH1 CL E G H | 89765 | 12371 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 31 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RSPH3 CL E G H | 83861 | 21054 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 5 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RSPH4A CL E G H | 345895 | 21558 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 58 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RSPH9 CL E G H | 221421 | 21057 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 20 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RSPO2 CL E G H | 340419 | 28583 | ORPHA:3301 | Tetraamelia-multiple malformations syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | RXYLT1 CL E G H | 10329 | 13530 | ORPHA:899 | Walker-Warburg syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SALL1 CL E G H | 6299 | 10524 | OMIM:107480 | Townes-Brocks syndrome 1 | | | | 124 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | SAMHD1 CL E G H | 25939 | 15925 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 55 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SAMHD1 CL E G H | 25939 | 15925 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 55 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | SAMHD1 CL E G H | 25939 | 15925 | OMIM:612952 | Aicardi-Goutieres syndrome 5 | | | | 55 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 1053 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 1053 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SCO2 CL E G H | 9997 | 10604 | OMIM:604377 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | | | | 40 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SCO2 CL E G H | 9997 | 10604 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 40 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SDHA CL E G H | 6389 | 10680 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 304 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SEC24D CL E G H | 9871 | 10706 | ORPHA:2050 | Cole-Carpenter syndrome | | | | 5 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SEC24D CL E G H | 9871 | 10706 | OMIM:616294 | Cole-Carpenter syndrome 2 | . | | | 5 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SF3B2 CL E G H | 10992 | 10769 | OMIM:164210 | Hemifacial microsomia | . | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SF3B4 CL E G H | 10262 | 10771 | OMIM:154400 | Acrofacial dysostosis 1, Nager type | . | | | 49 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SHH CL E G H | 6469 | 10848 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 67 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SHH CL E G H | 6469 | 10848 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 67 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SHH CL E G H | 6469 | 10848 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 67 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SHH CL E G H | 6469 | 10848 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 67 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SHOC2 CL E G H | 8036 | 15454 | ORPHA:2701 | Noonan syndrome-like disorder with loose anagen hair | HP:0040282 - Frequent | | | 74 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SIK3 CL E G H | 23387 | 29165 | OMIM:618162 | Spondyloepimetaphyseal dysplasia, Krakow type | . | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SIX3 CL E G H | 6496 | 10889 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SKI CL E G H | 6497 | 10896 | OMIM:182212 | Shprintzen-Goldberg craniosynostosis syndrome | | | | 150 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SKI CL E G H | 6497 | 10896 | ORPHA:2462 | Shprintzen-Goldberg syndrome | | | | 150 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | SLC12A2 CL E G H | 6558 | 10911 | OMIM:619080 | KILQUIST SYNDROME; KILQS | | | | 2 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | SLC12A6 CL E G H | 9990 | 10914 | OMIM:218000 | Agenesis of the corpus callosum with peripheral neuropathy | | | | 163 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | | | | 2 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SLC13A5 CL E G H | 284111 | 23089 | ORPHA:1946 | Amelocerebrohypohidrotic syndrome | HP:0040283 - Occasional | | | 73 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SLC17A5 CL E G H | 26503 | 10933 | OMIM:269920 | Infantile sialic acid storage disease | . | | | 78 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC19A3 CL E G H | 80704 | 16266 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 110 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC25A19 CL E G H | 60386 | 14409 | OMIM:613710 | Thiamine metabolism dysfunction syndrome 4 (bilateral striatal degenerationand progressive polyneuropathy type) | | | | 36 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SLC25A24 CL E G H | 29957 | 20662 | OMIM:612289 | Fontaine progeroid syndrome | . | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC25A4 CL E G H | 291 | 10990 | OMIM:615418 | Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type) | | | | 68 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC25A4 CL E G H | 291 | 10990 | OMIM:617184 | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | | | | 68 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SLC29A3 CL E G H | 55315 | 23096 | ORPHA:168569 | H syndrome | HP:0040283 - Occasional | | | 68 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:71277 | Classic glucose transporter type 1 deficiency syndrome | | | | 255 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:606777 | Glut1 deficiency syndrome 1 | | | | 255 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:612126 | Glut1 deficiency syndrome 2 | | | | 255 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:168577 | Hereditary cryohydrocytosis with reduced stomatin | | | | 255 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:168577 | Hereditary cryohydrocytosis with reduced stomatin | | | | 255 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:608885 | Stomatin-Deficient cryohydrocytosis with neurologic defects | | | | 255 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC39A8 CL E G H | 64116 | 20862 | ORPHA:468699 | SLC39A8-CDG | | | | 11 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SLC6A3 CL E G H | 6531 | 11049 | OMIM:613135 | Parkinsonism-Dystonia, infantile, 1 | | | | 13 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SLX4 CL E G H | 84464 | 23845 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 274 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:99966 | Atypical teratoid rhabdoid tumor | HP:0040282 - Frequent | | | 87 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 87 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 47 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SMC1A CL E G H | 8243 | 11111 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 135 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SMO CL E G H | 6608 | 11119 | OMIM:241800 | Hypothalamic hamartomascongenital hypothalamic hamartoma syndrome, included | . | | | 22 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 22 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SMOC1 CL E G H | 64093 | 20318 | ORPHA:1106 | Microphthalmia with limb anomalies | HP:0040283 - Occasional | | | 15 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SNX10 CL E G H | 29887 | 14974 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | HP:0040281 - Very frequent | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SOX2 CL E G H | 6657 | 11195 | ORPHA:77298 | Anophthalmia/microphthalmia-esophageal atresia syndrome | HP:0040283 - Occasional | | | 33 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SOX9 CL E G H | 6662 | 11204 | OMIM:114290 | Campomelic dysplasia | . | | | 109 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SPAG1 CL E G H | 6674 | 11212 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SPEF2 CL E G H | 79925 | 26293 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 15 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SPTBN1 CL E G H | 6711 | 11275 | OMIM:619475 | DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SPTBN1 CL E G H | 6711 | 11275 | OMIM:619475 | DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | STAG2 CL E G H | 10735 | 11355 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | STAG2 CL E G H | 10735 | 11355 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | STAT2 CL E G H | 6773 | 11363 | OMIM:616636 | Immunodeficiency 44 | | | | 9 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | STIL CL E G H | 6491 | 10879 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 99 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | STIL CL E G H | 6491 | 10879 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 99 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | STIL CL E G H | 6491 | 10879 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 99 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | STIL CL E G H | 6491 | 10879 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 99 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | STK36 CL E G H | 27148 | 17209 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 3 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 85 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 70 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SUCLG1 CL E G H | 8802 | 11449 | ORPHA:17 | Fatal infantile lactic acidosis with methylmalonic aciduria | | | | 60 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SUCLG1 CL E G H | 8802 | 11449 | OMIM:245400 | Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria) | | | | 60 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SUFU CL E G H | 51684 | 16466 | OMIM:109400 | Basal cell nevus syndrome | | | | 124 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:377 | Gorlin syndrome | HP:0040283 - Occasional | | | 124 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 124 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 124 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SUMF1 CL E G H | 285362 | 20376 | ORPHA:585 | Multiple sulfatase deficiency | HP:0040282 - Frequent | | | 80 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | SUMF1 CL E G H | 285362 | 20376 | OMIM:272200 | Multiple sulfatase deficiency | | | | 80 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | SUMF1 CL E G H | 285362 | 20376 | OMIM:272200 | Multiple sulfatase deficiency | . | | | 80 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SURF1 CL E G H | 6834 | 11474 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 73 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SURF1 CL E G H | 6834 | 11474 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 73 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | SURF1 CL E G H | 6834 | 11474 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | 73 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TACO1 CL E G H | 51204 | 24316 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 23 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TAF2 CL E G H | 6873 | 11536 | OMIM:615599 | Mental retardation, autosomal recessive 40 | | | | 7 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TAF2 CL E G H | 6873 | 11536 | ORPHA:397951 | Microcephaly-thin corpus callosum-intellectual disability syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TAOK1 CL E G H | 57551 | 29259 | OMIM:619575 | DEVELOPMENTAL DELAY WITH OR WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES; DDIB | | | | | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | TBCK CL E G H | 93627 | 28261 | OMIM:616900 | Hypotonia, infantile, with psychomotor retardation and characteristic facies 3 | | | | 13 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 20 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 20 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 20 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TBX15 CL E G H | 6913 | 11594 | OMIM:260660 | Cousin syndrome | . | | | 5 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TBXT CL E G H | 6862 | 11515 | OMIM:182940 | Neural tube defects, susceptibility to | . | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TCIRG1 CL E G H | 10312 | 11647 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | HP:0040281 - Very frequent | | | 82 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TCIRG1 CL E G H | 10312 | 11647 | OMIM:259700 | Osteopetrosis, autosomal recessive 1 | | | | 82 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TCTN1 CL E G H | 79600 | 26113 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TCTN1 CL E G H | 79600 | 26113 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TCTN2 CL E G H | 79867 | 25774 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 76 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TCTN2 CL E G H | 79867 | 25774 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 76 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TCTN3 CL E G H | 26123 | 24519 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 31 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | 238 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | TET3 CL E G H | 200424 | 28313 | OMIM:618798 | BECK-FAHRNER SYNDROME; BEFAHRS | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TGFBR1 CL E G H | 7046 | 11772 | OMIM:609192 | Loeys-Dietz syndrome 1 | | | | 239 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TGFBR2 CL E G H | 7048 | 11773 | OMIM:610168 | Loeys-Dietz syndrome 2 | | | | 253 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TH CL E G H | 7054 | 11782 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | | | | 80 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TH CL E G H | 7054 | 11782 | OMIM:605407 | Segawa syndrome, autosomal recessive | | | | 80 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 6 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 6 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 6 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TIMM50 CL E G H | 92609 | 23656 | OMIM:617698 | 3-methylglutaconic aciduria, type IX | | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TIMMDC1 CL E G H | 51300 | 1321 | ORPHA:2609 | Isolated complex I deficiency | | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 3 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 3 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 3 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM107 CL E G H | 84314 | 28128 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 4 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TMEM126B CL E G H | 55863 | 30883 | ORPHA:2609 | Isolated complex I deficiency | | | | 4 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM138 CL E G H | 51524 | 26944 | ORPHA:2318 | Joubert syndrome with oculorenal defect | HP:0040283 - Occasional | | | 39 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM216 CL E G H | 51259 | 25018 | OMIM:608091 | Joubert syndrome 2 | . | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM216 CL E G H | 51259 | 25018 | ORPHA:2318 | Joubert syndrome with oculorenal defect | HP:0040283 - Occasional | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM216 CL E G H | 51259 | 25018 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 45 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM218 CL E G H | 219854 | 27344 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM222 CL E G H | 84065 | 25363 | OMIM:619470 | NEURODEVELOPMENTAL DISORDER WITH MOTOR AND SPEECH DELAY AND BEHAVIORAL ABNORMALITIES; NEDMOSBA | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM231 CL E G H | 79583 | 37234 | ORPHA:2318 | Joubert syndrome with oculorenal defect | HP:0040283 - Occasional | | | 33 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM231 CL E G H | 79583 | 37234 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 33 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 82 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM237 CL E G H | 65062 | 14432 | OMIM:614424 | Joubert syndrome 14 | . | | | 82 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:2318 | Joubert syndrome with oculorenal defect | HP:0040283 - Occasional | | | 82 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:220497 | Joubert syndrome with renal defect | HP:0040283 - Occasional | | | 82 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM237 CL E G H | 65062 | 14432 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 82 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM67 CL E G H | 91147 | 28396 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | 166 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM67 CL E G H | 91147 | 28396 | ORPHA:1454 | Joubert syndrome with hepatic defect | HP:0040283 - Occasional | | | 166 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM67 CL E G H | 91147 | 28396 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 166 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TMEM67 CL E G H | 91147 | 28396 | OMIM:607361 | Meckel syndrome 3 | HP:0040283 - Occasional | | | 166 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TNFRSF11A CL E G H | 8792 | 11908 | OMIM:612301 | OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7 | | | | 72 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TNFSF11 CL E G H | 8600 | 11926 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | HP:0040281 - Very frequent | | | 44 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TNFSF11 CL E G H | 8600 | 11926 | OMIM:259710 | Osteopetrosis, autosomal recessive 2 | | | | 44 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TOE1 CL E G H | 114034 | 15954 | OMIM:614969 | Pontocerebellar hypoplasia, type 7 | | | | 6 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TOGARAM1 CL E G H | 23116 | 19959 | ORPHA:475 | Joubert syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TP53 CL E G H | 7157 | 11998 | OMIM:260500 | Papilloma of choroid plexus | . | | | 911 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:2807 | Papilloma of choroid plexus | HP:0040281 - Very frequent | | | 911 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TPK1 CL E G H | 27010 | 17358 | OMIM:614458 | Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type) | | | | 21 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 2 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 2 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRAPPC12 CL E G H | 51112 | 24284 | ORPHA:500144 | Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TREM2 CL E G H | 54209 | 17761 | ORPHA:2770 | Nasu-Hakola disease | HP:0040283 - Occasional | | | 31 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TREX1 CL E G H | 11277 | 12269 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 56 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | TREX1 CL E G H | 11277 | 12269 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 56 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TRIM71 CL E G H | 131405 | 32669 | OMIM:618667 | HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1; HYDCC1 | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TRMT1 CL E G H | 55621 | 25980 | OMIM:618302 | Intellectual developmental disorder, autosomal recessive 68 | | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRMT10C CL E G H | 54931 | 26022 | OMIM:616974 | Combined oxidative phosphorylation deficiency 30 | | | | 3 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNK CL E G H | 4566 | 7489 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNN CL E G H | 4570 | 7493 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNS1 CL E G H | 4574 | 7497 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TRNT1 CL E G H | 51095 | 17341 | OMIM:616084 | SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD | | | | 28 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNV CL E G H | 4577 | 7500 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TRNW CL E G H | 4578 | 7501 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TRPV4 CL E G H | 59341 | 18083 | ORPHA:2635 | Metatropic dysplasia | HP:0040283 - Occasional | | | 214 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TSC1 CL E G H | 7248 | 12362 | ORPHA:538 | Lymphangioleiomyomatosis | HP:0040283 - Occasional | | | 1090 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TSC1 CL E G H | 7248 | 12362 | ORPHA:805 | Tuberous sclerosis complex | | | | 1090 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TSC2 CL E G H | 7249 | 12363 | ORPHA:538 | Lymphangioleiomyomatosis | HP:0040283 - Occasional | | | 2738 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TSC2 CL E G H | 7249 | 12363 | ORPHA:805 | Tuberous sclerosis complex | | | | 2738 | | |
HP:0002921 | HP:0012510 | Extra-axial cerebrospinal fluid accumulation | 1 | TSEN15 CL E G H | 116461 | 16791 | OMIM:617026 | Pontocerebellar hypoplasia, type 2F | | | | 3 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TSPOAP1 CL E G H | 9256 | 16831 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TTC12 CL E G H | 54970 | 23700 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TTC26 CL E G H | 79989 | 21882 | OMIM:619534 | BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TTR CL E G H | 7276 | 12405 | OMIM:105210 | Amyloidosis, hereditary, transthyretin-related | | | | 107 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TUBB3 CL E G H | 10381 | 20772 | ORPHA:300570 | Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation | | | | 64 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TXN2 CL E G H | 25828 | 17772 | ORPHA:478029 | Combined oxidative phosphorylation defect type 29 | | | | 1 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TXN2 CL E G H | 25828 | 17772 | ORPHA:478029 | Combined oxidative phosphorylation defect type 29 | | | | 1 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | TXN2 CL E G H | 25828 | 17772 | OMIM:616811 | Combined oxidative phosphorylation deficiency 29 | | | | 1 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TXN2 CL E G H | 25828 | 17772 | OMIM:616811 | Combined oxidative phosphorylation deficiency 29 | | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TXNDC15 CL E G H | 79770 | 20652 | ORPHA:564 | Meckel syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | TYMP CL E G H | 1890 | 3148 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 138 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | TYROBP CL E G H | 7305 | 12449 | ORPHA:2770 | Nasu-Hakola disease | HP:0040283 - Occasional | | | 22 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | UBE2T CL E G H | 29089 | 25009 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 116 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0002921 | HP:0025456 | Abnormal CSF protein concentration | 1 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 5 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 5 | | |
HP:0002921 | HP:0012229 | CSF pleocytosis | 1 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 5 | | |
HP:0002921 | HP:0025454 | Abnormal CSF metabolite concentration | 1 | UQCC2 CL E G H | 84300 | 21237 | OMIM:615824 | Mitochondrial complex III deficiency, nuclear type 7 | | | | 7 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | USP7 CL E G H | 7874 | 12630 | ORPHA:500055 | 16p13.2 microdeletion syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | VAC14 CL E G H | 55697 | 25507 | ORPHA:3472 | Yunis-Varon syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | VANGL1 CL E G H | 81839 | 15512 | OMIM:182940 | Neural tube defects, susceptibility to | . | | | 111 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | VANGL1 CL E G H | 81839 | 15512 | OMIM:600145 | Sacral defect with anterior meningocele | | | | 111 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | VANGL2 CL E G H | 57216 | 15511 | OMIM:182940 | Neural tube defects, susceptibility to | . | | | 2 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | VPS33A CL E G H | 65082 | 18179 | ORPHA:505248 | Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | VSX1 CL E G H | 30813 | 12723 | OMIM:614195 | Craniofacial anomalies and anterior segment dysgenesis syndrome | . | | | 47 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | WASHC5 CL E G H | 9897 | 28984 | ORPHA:7 | 3C syndrome | HP:0040282 - Frequent | | | 83 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | WASHC5 CL E G H | 9897 | 28984 | OMIM:220210 | Ritscher-Schinzel syndrome 1 | . | | | 83 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | WDR81 CL E G H | 124997 | 26600 | OMIM:617967 | Hydrocephalus, congenital, 3, with brain anomalies | . | | | 27 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | WNT3 CL E G H | 7473 | 12782 | OMIM:273395 | Tetraamelia, autosomal recessive | . | | | 12 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | WNT3 CL E G H | 7473 | 12782 | ORPHA:3301 | Tetraamelia-multiple malformations syndrome | HP:0040281 - Very frequent | | | 12 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | XRCC2 CL E G H | 7516 | 12829 | ORPHA:84 | Fanconi anemia | HP:0040283 - Occasional | | | 125 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZBTB20 CL E G H | 26137 | 13503 | ORPHA:3042 | Intellectual disability-cataracts-calcified pinnae-myopathy syndrome | HP:0040281 - Very frequent | | | 17 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZBTB24 CL E G H | 9841 | 21143 | ORPHA:2268 | ICF syndrome | | | | 9 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040283 - Occasional | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZIC2 CL E G H | 7546 | 12873 | OMIM:609637 | Holoprosencephaly 5 | . | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040283 - Occasional | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040283 - Occasional | | | 34 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZIC3 CL E G H | 7547 | 12874 | OMIM:306955 | Heterotaxy, visceral, 1, X-linked | | | | 39 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZIC3 CL E G H | 7547 | 12874 | OMIM:314390 | VACTERL association, X-linked | . | | | 39 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZMYND10 CL E G H | 51364 | 19412 | ORPHA:244 | Primary ciliary dyskinesia | HP:0040284 - Very rare | | | 20 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZNF423 CL E G H | 23090 | 16762 | ORPHA:2318 | Joubert syndrome with oculorenal defect | HP:0040283 - Occasional | | | 49 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZNHIT3 CL E G H | 9326 | 12309 | ORPHA:2836 | PEHO syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0002921 | HP:0000238 | Hydrocephalus | 1 | ZPR1 CL E G H | 8882 | 13051 | OMIM:619321 | GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF | | | | | | |
HP:0002921 | HP:0034406 | Elevated CSF angiotensin-converting enzyme concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0012654 | Abnormal CSF dopamine concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0032928 | Elevated CSF neurofilamant light chain concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0030860 | Abnormal CSF amyloid concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0032652 | Elevated CSF chitotriosidase 1 concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0034462 | Increased CSF L-alloisoleucine concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500117 | Abnormal CSF urate concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0032651 | Elevated CSF chitinase-3-like protein 1 concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0025459 | Increased CSF/serum albumin ratio | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0034460 | Increased CSF uracil concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0025688 | Abnormal amyloid beta peptide CSF concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0410312 | Hypersegmentation of neutrophil nuclei in CSF | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0032650 | Elevated CSF glial fibrillary acidic protein concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0012756 | CSF polymorphonuclear pleocytosis | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0034455 | Increased CSF taurine concentration | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0410311 | Hyposegmentation of neutrophil nuclei in CSF | 2 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | | | | 15 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ABHD5 CL E G H | 51099 | 21396 | ORPHA:98907 | Neutral lipid storage disease with ichthyosis | HP:0040282 - Frequent | | | 90 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | ADAR CL E G H | 103 | 225 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 116 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | ADAR CL E G H | 103 | 225 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 116 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | ADAR CL E G H | 103 | 225 | OMIM:615010 | Aicardi-Goutieres syndrome 6 | | | | 116 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | | | | 26 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | AIFM1 CL E G H | 9131 | 8768 | OMIM:300816 | Combined oxidative phosphorylation deficiency 6 | | | | 60 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | AIFM1 CL E G H | 9131 | 8768 | ORPHA:238329 | Severe X-linked mitochondrial encephalomyopathy | | | | 60 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ALDH4A1 CL E G H | 8659 | 406 | ORPHA:79101 | Hyperprolinemia type 2 | | | | 74 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ALDH4A1 CL E G H | 8659 | 406 | ORPHA:79101 | Hyperprolinemia type 2 | HP:0040282 - Frequent | | | 74 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | ALDH5A1 CL E G H | 7915 | 408 | OMIM:271980 | Succinic semialdehyde dehydrogenase deficiency | | | | 108 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ARSA CL E G H | 410 | 713 | OMIM:250100 | Metachromatic leukodystrophy | . | | | 253 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040282 - Frequent | | | 253 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | HP:0040282 - Frequent | | | 253 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ARSA CL E G H | 410 | 713 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | HP:0040282 - Frequent | | | 253 | | |
HP:0002921 | HP:0032274 | Increased CSF N-acetylaspartic acid concentration | 2 | ASPA CL E G H | 443 | 756 | OMIM:271900 | Canavan disease | . | | | 48 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 239 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 239 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ATP6 CL E G H | 4508 | 7414 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ATPAF2 CL E G H | 91647 | 18802 | OMIM:604273 | Mitochondrial complex V (atp synthase) deficiency, nuclear type 1 | | | | 32 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | B4GAT1 CL E G H | 11041 | 15685 | OMIM:615287 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13 | | | | 17 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | BCAT2 CL E G H | 587 | 977 | OMIM:618850 | HYPERVALINEMIA AND HYPERLEUCINE-ISOLEUCINEMIA; HVLI | | | | | | |
HP:0002921 | HP:0010953 | Noncommunicating hydrocephalus | 2 | BICRA CL E G H | 29998 | 4332 | OMIM:619325 | COFFIN-SIRIS SYNDROME 12; CSS12 | | | | 2 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | | | | 14 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | BTNL2 CL E G H | 56244 | 1142 | ORPHA:797 | Sarcoidosis | HP:0040283 - Occasional | | | 1 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 449 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 449 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | CD59 CL E G H | 966 | 1689 | OMIM:612300 | Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy | . | | | 3 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | CDC42BPB CL E G H | 9578 | 1738 | OMIM:619841 | | | | | | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | CDCA7 CL E G H | 83879 | 14628 | ORPHA:2268 | ICF syndrome | HP:0040282 - Frequent | | | 4 | | |
HP:0002921 | HP:0041043 | Neutrophil nuclear clefts | 2 | CEBPE CL E G H | 1053 | 1836 | OMIM:245480 | Specific granule deficiency | . | | | 3 | | |
HP:0002921 | HP:0002343 | Normal pressure hydrocephalus | 2 | CFAP43 CL E G H | 80217 | 26684 | OMIM:236690 | Hydrocephalus, normal pressure, 1 | | | | 6 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | CLPB CL E G H | 81570 | 30664 | OMIM:616271 | 3-Methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia | | | | 38 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COQ8A CL E G H | 56997 | 16812 | ORPHA:139485 | Autosomal recessive ataxia due to ubiquinone deficiency | | | | 136 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX10 CL E G H | 1352 | 2260 | OMIM:619046 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN3 | | | | 82 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX14 CL E G H | 84987 | 28216 | OMIM:619053 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10; MC4DN10 | | | | 4 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX15 CL E G H | 1355 | 2263 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 104 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX20 CL E G H | 116228 | 26970 | OMIM:619054 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11; MC4DN11 | | | | 25 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX4I1 CL E G H | 1327 | 2265 | OMIM:619060 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16 | | | | | | |
HP:0002921 | HP:0033503 | Elevated CSF fumarate concentration | 2 | COX4I1 CL E G H | 1327 | 2265 | OMIM:619060 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16 | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX6B1 CL E G H | 1340 | 2280 | OMIM:619051 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7 | | | | 10 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | COX8A CL E G H | 1351 | 2294 | OMIM:619059 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15 | | | | 1 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | DARS2 CL E G H | 55157 | 25538 | ORPHA:137898 | Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome | | | | 60 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | DDC CL E G H | 1644 | 2719 | OMIM:608643 | Aromatic L-amino acid decarboxylase deficiency | | | | 43 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | DLAT CL E G H | 1737 | 2896 | ORPHA:79244 | Pyruvate dehydrogenase E2 deficiency | | | | 82 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | DNAI1 CL E G H | 27019 | 2954 | OMIM:244400 | Ciliary dyskinesia, primary, 1 | . | | | 73 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | DNM1L CL E G H | 10059 | 2973 | OMIM:614388 | Encephalopathy due to defective mitochondrial and peroxisomal fission 1 | | | | 94 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | DNMT3B CL E G H | 1789 | 2979 | ORPHA:2268 | ICF syndrome | HP:0040282 - Frequent | | | 79 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ECHS1 CL E G H | 1892 | 3151 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 33 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ECHS1 CL E G H | 1892 | 3151 | OMIM:616277 | Mitochondrial short-chain enoyl-coa hydratase 1 deficiency | | | | 33 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | EGR2 CL E G H | 1959 | 3239 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | . | | | 58 | | |
HP:0002921 | HP:0002343 | Normal pressure hydrocephalus | 2 | ERCC6 CL E G H | 2074 | 3438 | OMIM:133540 | Cockayne syndrome, type B | . | | | 199 | | |
HP:0002921 | HP:0025455 | Decreased CSF 5-hydroxyindolacetic acid concentration | 2 | ERCC6 CL E G H | 2074 | 3438 | OMIM:278800 | De Sanctis-Cacchione syndrome | | | | 199 | | |
HP:0002921 | HP:0002343 | Normal pressure hydrocephalus | 2 | ERCC8 CL E G H | 1161 | 3439 | OMIM:216400 | Cockayne syndrome A | . | | | 55 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | FARS2 CL E G H | 10667 | 21062 | OMIM:614946 | Combined oxidative phosphorylation deficiency 14 | | | | 36 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | FBN1 CL E G H | 2200 | 3603 | ORPHA:2462 | Shprintzen-Goldberg syndrome | HP:0040282 - Frequent | | | 1361 | | |
HP:0002921 | HP:0010953 | Noncommunicating hydrocephalus | 2 | FOXJ1 CL E G H | 2302 | 3816 | OMIM:618699 | CILIARY DYSKINESIA, PRIMARY, 43; CILD43 | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:2609 | Isolated complex I deficiency | | | | 61 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 61 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | FTL CL E G H | 2512 | 3999 | ORPHA:157846 | Neuroferritinopathy | HP:0040284 - Very rare | | | 33 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | GALC CL E G H | 2581 | 4115 | ORPHA:206448 | Adult Krabbe disease | HP:0040282 - Frequent | | | 160 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | GALC CL E G H | 2581 | 4115 | ORPHA:206436 | Infantile Krabbe disease | HP:0040281 - Very frequent | | | 160 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | GALC CL E G H | 2581 | 4115 | OMIM:245200 | Krabbe disease | . | | | 160 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | GALC CL E G H | 2581 | 4115 | ORPHA:206443 | Late-infantile/juvenile Krabbe disease | HP:0040281 - Very frequent | | | 160 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | GBE1 CL E G H | 2632 | 4180 | OMIM:263570 | Polyglucosan body neuropathy, adult form | | | | 86 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | GCDH CL E G H | 2639 | 4189 | ORPHA:25 | Glutaryl-CoA dehydrogenase deficiency | HP:0040282 - Frequent | | | 115 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | GCH1 CL E G H | 2643 | 4193 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 86 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | GFAP CL E G H | 2670 | 4235 | OMIM:203450 | Alexander disease | . | | | 188 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | GFM1 CL E G H | 85476 | 13780 | OMIM:609060 | Combined oxidative phosphorylation deficiency 1 | | | | 85 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | GFM2 CL E G H | 84340 | 29682 | ORPHA:565624 | Combined oxidative phosphorylation defect type 39 | | | | 43 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | GFM2 CL E G H | 84340 | 29682 | OMIM:618397 | Combined oxidative phosphorylation deficiency 39 | | | | 43 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | | | | 6 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | HELLS CL E G H | 3070 | 4861 | ORPHA:2268 | ICF syndrome | HP:0040282 - Frequent | | | 6 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | HERC1 CL E G H | 8925 | 4867 | OMIM:617011 | Macrocephaly, dysmorphic facies, and psychomotor retardation | | | | 16 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | HERC1 CL E G H | 8925 | 4867 | ORPHA:457359 | Megalencephaly-severe kyphoscoliosis-overgrowth syndrome | HP:0040283 - Occasional | | | 16 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:123400 | Creutzfeldt-Jakob disease | HP:0040283 - Occasional | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:797 | Sarcoidosis | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | HPDL CL E G H | 84842 | 28242 | OMIM:619026 | NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | HSD17B10 CL E G H | 3028 | 4800 | ORPHA:391428 | HSD10 disease, infantile type | | | | 19 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | HTRA2 CL E G H | 27429 | 14348 | OMIM:617248 | 3-methylglutaconic aciduria, type VIII | | | | 39 | | |
HP:0002921 | HP:0006882 | Severe hydrocephalus | 2 | HYLS1 CL E G H | 219844 | 26558 | OMIM:236680 | Hydrolethalus syndrome 1 | | | | 31 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | IFIH1 CL E G H | 64135 | 18873 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 28 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | IFIH1 CL E G H | 64135 | 18873 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 28 | | |
HP:0002921 | HP:0010953 | Noncommunicating hydrocephalus | 2 | IFNG CL E G H | 3458 | 5438 | ORPHA:805 | Tuberous sclerosis complex | HP:0040283 - Occasional | | | 23 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | IMPDH2 CL E G H | 3615 | 6053 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 1 | | |
HP:0002921 | HP:0040207 | Abnormal CSF biopterin concentration | 2 | KARS1 CL E G H | 3735 | 6215 | OMIM:619147 | LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID | | | | | | |
HP:0002921 | HP:0010953 | Noncommunicating hydrocephalus | 2 | KDM4B CL E G H | 23030 | 29136 | OMIM:619320 | INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65; MRD65 | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | LIG3 CL E G H | 3980 | 6600 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040282 - Frequent | | | 1 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | LIPT1 CL E G H | 51601 | 29569 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 21 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | LMNB1 CL E G H | 4001 | 6637 | ORPHA:99027 | Adult-onset autosomal dominant leukodystrophy | HP:0040284 - Very rare | | | 44 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 8 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 8 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | LRPPRC CL E G H | 10128 | 15714 | ORPHA:70472 | Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | | | | 191 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | LRPPRC CL E G H | 10128 | 15714 | OMIM:220111 | Leigh syndrome, french Canadian type | | | | 191 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | LSM11 CL E G H | 134353 | 30860 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | LSM11 CL E G H | 134353 | 30860 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | LYRM4 CL E G H | 57128 | 21365 | OMIM:615595 | Combined oxidative phosphorylation deficiency 19 | | | | 4 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | LYRM7 CL E G H | 90624 | 28072 | OMIM:615838 | Mitochondrial complex III deficiency, nuclear type 8 | | | | 10 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309282 | Alpha-mannosidosis, infantile form | HP:0040284 - Very rare | | | 136 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | MDH2 CL E G H | 4191 | 6971 | OMIM:617339 | Epileptic encephalopathy, early infantile, 51 | | | | 4 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | MECP2 CL E G H | 4204 | 6990 | ORPHA:778 | Rett syndrome | | | | 950 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | MICU1 CL E G H | 10367 | 1530 | OMIM:615673 | Myopathy with extrapyramidal signs | | | | 14 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | MPDZ CL E G H | 8777 | 7208 | OMIM:615219 | Hydrocephalus, congenital, 2, with or without brain or eye anomalies | . | | | 29 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | | | | 56 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | MPZ CL E G H | 4359 | 7225 | ORPHA:101082 | Charcot-Marie-Tooth disease type 1B | HP:0040282 - Frequent | | | 134 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | MPZ CL E G H | 4359 | 7225 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | . | | | 134 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | MRPS34 CL E G H | 65993 | 16618 | OMIM:617664 | Combined oxidative phosphorylation deficiency 32 | | | | 1 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | MTFMT CL E G H | 123263 | 29666 | OMIM:614947 | Combined oxidative phosphorylation deficiency 15 | | | | 29 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | MTFMT CL E G H | 123263 | 29666 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 29 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NARS2 CL E G H | 79731 | 26274 | OMIM:616239 | Combined oxidative phosphorylation deficiency 24 | | | | 34 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NAXE CL E G H | 128240 | 18453 | OMIM:617186 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | | | | 9 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND1 CL E G H | 4535 | 7455 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND1 CL E G H | 4535 | 7455 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND2 CL E G H | 4536 | 7456 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND2 CL E G H | 4536 | 7456 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND3 CL E G H | 4537 | 7458 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND3 CL E G H | 4537 | 7458 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND4 CL E G H | 4538 | 7459 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND5 CL E G H | 4540 | 7461 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | ND6 CL E G H | 4541 | 7462 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA1 CL E G H | 4694 | 7683 | ORPHA:2609 | Isolated complex I deficiency | | | | 7 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA10 CL E G H | 4705 | 7684 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 91 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA11 CL E G H | 126328 | 20371 | ORPHA:2609 | Isolated complex I deficiency | | | | 32 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA12 CL E G H | 55967 | 23987 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 7 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA12 CL E G H | 55967 | 23987 | OMIM:618244 | Mitochondrial complex I deficiency, nuclear type 23 | | | | 7 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA13 CL E G H | 51079 | 17194 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 3 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA2 CL E G H | 4695 | 7685 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 19 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA4 CL E G H | 4697 | 7687 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 4 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA6 CL E G H | 4700 | 7690 | ORPHA:2609 | Isolated complex I deficiency | | | | 1 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA6 CL E G H | 4700 | 7690 | OMIM:618253 | Mitochondrial complex I deficiency, nuclear type 33 | | | | 1 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA8 CL E G H | 4702 | 7692 | OMIM:619272 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37; MC1DN37 | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFA9 CL E G H | 4704 | 7693 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF1 CL E G H | 51103 | 18828 | ORPHA:2609 | Isolated complex I deficiency | | | | 40 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:2609 | Isolated complex I deficiency | | | | 26 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 26 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:2609 | Isolated complex I deficiency | | | | 31 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 31 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF3 CL E G H | 25915 | 29918 | OMIM:618240 | Mitochondrial complex I deficiency, nuclear type 18 | | | | 31 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF4 CL E G H | 29078 | 21034 | ORPHA:2609 | Isolated complex I deficiency | | | | 50 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:2609 | Isolated complex I deficiency | | | | 34 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 34 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF5 CL E G H | 79133 | 15899 | OMIM:618238 | Mitochondrial complex I deficiency, nuclear type 16 | | | | 34 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 39 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFAF8 CL E G H | 284184 | 33551 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFB10 CL E G H | 4716 | 7696 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2609 | Isolated complex I deficiency | | | | 3 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFB3 CL E G H | 4709 | 7698 | ORPHA:2609 | Isolated complex I deficiency | | | | 9 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFB8 CL E G H | 4714 | 7703 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFB8 CL E G H | 4714 | 7703 | OMIM:618252 | Mitochondrial complex I deficiency, nuclear type 32 | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFB9 CL E G H | 4715 | 7704 | ORPHA:2609 | Isolated complex I deficiency | | | | 16 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:2609 | Isolated complex I deficiency | | | | 81 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 81 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:2609 | Isolated complex I deficiency | | | | 65 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 65 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 65 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:2609 | Isolated complex I deficiency | | | | 22 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 22 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS3 CL E G H | 4722 | 7710 | OMIM:618230 | Mitochondrial complex I deficiency, nuclear type 8 | | | | 22 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:2609 | Isolated complex I deficiency | | | | 27 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | | | | 27 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | | | | 27 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS6 CL E G H | 4726 | 7713 | ORPHA:2609 | Isolated complex I deficiency | | | | 21 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:2609 | Isolated complex I deficiency | | | | 38 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 38 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:2609 | Isolated complex I deficiency | | | | 42 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 42 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:2609 | Isolated complex I deficiency | | | | 74 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 74 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFV1 CL E G H | 4723 | 7716 | OMIM:618225 | Mitochondrial complex I deficiency, nuclear type 4 | | | | 74 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:2609 | Isolated complex I deficiency | | | | 27 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 27 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0025457 | Decreased CSF protein concentration | 2 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | HP:0040282 - Frequent | | | 32 | | |
HP:0002921 | HP:0040207 | Abnormal CSF biopterin concentration | 2 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | | | | 32 | | |
HP:0002921 | HP:0025455 | Decreased CSF 5-hydroxyindolacetic acid concentration | 2 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | HP:0040282 - Frequent | | | 32 | | |
HP:0002921 | HP:0500238 | Abnormal CSF albumin concentration | 2 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | | | | 32 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | | | | 32 | | |
HP:0002921 | HP:0500238 | Abnormal CSF albumin concentration | 2 | NGLY1 CL E G H | 55768 | 17646 | OMIM:615273 | Congenital disorder of deglycosylation | | | | 32 | | |
HP:0002921 | HP:0025455 | Decreased CSF 5-hydroxyindolacetic acid concentration | 2 | NGLY1 CL E G H | 55768 | 17646 | OMIM:615273 | Congenital disorder of deglycosylation | | | | 32 | | |
HP:0002921 | HP:0030978 | Decreased CSF/serum albumin ratio | 2 | NGLY1 CL E G H | 55768 | 17646 | OMIM:615273 | Congenital disorder of deglycosylation | | | | 32 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:603472 | NEURONAL INTRANUCLEAR INCLUSION DISEASE | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:619473 | OCULOPHARYNGODISTAL MYOPATHY 3; OPDM3 | | | | | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | NR4A2 CL E G H | 4929 | 7981 | OMIM:619911 | | | | | 27 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | NR4A2 CL E G H | 4929 | 7981 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 27 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NUBPL CL E G H | 80224 | 20278 | ORPHA:2609 | Isolated complex I deficiency | | | | 89 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | NUBPL CL E G H | 80224 | 20278 | OMIM:618242 | Mitochondrial complex I deficiency, nuclear type 21 | | | | 89 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | . | | | 23 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | P4HB CL E G H | 5034 | 8548 | ORPHA:2050 | Cole-Carpenter syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | P4HB CL E G H | 5034 | 8548 | OMIM:112240 | Cole-Carpenter syndrome 1 | . | | | 2 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 88 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 88 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PDHA1 CL E G H | 5160 | 8806 | OMIM:312170 | Pyruvate dehydrogenase e1-alpha deficiency | | | | 88 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 88 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PDHX CL E G H | 8050 | 21350 | ORPHA:255182 | Pyruvate dehydrogenase E3-binding protein deficiency | | | | 98 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | PDHX CL E G H | 8050 | 21350 | ORPHA:255182 | Pyruvate dehydrogenase E3-binding protein deficiency | | | | 98 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PET100 CL E G H | 100131801 | 40038 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 6 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PET100 CL E G H | 100131801 | 40038 | OMIM:619055 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12 | | | | 6 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PEX7 CL E G H | 5191 | 8860 | OMIM:266500 | Refsum disease | . | | | 72 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PHYH CL E G H | 5264 | 8940 | OMIM:266500 | Refsum disease | . | | | 45 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PMP22 CL E G H | 5376 | 9118 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | . | | | 79 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | PNPO CL E G H | 55163 | 30260 | ORPHA:79096 | Pyridoxal phosphate-responsive seizures | | | | 92 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | PNPO CL E G H | 55163 | 30260 | OMIM:610090 | Pyridoxamine 5-prime-phosphate oxidase deficiency | | | | 92 | | |
HP:0002921 | HP:0040203 | Abnormal CSF neopterin concentration | 2 | PNPT1 CL E G H | 87178 | 23166 | ORPHA:319514 | Combined oxidative phosphorylation defect type 13 | | | | 60 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PNPT1 CL E G H | 87178 | 23166 | ORPHA:319514 | Combined oxidative phosphorylation defect type 13 | | | | 60 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | PNPT1 CL E G H | 87178 | 23166 | OMIM:614932 | Combined oxidative phosphorylation deficiency 13 | | | | 60 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | POLG CL E G H | 5428 | 9179 | OMIM:203700 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | . | | | 464 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | POLG CL E G H | 5428 | 9179 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040282 - Frequent | | | 464 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | POLG CL E G H | 5428 | 9179 | OMIM:258450 | Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive | . | | | 464 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PRF1 CL E G H | 5551 | 9360 | OMIM:603553 | Hemophagocytic lymphohistiocytosis, familial, 2 | | | | 58 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PRNP CL E G H | 5621 | 9449 | OMIM:123400 | Creutzfeldt-Jakob disease | HP:0040283 - Occasional | | | 69 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PRNP CL E G H | 5621 | 9449 | ORPHA:282166 | Inherited Creutzfeldt-Jakob disease | HP:0040283 - Occasional | | | 69 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 94 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 94 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PRX CL E G H | 57716 | 13797 | OMIM:145900 | Hypertrophic neuropathy of dejerine-sottas | . | | | 170 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PSAP CL E G H | 5660 | 9498 | ORPHA:206436 | Infantile Krabbe disease | HP:0040281 - Very frequent | | | 81 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PSAP CL E G H | 5660 | 9498 | OMIM:611722 | KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY | | | | 81 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040282 - Frequent | | | 81 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | HP:0040282 - Frequent | | | 81 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | PSAP CL E G H | 5660 | 9498 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | HP:0040282 - Frequent | | | 81 | | |
HP:0002921 | HP:0500183 | Abnormal CSF carboxylic acid concentration | 2 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | PTEN CL E G H | 5728 | 9588 | ORPHA:2969 | Proteus-like syndrome | HP:0040282 - Frequent | | | 948 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | RANBP2 CL E G H | 5903 | 9848 | OMIM:608033 | Encephalopathy, acute, infection-induced, susceptibility to, 3 | . | | | 57 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | RANBP2 CL E G H | 5903 | 9848 | ORPHA:88619 | Familial acute necrotizing encephalopathy | HP:0040281 - Very frequent | | | 57 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | RARS2 CL E G H | 57038 | 21406 | OMIM:611523 | Pontocerebellar hypoplasia, type 6 | | | | 93 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | RMND1 CL E G H | 55005 | 21176 | OMIM:614922 | Combined oxidative phosphorylation deficiency 11 | | | | 26 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | RNASEH2A CL E G H | 10535 | 18518 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 33 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | RNASEH2A CL E G H | 10535 | 18518 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 33 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | RNASEH2A CL E G H | 10535 | 18518 | OMIM:610333 | Aicardi-Goutieres syndrome 4 | . | | | 33 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | RNASEH2B CL E G H | 79621 | 25671 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 34 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | RNASEH2B CL E G H | 79621 | 25671 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 34 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | RNASEH2B CL E G H | 79621 | 25671 | OMIM:610181 | Aicardi-Goutieres syndrome 2 | | | | 34 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | RNASEH2C CL E G H | 84153 | 24116 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 60 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | RNASEH2C CL E G H | 84153 | 24116 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 60 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | RNASEH2C CL E G H | 84153 | 24116 | OMIM:610329 | Aicardi-Goutieres syndrome 3 | . | | | 60 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | RNU7-1 CL E G H | 100147744 | 34033 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | RNU7-1 CL E G H | 100147744 | 34033 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0002921 | HP:0410073 | Increased level of ribose in CSF | 2 | RPIA CL E G H | 22934 | 10297 | OMIM:608611 | Ribose 5-phosphate isomerase deficiency | | | | 18 | | |
HP:0002921 | HP:0410075 | Increased level of xylitol in CSF | 2 | RPIA CL E G H | 22934 | 10297 | OMIM:608611 | Ribose 5-phosphate isomerase deficiency | | | | 18 | | |
HP:0002921 | HP:0410071 | Increased level of ribitol in CSF | 2 | RPIA CL E G H | 22934 | 10297 | OMIM:608611 | Ribose 5-phosphate isomerase deficiency | | | | 18 | | |
HP:0002921 | HP:0410056 | Decreased CSF erythritol concentration | 2 | RPIA CL E G H | 22934 | 10297 | OMIM:608611 | Ribose 5-phosphate isomerase deficiency | | | | 18 | | |
HP:0002921 | HP:0410058 | Increased level of D-threitol in CSF | 2 | RPIA CL E G H | 22934 | 10297 | OMIM:608611 | Ribose 5-phosphate isomerase deficiency | | | | 18 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | RRM2B CL E G H | 50484 | 17296 | OMIM:612075 | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) | | | | 125 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | RRM2B CL E G H | 50484 | 17296 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040282 - Frequent | | | 125 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | SAMHD1 CL E G H | 25939 | 15925 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 55 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | SAMHD1 CL E G H | 25939 | 15925 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 55 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | SAMHD1 CL E G H | 25939 | 15925 | OMIM:612952 | Aicardi-Goutieres syndrome 5 | HP:0040283 - Occasional | | | 55 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 1053 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 1053 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SCO2 CL E G H | 9997 | 10604 | OMIM:604377 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | | | | 40 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SCO2 CL E G H | 9997 | 10604 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 40 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SDHA CL E G H | 6389 | 10680 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 304 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | SEC24D CL E G H | 9871 | 10706 | ORPHA:2050 | Cole-Carpenter syndrome | HP:0040282 - Frequent | | | 5 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | SKI CL E G H | 6497 | 10896 | ORPHA:2462 | Shprintzen-Goldberg syndrome | HP:0040282 - Frequent | | | 150 | | |
HP:0002921 | HP:0500238 | Abnormal CSF albumin concentration | 2 | SLC12A2 CL E G H | 6558 | 10911 | OMIM:619080 | KILQUIST SYNDROME; KILQS | | | | 2 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | SLC12A6 CL E G H | 9990 | 10914 | OMIM:218000 | Agenesis of the corpus callosum with peripheral neuropathy | . | | | 163 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | | | | 2 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SLC19A3 CL E G H | 80704 | 16266 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 110 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SLC25A19 CL E G H | 60386 | 14409 | OMIM:613710 | Thiamine metabolism dysfunction syndrome 4 (bilateral striatal degenerationand progressive polyneuropathy type) | | | | 36 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SLC25A4 CL E G H | 291 | 10990 | OMIM:615418 | Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type) | | | | 68 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SLC25A4 CL E G H | 291 | 10990 | OMIM:617184 | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | | | | 68 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:71277 | Classic glucose transporter type 1 deficiency syndrome | | | | 255 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:606777 | Glut1 deficiency syndrome 1 | | | | 255 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:612126 | Glut1 deficiency syndrome 2 | | | | 255 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:612126 | Glut1 deficiency syndrome 2 | | | | 255 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:168577 | Hereditary cryohydrocytosis with reduced stomatin | HP:0040283 - Occasional | | | 255 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:168577 | Hereditary cryohydrocytosis with reduced stomatin | | | | 255 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:608885 | Stomatin-Deficient cryohydrocytosis with neurologic defects | | | | 255 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SLC39A8 CL E G H | 64116 | 20862 | ORPHA:468699 | SLC39A8-CDG | | | | 11 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | SLC6A3 CL E G H | 6531 | 11049 | OMIM:613135 | Parkinsonism-Dystonia, infantile, 1 | | | | 13 | | |
HP:0002921 | HP:0012446 | Decreased CSF 5-methyltetrahydrofolate concentration | 2 | SPTBN1 CL E G H | 6711 | 11275 | OMIM:619475 | DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA | | | | | | |
HP:0002921 | HP:0040203 | Abnormal CSF neopterin concentration | 2 | STAT2 CL E G H | 6773 | 11363 | OMIM:616636 | Immunodeficiency 44 | | | | 9 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SUCLG1 CL E G H | 8802 | 11449 | ORPHA:17 | Fatal infantile lactic acidosis with methylmalonic aciduria | | | | 60 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SUCLG1 CL E G H | 8802 | 11449 | OMIM:245400 | Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria) | | | | 60 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | SUMF1 CL E G H | 285362 | 20376 | OMIM:272200 | Multiple sulfatase deficiency | . | | | 80 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SURF1 CL E G H | 6834 | 11474 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 73 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SURF1 CL E G H | 6834 | 11474 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 73 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | SURF1 CL E G H | 6834 | 11474 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | 73 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TACO1 CL E G H | 51204 | 24316 | ORPHA:255241 | Leigh syndrome with leukodystrophy | | | | 23 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 20 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 20 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 20 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | TH CL E G H | 7054 | 11782 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | | | | 80 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | TH CL E G H | 7054 | 11782 | OMIM:605407 | Segawa syndrome, autosomal recessive | | | | 80 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 6 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 6 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 6 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TIMM50 CL E G H | 92609 | 23656 | OMIM:617698 | 3-methylglutaconic aciduria, type IX | | | | 1 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TIMMDC1 CL E G H | 51300 | 1321 | ORPHA:2609 | Isolated complex I deficiency | | | | 1 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 3 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 3 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 3 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TMEM126B CL E G H | 55863 | 30883 | ORPHA:2609 | Isolated complex I deficiency | | | | 4 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TPK1 CL E G H | 27010 | 17358 | OMIM:614458 | Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type) | | | | 21 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 2 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 2 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 2 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRAPPC12 CL E G H | 51112 | 24284 | ORPHA:500144 | Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome | | | | 2 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | TREX1 CL E G H | 11277 | 12269 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 56 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | TREX1 CL E G H | 11277 | 12269 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 56 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0002921 | HP:0009709 | Increased CSF interferon alpha | 2 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | TRIM71 CL E G H | 131405 | 32669 | OMIM:618667 | HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1; HYDCC1 | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRMT10C CL E G H | 54931 | 26022 | OMIM:616974 | Combined oxidative phosphorylation deficiency 30 | | | | 3 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNK CL E G H | 4566 | 7489 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNN CL E G H | 4570 | 7493 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNS1 CL E G H | 4574 | 7497 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | TRNT1 CL E G H | 51095 | 17341 | OMIM:616084 | SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD | | | | 28 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNV CL E G H | 4577 | 7500 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | | | | | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TRNW CL E G H | 4578 | 7501 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | | | | | | |
HP:0002921 | HP:0010953 | Noncommunicating hydrocephalus | 2 | TSC1 CL E G H | 7248 | 12362 | ORPHA:805 | Tuberous sclerosis complex | HP:0040283 - Occasional | | | 1090 | | |
HP:0002921 | HP:0010953 | Noncommunicating hydrocephalus | 2 | TSC2 CL E G H | 7249 | 12363 | ORPHA:805 | Tuberous sclerosis complex | HP:0040283 - Occasional | | | 2738 | | |
HP:0002921 | HP:0034200 | Abnormal CSF homovanillic acid concentration | 2 | TSPOAP1 CL E G H | 9256 | 16831 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | | | | 2 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TTR CL E G H | 7276 | 12405 | OMIM:105210 | Amyloidosis, hereditary, transthyretin-related | . | | | 107 | | |
HP:0002921 | HP:0002343 | Normal pressure hydrocephalus | 2 | TUBB3 CL E G H | 10381 | 20772 | ORPHA:300570 | Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation | HP:0040283 - Occasional | | | 64 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TXN2 CL E G H | 25828 | 17772 | ORPHA:478029 | Combined oxidative phosphorylation defect type 29 | | | | 1 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TXN2 CL E G H | 25828 | 17772 | ORPHA:478029 | Combined oxidative phosphorylation defect type 29 | HP:0040281 - Very frequent | | | 1 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | TXN2 CL E G H | 25828 | 17772 | OMIM:616811 | Combined oxidative phosphorylation deficiency 29 | | | | 1 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TXN2 CL E G H | 25828 | 17772 | OMIM:616811 | Combined oxidative phosphorylation deficiency 29 | | | | 1 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | TYMP CL E G H | 1890 | 3148 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040282 - Frequent | | | 138 | | |
HP:0002921 | HP:0002922 | Increased CSF protein concentration | 2 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 5 | | |
HP:0002921 | HP:0200149 | CSF lymphocytic pleiocytosis | 2 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 5 | | |
HP:0002921 | HP:0031884 | Abnormal CSF glucose concentration | 2 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | | | | 5 | | |
HP:0002921 | HP:0030085 | Abnormal CSF lactate concentration | 2 | UQCC2 CL E G H | 84300 | 21237 | OMIM:615824 | Mitochondrial complex III deficiency, nuclear type 7 | | | | 7 | | |
HP:0002921 | HP:0001334 | Communicating hydrocephalus | 2 | ZBTB24 CL E G H | 9841 | 21143 | ORPHA:2268 | ICF syndrome | HP:0040282 - Frequent | | | 9 | | |
HP:0002921 | HP:0025686 | Abnormal amyloid beta 40 peptide CSF concentration | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0410199 | Increased CSF urate concentration | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0030862 | Elevated CSF amyloid concentration | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0012655 | Elevated CSF dopamine concentration | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0040208 | Elevated CSF biopterin level | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0030861 | Decreased CSF amyloid concentration | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0040205 | Decreased CSF neopterin level | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0025683 | Abnormal amyloid beta 42 peptide CSF concentration | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0030086 | Reduced CSF lactate | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0031885 | Hyperglycorrhachia | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0012656 | Reduced CSF dopamine concentration | 3 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | | | | 15 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | ADAR CL E G H | 103 | 225 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 116 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | | | | 26 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | AIFM1 CL E G H | 9131 | 8768 | OMIM:300816 | Combined oxidative phosphorylation deficiency 6 | . | | | 60 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | AIFM1 CL E G H | 9131 | 8768 | ORPHA:238329 | Severe X-linked mitochondrial encephalomyopathy | HP:0040282 - Frequent | | | 60 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ALDH4A1 CL E G H | 8659 | 406 | ORPHA:79101 | Hyperprolinemia type 2 | HP:0040283 - Occasional | | | 74 | | |
HP:0002921 | HP:0032532 | Elevated CSF 4-hydroxybutyric acid concentration | 3 | ALDH5A1 CL E G H | 7915 | 408 | OMIM:271980 | Succinic semialdehyde dehydrogenase deficiency | . | | | 108 | | |
HP:0002921 | HP:0032531 | Elevated CSF gamma-aminobutyric acid concentration | 3 | ALDH5A1 CL E G H | 7915 | 408 | OMIM:271980 | Succinic semialdehyde dehydrogenase deficiency | . | | | 108 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ATP6 CL E G H | 4508 | 7414 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ATPAF2 CL E G H | 91647 | 18802 | OMIM:604273 | Mitochondrial complex V (atp synthase) deficiency, nuclear type 1 | | | | 32 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | | | | 14 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | CLPB CL E G H | 81570 | 30664 | OMIM:616271 | 3-Methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia | | | | 38 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COQ8A CL E G H | 56997 | 16812 | ORPHA:139485 | Autosomal recessive ataxia due to ubiquinone deficiency | HP:0040283 - Occasional | | | 136 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX10 CL E G H | 1352 | 2260 | OMIM:619046 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN3 | | | | 82 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX14 CL E G H | 84987 | 28216 | OMIM:619053 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10; MC4DN10 | | | | 4 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX15 CL E G H | 1355 | 2263 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 104 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX20 CL E G H | 116228 | 26970 | OMIM:619054 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11; MC4DN11 | | | | 25 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX4I1 CL E G H | 1327 | 2265 | OMIM:619060 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16 | | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX6B1 CL E G H | 1340 | 2280 | OMIM:619051 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7 | | | | 10 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | COX8A CL E G H | 1351 | 2294 | OMIM:619059 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15 | | | | 1 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | DARS2 CL E G H | 55157 | 25538 | ORPHA:137898 | Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome | HP:0040283 - Occasional | | | 60 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | DDC CL E G H | 1644 | 2719 | OMIM:608643 | Aromatic L-amino acid decarboxylase deficiency | | | | 43 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | DLAT CL E G H | 1737 | 2896 | ORPHA:79244 | Pyruvate dehydrogenase E2 deficiency | | | | 82 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | DNM1L CL E G H | 10059 | 2973 | OMIM:614388 | Encephalopathy due to defective mitochondrial and peroxisomal fission 1 | | | | 94 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ECHS1 CL E G H | 1892 | 3151 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 33 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ECHS1 CL E G H | 1892 | 3151 | OMIM:616277 | Mitochondrial short-chain enoyl-coa hydratase 1 deficiency | . | | | 33 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | FARS2 CL E G H | 10667 | 21062 | OMIM:614946 | Combined oxidative phosphorylation deficiency 14 | | | | 36 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 61 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 61 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | GCH1 CL E G H | 2643 | 4193 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | HP:0040282 - Frequent | | | 86 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | GFM1 CL E G H | 85476 | 13780 | OMIM:609060 | Combined oxidative phosphorylation deficiency 1 | . | | | 85 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | GFM2 CL E G H | 84340 | 29682 | ORPHA:565624 | Combined oxidative phosphorylation defect type 39 | HP:0040282 - Frequent | | | 43 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | GFM2 CL E G H | 84340 | 29682 | OMIM:618397 | Combined oxidative phosphorylation deficiency 39 | . | | | 43 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | | | | 6 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | HPDL CL E G H | 84842 | 28242 | OMIM:619026 | NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA | | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | HSD17B10 CL E G H | 3028 | 4800 | ORPHA:391428 | HSD10 disease, infantile type | HP:0040281 - Very frequent | | | 19 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | HTRA2 CL E G H | 27429 | 14348 | OMIM:617248 | 3-methylglutaconic aciduria, type VIII | . | | | 39 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | IFIH1 CL E G H | 64135 | 18873 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 28 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | IMPDH2 CL E G H | 3615 | 6053 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | HP:0040282 - Frequent | | | 1 | | |
HP:0002921 | HP:0040209 | Decreased CSF biopterin level | 3 | KARS1 CL E G H | 3735 | 6215 | OMIM:619147 | LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID | | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | LIPT1 CL E G H | 51601 | 29569 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 21 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | HP:0040281 - Very frequent | | | 8 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 8 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | LRPPRC CL E G H | 10128 | 15714 | ORPHA:70472 | Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | HP:0040281 - Very frequent | | | 191 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | LRPPRC CL E G H | 10128 | 15714 | OMIM:220111 | Leigh syndrome, french Canadian type | . | | | 191 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | LSM11 CL E G H | 134353 | 30860 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | LYRM4 CL E G H | 57128 | 21365 | OMIM:615595 | Combined oxidative phosphorylation deficiency 19 | | | | 4 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | LYRM7 CL E G H | 90624 | 28072 | OMIM:615838 | Mitochondrial complex III deficiency, nuclear type 8 | | | | 10 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | MDH2 CL E G H | 4191 | 6971 | OMIM:617339 | Epileptic encephalopathy, early infantile, 51 | . | | | 4 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | MECP2 CL E G H | 4204 | 6990 | ORPHA:778 | Rett syndrome | HP:0040283 - Occasional | | | 950 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | HP:0040284 - Very rare | | | 56 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | MRPS34 CL E G H | 65993 | 16618 | OMIM:617664 | Combined oxidative phosphorylation deficiency 32 | . | | | 1 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | MTFMT CL E G H | 123263 | 29666 | OMIM:614947 | Combined oxidative phosphorylation deficiency 15 | . | | | 29 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | MTFMT CL E G H | 123263 | 29666 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 29 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NARS2 CL E G H | 79731 | 26274 | OMIM:616239 | Combined oxidative phosphorylation deficiency 24 | . | | | 34 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NAXE CL E G H | 128240 | 18453 | OMIM:617186 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | . | | | 9 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND1 CL E G H | 4535 | 7455 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND1 CL E G H | 4535 | 7455 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND2 CL E G H | 4536 | 7456 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND2 CL E G H | 4536 | 7456 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND3 CL E G H | 4537 | 7458 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND3 CL E G H | 4537 | 7458 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND4 CL E G H | 4538 | 7459 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND5 CL E G H | 4540 | 7461 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | ND6 CL E G H | 4541 | 7462 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA1 CL E G H | 4694 | 7683 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 7 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA10 CL E G H | 4705 | 7684 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 91 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA11 CL E G H | 126328 | 20371 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 32 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA12 CL E G H | 55967 | 23987 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 7 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA12 CL E G H | 55967 | 23987 | OMIM:618244 | Mitochondrial complex I deficiency, nuclear type 23 | | | | 7 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA13 CL E G H | 51079 | 17194 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 3 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA2 CL E G H | 4695 | 7685 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 19 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA4 CL E G H | 4697 | 7687 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 4 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA6 CL E G H | 4700 | 7690 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 1 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA6 CL E G H | 4700 | 7690 | OMIM:618253 | Mitochondrial complex I deficiency, nuclear type 33 | | | | 1 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA8 CL E G H | 4702 | 7692 | OMIM:619272 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37; MC1DN37 | | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFA9 CL E G H | 4704 | 7693 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 27 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF1 CL E G H | 51103 | 18828 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 40 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 26 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 26 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 31 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF3 CL E G H | 25915 | 29918 | OMIM:618240 | Mitochondrial complex I deficiency, nuclear type 18 | | | | 31 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF4 CL E G H | 29078 | 21034 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 50 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 34 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 34 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF5 CL E G H | 79133 | 15899 | OMIM:618238 | Mitochondrial complex I deficiency, nuclear type 16 | | | | 34 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 39 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFAF8 CL E G H | 284184 | 33551 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFB10 CL E G H | 4716 | 7696 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 3 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFB3 CL E G H | 4709 | 7698 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 9 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFB8 CL E G H | 4714 | 7703 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFB8 CL E G H | 4714 | 7703 | OMIM:618252 | Mitochondrial complex I deficiency, nuclear type 32 | . | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFB9 CL E G H | 4715 | 7704 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 16 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 81 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 81 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 65 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 65 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 65 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 22 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 22 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS3 CL E G H | 4722 | 7710 | OMIM:618230 | Mitochondrial complex I deficiency, nuclear type 8 | | | | 22 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 27 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 27 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | | | | 27 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS6 CL E G H | 4726 | 7713 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 21 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 38 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 38 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 42 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 42 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 74 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 74 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFV1 CL E G H | 4723 | 7716 | OMIM:618225 | Mitochondrial complex I deficiency, nuclear type 4 | | | | 74 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 27 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 27 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0025458 | Decreased CSF albumin concentration | 3 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | HP:0040282 - Frequent | | | 32 | | |
HP:0002921 | HP:0040209 | Decreased CSF biopterin level | 3 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | HP:0040282 - Frequent | | | 32 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | HP:0040282 - Frequent | | | 32 | | |
HP:0002921 | HP:0025458 | Decreased CSF albumin concentration | 3 | NGLY1 CL E G H | 55768 | 17646 | OMIM:615273 | Congenital disorder of deglycosylation | | | | 32 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | NR4A2 CL E G H | 4929 | 7981 | OMIM:619911 | | | | | 27 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | NR4A2 CL E G H | 4929 | 7981 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | HP:0040282 - Frequent | | | 27 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NUBPL CL E G H | 80224 | 20278 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 89 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | NUBPL CL E G H | 80224 | 20278 | OMIM:618242 | Mitochondrial complex I deficiency, nuclear type 21 | | | | 89 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 88 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 88 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PDHA1 CL E G H | 5160 | 8806 | OMIM:312170 | Pyruvate dehydrogenase e1-alpha deficiency | . | | | 88 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | HP:0040281 - Very frequent | | | 88 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PDHX CL E G H | 8050 | 21350 | ORPHA:255182 | Pyruvate dehydrogenase E3-binding protein deficiency | HP:0040281 - Very frequent | | | 98 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | PDHX CL E G H | 8050 | 21350 | ORPHA:255182 | Pyruvate dehydrogenase E3-binding protein deficiency | | | | 98 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PET100 CL E G H | 100131801 | 40038 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 6 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PET100 CL E G H | 100131801 | 40038 | OMIM:619055 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12 | | | | 6 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | PNPO CL E G H | 55163 | 30260 | ORPHA:79096 | Pyridoxal phosphate-responsive seizures | HP:0040282 - Frequent | | | 92 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | PNPO CL E G H | 55163 | 30260 | OMIM:610090 | Pyridoxamine 5-prime-phosphate oxidase deficiency | . | | | 92 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PNPT1 CL E G H | 87178 | 23166 | ORPHA:319514 | Combined oxidative phosphorylation defect type 13 | HP:0040282 - Frequent | | | 60 | | |
HP:0002921 | HP:0040204 | Elevated CSF neopterin level | 3 | PNPT1 CL E G H | 87178 | 23166 | ORPHA:319514 | Combined oxidative phosphorylation defect type 13 | HP:0040283 - Occasional | | | 60 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | PNPT1 CL E G H | 87178 | 23166 | OMIM:614932 | Combined oxidative phosphorylation deficiency 13 | | | | 60 | | |
HP:0002921 | HP:0500184 | Abnormal CSF amino acid concentration | 3 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | RARS2 CL E G H | 57038 | 21406 | OMIM:611523 | Pontocerebellar hypoplasia, type 6 | . | | | 93 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | RMND1 CL E G H | 55005 | 21176 | OMIM:614922 | Combined oxidative phosphorylation deficiency 11 | . | | | 26 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | RNASEH2A CL E G H | 10535 | 18518 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 33 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | RNASEH2B CL E G H | 79621 | 25671 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 34 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | RNASEH2B CL E G H | 79621 | 25671 | OMIM:610181 | Aicardi-Goutieres syndrome 2 | | | | 34 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | RNASEH2C CL E G H | 84153 | 24116 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 60 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | RNU7-1 CL E G H | 100147744 | 34033 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | RRM2B CL E G H | 50484 | 17296 | OMIM:612075 | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) | | | | 125 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | SAMHD1 CL E G H | 25939 | 15925 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 55 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SCO2 CL E G H | 9997 | 10604 | OMIM:604377 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | . | | | 40 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SCO2 CL E G H | 9997 | 10604 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 40 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SDHA CL E G H | 6389 | 10680 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 304 | | |
HP:0002921 | HP:0500239 | Increased CSF albumin concentration | 3 | SLC12A2 CL E G H | 6558 | 10911 | OMIM:619080 | KILQUIST SYNDROME; KILQS | | | | 2 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | . | | | 2 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SLC19A3 CL E G H | 80704 | 16266 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 110 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SLC25A19 CL E G H | 60386 | 14409 | OMIM:613710 | Thiamine metabolism dysfunction syndrome 4 (bilateral striatal degenerationand progressive polyneuropathy type) | . | | | 36 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SLC25A4 CL E G H | 291 | 10990 | OMIM:615418 | Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type) | | | | 68 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SLC25A4 CL E G H | 291 | 10990 | OMIM:617184 | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | | | | 68 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:71277 | Classic glucose transporter type 1 deficiency syndrome | HP:0040281 - Very frequent | | | 255 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:606777 | Glut1 deficiency syndrome 1 | . | | | 255 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:612126 | Glut1 deficiency syndrome 2 | . | | | 255 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:612126 | Glut1 deficiency syndrome 2 | | | | 255 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:168577 | Hereditary cryohydrocytosis with reduced stomatin | HP:0040282 - Frequent | | | 255 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:608885 | Stomatin-Deficient cryohydrocytosis with neurologic defects | . | | | 255 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SLC39A8 CL E G H | 64116 | 20862 | ORPHA:468699 | SLC39A8-CDG | HP:0040283 - Occasional | | | 11 | | |
HP:0002921 | HP:0034201 | Increased CSF homovanillic acid concentration | 3 | SLC6A3 CL E G H | 6531 | 11049 | OMIM:613135 | Parkinsonism-Dystonia, infantile, 1 | | | | 13 | | |
HP:0002921 | HP:0040204 | Elevated CSF neopterin level | 3 | STAT2 CL E G H | 6773 | 11363 | OMIM:616636 | Immunodeficiency 44 | | | | 9 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SUCLG1 CL E G H | 8802 | 11449 | ORPHA:17 | Fatal infantile lactic acidosis with methylmalonic aciduria | HP:0040282 - Frequent | | | 60 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SUCLG1 CL E G H | 8802 | 11449 | OMIM:245400 | Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria) | | | | 60 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SURF1 CL E G H | 6834 | 11474 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 73 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SURF1 CL E G H | 6834 | 11474 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 73 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | SURF1 CL E G H | 6834 | 11474 | OMIM:220110 | Mitochondrial complex IV deficiency | . | | | 73 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TACO1 CL E G H | 51204 | 24316 | ORPHA:255241 | Leigh syndrome with leukodystrophy | HP:0040282 - Frequent | | | 23 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 20 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | TH CL E G H | 7054 | 11782 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | HP:0040282 - Frequent | | | 80 | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | TH CL E G H | 7054 | 11782 | OMIM:605407 | Segawa syndrome, autosomal recessive | . | | | 80 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 6 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TIMM50 CL E G H | 92609 | 23656 | OMIM:617698 | 3-methylglutaconic aciduria, type IX | | | | 1 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TIMMDC1 CL E G H | 51300 | 1321 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 1 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 3 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TMEM126B CL E G H | 55863 | 30883 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 4 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TPK1 CL E G H | 27010 | 17358 | OMIM:614458 | Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type) | | | | 21 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRAPPC12 CL E G H | 51112 | 24284 | ORPHA:500144 | Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | TREX1 CL E G H | 11277 | 12269 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040282 - Frequent | | | 56 | | |
HP:0002921 | HP:0009704 | Chronic CSF lymphocytosis | 3 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRMT10C CL E G H | 54931 | 26022 | OMIM:616974 | Combined oxidative phosphorylation deficiency 30 | . | | | 3 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNK CL E G H | 4566 | 7489 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNN CL E G H | 4570 | 7493 | OMIM:220110 | Mitochondrial complex IV deficiency | . | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNS1 CL E G H | 4574 | 7497 | OMIM:220110 | Mitochondrial complex IV deficiency | . | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNV CL E G H | 4577 | 7500 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TRNW CL E G H | 4578 | 7501 | ORPHA:255210 | Mitochondrial DNA-associated Leigh syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002921 | HP:0003785 | Decreased CSF homovanillic acid concentration | 3 | TSPOAP1 CL E G H | 9256 | 16831 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | HP:0040282 - Frequent | | | 2 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TXN2 CL E G H | 25828 | 17772 | ORPHA:478029 | Combined oxidative phosphorylation defect type 29 | HP:0040281 - Very frequent | | | 1 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | TXN2 CL E G H | 25828 | 17772 | OMIM:616811 | Combined oxidative phosphorylation deficiency 29 | | | | 1 | | |
HP:0002921 | HP:0011972 | Hypoglycorrhachia | 3 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 5 | | |
HP:0002921 | HP:0002490 | Increased CSF lactate | 3 | UQCC2 CL E G H | 84300 | 21237 | OMIM:615824 | Mitochondrial complex III deficiency, nuclear type 7 | | | | 7 | | |
HP:0002921 | HP:0500240 | Abnormal CSF carnosine concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500247 | Abnormal CSF alpha-aminobutyrate concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0025685 | Increased amyloid beta 42 peptide CSF concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0025684 | Decreased amyloid beta 42 peptide CSF concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500245 | Abnormal CSF citrulline concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500235 | Abnormal CSF histidine concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500214 | Abnormal CSF aromatic amino acid concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0025687 | Increased amyloid beta 40 peptide CSF concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500241 | Abnormal CSF homocarnosine concentration | 4 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500195 | Abnormal CSF glutamine family amino acid concentration | 4 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | | | | 15 | | |
HP:0002921 | HP:0500243 | Abnormal CSF ornithine concentration | 4 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | HP:0040282 - Frequent | | | 15 | | |
HP:0002921 | HP:0500205 | Abnormal CSF aspartate family amino acid concentration | 4 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | | | | 15 | | |
HP:0002921 | HP:0500205 | Abnormal CSF aspartate family amino acid concentration | 4 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | | | | 26 | | |
HP:0002921 | HP:0500225 | Abnormal CSF serine family amino acid concentration | 4 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | | | | 14 | | |
HP:0002921 | HP:0500231 | Abnormal CSF pyruvate family amino acid concentration | 4 | DLAT CL E G H | 1737 | 2896 | ORPHA:79244 | Pyruvate dehydrogenase E2 deficiency | HP:0040281 - Very frequent | | | 82 | | |
HP:0002921 | HP:0500185 | Abnormal CSF branched chain amino acid concentration | 4 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0500195 | Abnormal CSF glutamine family amino acid concentration | 4 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0002921 | HP:0500225 | Abnormal CSF serine family amino acid concentration | 4 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | | | | 6 | | |
HP:0002921 | HP:0500231 | Abnormal CSF pyruvate family amino acid concentration | 4 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | HP:0040281 - Very frequent | | | 8 | | |
HP:0002921 | HP:0500231 | Abnormal CSF pyruvate family amino acid concentration | 4 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0500225 | Abnormal CSF serine family amino acid concentration | 4 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0500231 | Abnormal CSF pyruvate family amino acid concentration | 4 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | HP:0040281 - Very frequent | | | 88 | | |
HP:0002921 | HP:0500231 | Abnormal CSF pyruvate family amino acid concentration | 4 | PDHX CL E G H | 8050 | 21350 | ORPHA:255182 | Pyruvate dehydrogenase E3-binding protein deficiency | HP:0040281 - Very frequent | | | 98 | | |
HP:0002921 | HP:0500231 | Abnormal CSF pyruvate family amino acid concentration | 4 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0500225 | Abnormal CSF serine family amino acid concentration | 4 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |
HP:0002921 | HP:0500211 | Abnormal CSF threonine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500237 | Decreased CSF histidine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500216 | Abnormal CSF aspartate concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500246 | Increased CSF citrulline concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500236 | Increased CSF histidine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500215 | Abnormal CSF phenylalanine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500244 | Increased CSF ornithine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500242 | Increased CSF homocarnosine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500219 | Abnormal CSF tyrosine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500199 | Abnormal CSF glutamate concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500218 | Abnormal CSF tryptophan concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500248 | Increased CSF alpha-aminobutyrate concentration | 5 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500206 | Abnormal CSF lysine concentration | 5 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | | | | 15 | | |
HP:0002921 | HP:0500202 | Abnormal CSF arginine concentration | 5 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | | | | 15 | | |
HP:0002921 | HP:0500209 | Abnormal CSF methionine concentration | 5 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | | | | 26 | | |
HP:0002921 | HP:0500229 | Abnormal CSF glycine concentration | 5 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | | | | 14 | | |
HP:0002921 | HP:0500186 | Abnormal CSF valine concentration | 5 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0500189 | Abnormal CSF leucine concentration | 5 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0500192 | Abnormal CSF isoleucine concentration | 5 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0500196 | Abnormal CSF glutamine concentration | 5 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0002921 | HP:0500229 | Abnormal CSF glycine concentration | 5 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | | | | 6 | | |
HP:0002921 | HP:0500232 | Abnormal CSF alanine concentration | 5 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0500229 | Abnormal CSF glycine concentration | 5 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0500232 | Abnormal CSF alanine concentration | 5 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0500226 | Abnormal CSF serine concentration | 5 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |
HP:0002921 | HP:0500229 | Abnormal CSF glycine concentration | 5 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |
HP:0002921 | HP:0500224 | Decreased CSF phenylalanine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500217 | Increased CSF aspartate concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500194 | Decreased CSF isoleucine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500223 | Increased CSF phenylalanine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500207 | Decreased CSF lysine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500190 | Decreased CSF leucine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500222 | Increased CSF tryptophan concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500203 | Increased CSF arginine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500188 | Decreased CSF valine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500221 | Decreased CSF tyrosine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500201 | Decreased CSF glutamate concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500220 | Increased CSF tyrosine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500200 | Increased CSF glutamate concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500234 | Decreased CSF alanine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500213 | Decreased CSF threonine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500227 | Increased CSF serine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500212 | Increased CSF threonine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500197 | Increased CSF glutamine concentration | 6 | CL E G H | | | | | | | | | | |
HP:0002921 | HP:0500204 | Decreased CSF arginine concentration | 6 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | HP:0040282 - Frequent | | | 15 | | |
HP:0002921 | HP:0500208 | Increased CSF lysine concentration | 6 | AASS CL E G H | 10157 | 17366 | ORPHA:2203 | Hyperlysinemia | HP:0040282 - Frequent | | | 15 | | |
HP:0002921 | HP:0500210 | Increased CSF methionine concentration | 6 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | | | | 26 | | |
HP:0002921 | HP:0500230 | Increased CSF glycine concentration | 6 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | | | | 14 | | |
HP:0002921 | HP:0500187 | Increased CSF valine concentration | 6 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0500191 | Increased CSF leucine concentration | 6 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0500193 | Increased CSF isoleucine concentration | 6 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0002921 | HP:0500198 | Decreased CSF glutamine concentration | 6 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0002921 | HP:0500230 | Increased CSF glycine concentration | 6 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | HP:0040282 - Frequent | | | 6 | | |
HP:0002921 | HP:0500233 | Increased CSF alanine concentration | 6 | NDUFA4 CL E G H | 4697 | 7687 | OMIM:619065 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21 | | | | 4 | | |
HP:0002921 | HP:0500230 | Increased CSF glycine concentration | 6 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0002921 | HP:0500233 | Increased CSF alanine concentration | 6 | PET117 CL E G H | 100303755 | 40045 | OMIM:619063 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19 | | | | | | |
HP:0002921 | HP:0500228 | Decreased CSF serine concentration | 6 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |
HP:0002921 | HP:0034390 | Decreased CSF glycine concentration | 6 | PSAT1 CL E G H | 29968 | 19129 | OMIM:610992 | Phosphoserine aminotransferase deficiency | | | | 27 | | |